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Summary 
 
NSP1, a non-structural protein encoded by rotavirus gene segment 5, has been 
suggested as a virulence determinant for rotavirus and to function as an antagonist of 
the interferon signalling pathway. Although non-essential for rotavirus replication in 
cell culture, and is the least conserved in all rotavirus proteins, NSP1 from different 
rotavirus strains of different species has been demonstrated to interact with several 
cellular proteins involved in the IFNβ induction pathway. NSP1 from a bovine 
rotavirus strain (UKtc) has been shown to interact with and to degrade IRF3 in a 
proteasome dependent manner whereas NSP1 from a porcine rotavirus strain (OSU) 
fails to target IRF3 but is able to interfere with IFNβ production via similar targeting 
of β-TrCP.  
 
The research presented in this thesis sought to gain a better understanding of the 
molecular determinants of NSP1 specificity for targeting the IFNβ pathway by 
mapping the regions in NSP1 sequences responsible for targeting specific cellular 
proteins. 
 
NSP1 hybrid constructs with sequences from both UKtcNSP1 and OSUNSP1 were 
generated and their interactions with both IRF3 and β-TrCP were tested in a series of 
assays. The initial attempts to map interaction sites using the mammalian two-hybrid 
assay were not successful. No reporter plasmid signal was generated indicating the 
expected interaction. The failure of this assay might be due to the insufficient 
expression of the NSP1 proteins as subsequent modification of the expression vector 
was shown to improve the expression level of NSP1 proteins in subsequent reporter 
assay analysis.  
 
Using IFNβ promoter reporter assays to demonstrate the functional consequence of 
NSP1 action in IRF3, it was found that the constructs containing the entire C-
terminal part of UKtcNSP1 were able to reduce IRF3-induced IFNβ promoter 
activity. Such constructs also caused IRF3 degradation in a proteasome dependent 
manner in agreement with previous studies. However, the sequence containing the 
last 135 amino acids from UKtcNSP1 was not sufficient for these activities. 
Collectively, these data suggested that the sequence between amino acid position 165 
and 135 from the C-terminus are required for this interaction and subsequent 
degradation of IRF3.  
 
Similar experiments focused on determining the interaction site for β-TrCP on NSP1 
were more difficult to interpret according the data presented. Unexpectedly in the 
light of published data, not only OSUNSP1 was able to degrade β-TrCP but 
UKtcNSP1 appeared to have the similar effect, as well as two reciprocal pairs of 
NSP1 hybrid constructs.  
 
In summary, it appears that sequences from the C-terminal part of UKtcNSP1 can 
function in a heterogeneous NSP1 context to target IRF3 from human cells. Further 
analysis is clearly required to fulfil the understanding of the role of NSP1 in rotavirus 
pathogenesis, including its interaction with β-TrCP.             
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1.1 Rotavirus 
 
1.1.1 The discovery of rotavirus 
 
Acute diarrheal diseases have been one of the major causes of death in children, and 
the young in a wide range of other mammalian and avian species worldwide. 
Diarrheal disease is one of the most important causes of death in children, 
particularly in those less than five years old in developing countries; in developed 
countries, the mortality rate is considerably lower however, it still represents a 
common infirmity, especially among the youth (Monto et al., 1983; Estes and 
Kapikian, 2007; Martella et al., 2010).  
  
Until the early 1970s, no important causative viral factors related to infectious 
diarrheal diseases had been discovered (Yow et al, 1970). The discovery of the 
Norwalk virus associated with viral gastroenteritis in older children and adults was a 
big breakthrough, revealing the important role of specific viruses in causing 
infectious diarrheal diseases (Kapikian et al., 1972). In 1973, another viral particle of 
about 70nm in diameter that was associated with severe diarrhea in infants and young 
children was directly visualized in duodenal mucosa by thin-section electron 
microscopy (EM), and due to the wheel-like structure observed it was subsequently 
designated rotavirus (rota: Latin for wheel) (Bishop et al., 1973; Flewett et al., 1974; 
Bishop et al., 1974). Human rotaviruses were then linked to previous discoveries of 
viral particles causing severe diarrhea in infant mice (EDIM), calves (NCDV) and 
monkeys (SA11) (Adams et al., 1963; Mebus et al., 1971; Malherbe and Strickland-
Chomley, 1967).  
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Investigators from many countries also reported the detection of rotavirus and it was 
soon found that rotaviruses were the most important etiologic agents of acute viral 
gastroenteritis in infants and young children, causing more than half a million deaths 
annually (Parashar et al., 2006). Globally almost every child has experienced 
rotavirus gastroenteritis by the age of 5, and children in the poorest areas of the 
world, such as South-East Asia and sub-Saharan Africa account for more than 80% 
of rotavirus related deaths (Ramig, 2004; Bishop, 2009).    
 
1.1.2 Classification of rotaviruses 
 
Rotavirus is one of the 16 recognized genera of the family Reoviridae, together with 
Aquareovirus, Cardoreovirus, Coltivirus, Crabreovirus, Cypovirus, Dinovernavirus, 
Fijivirus, Idnoreovirus, Mimoreovirus, Mycoreovirus, Orbivirus, Orthoreovirus, 
Oryzavirus, Phytoreovirus and Seadornavirus (Attoui et al, 2006; Estes and 
Kapikian, 2007; Deng et al, 2012). Members of the family Reoviridae are the largest 
and most diverse group of double-stranded RNA (dsRNA) viruses in terms of host 
range. All members of the Reoviridae family have dsRNA genomes consisting of 10-
12 segments and all of them have RNA-dependent RNA polymerase activity 
associated with the core of the virion, as cells do not have enzymes capable of 
transcribing dsRNA templates. The transcription process of the Reoviridae family is 
conserved, such that it uses template dsRNA contained within the viral particles 
rather than free RNA (Patton, 1986; Estes and Kapikian, 2007). 
 
Rotaviruses are divided into seven groups (group A-G) based on the predominant 
group antigen found on the structural protein VP6 that is detectable by serological 
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tests such like immunofluorescence (IF), enzyme-linked immunosorbent assay 
(ELISA) and immunoelectron-microscopy (IEM) (Pedley et al., 1986; Mattion et al., 
1994; Estes and Kapikian, 2007). Rotaviruses group A, B and C are found in humans 
and other animals; human rotavirus infections are predominantly caused by group A 
rotaviruses (Parashar et al., 2003), group B rotaviruses associated with epidemics of 
severe diarrhea was primarily reported in adults in China (Chen et al,. 1985; Hung et 
al, 1983) and group C rotaviruses have been reported to cause sporadic cases of acute 
diarrhea in children older than 3 years of age (Von Bonsdorff and Svensson, 1988). 
Rotaviruses of groups D, E, F, and G have been found only in other animals to date 
(Saif et al,. 1994). The genome of an avian group D rotavirus strain has been 
reported but much less data has yet been published on rotavirus groups E-G (Trojnar 
et al., 2010; Wakuda et al., 2011). The focus of this thesis is the Group A 
rotaviruses, which have been studied in more details than any other group. The 
general characteristics of Group A rotaviruses are summarised in Table 1.1.  
 
Table 1.1 General characteristics of Group A rotaviruses (Adapted and 
summarised from Estes and Kapikian, 2007) 
 
Structure 
1. Mature virions are approximately 70nm (100nm including 
VP4 spikes) in diameter and possess a triple layered 
icosahedral protein capsid 
2. 60 protein spikes extend from the outer layer of the particle 
3. Capsid contains all enzymes for mRNA production 
Genome 
1. 11 segments of double-stranded RNA and capable of 
genetic reassortment with co-infecting members of the 
same group 
2. Each RNA segment codes for at least one protein 
Replication 
1. Cytoplasmic replication in infected cells 
2. Viral cultivation in vitro is facilitated by treatment of 
mature virus with proteolytic enzymes 
3. Exhibit a unique morphogenic pathway 
4
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Group A rotaviruses are classified further into two independent serotypes, i.e: G-
serotype and P-serotype (Hoshino and Kapikian, 1996). Serotypes are defined by 
reactivity of viruses in plaque reduction or fluorescent foci reduction neutralization 
assays in antibody-negative animals (Estes and Kapikian, 2007). These assays 
measure the reactivity of antibody against the two neutralizing antigens VP7 and 
VP4 (Hoshino and Kapikian, 1996). At least 16 VP7 (G) serotypes have been 
identified and strains of animal and human origin may fall within the same serotype. 
Among these G serotypes, G1-4 and G9 are the most common human strains 
worldwide (Kobayashi et al., 2007; Angel et al., 2007). When studies on the 
protease-sensitive protein VP4 revealed the importance of anti-VP4 neutralization 
antibody in protection from rotavirus infection in vivo, a serotyping system based on 
VP4, named P-serotype, was proposed (Gorziglia et al., 1990). Nevertheless, 
discrimination of P-serotypes is more difficult to characterize. Although human 
rotavirus P-serotypes can be determined by ELISA with specific monoclonal 
antibodies, this method has not become common. So far at least 14 different P-
serotypes have been discriminated (Kobayashi et al., 2007). 
 
Sequence analysis and hybridization assays based on VP7 and VP4 genes are used to 
define the genetic typing of rotavirus, i.e: G (VP7)-genotype and P (VP4)-genotype 
(Kobayashi et al., 2007). G-genotype has shown a clear correlation with the 
serotypes whereas the sero-genotypic correlation has not been clearly defined in P-
typing (Estes and Kapikian, 2007). At least 28 different P-genotypes have been 
reported (Kobayashi et al., 2007). To integrate the P-serotype and genotype 
designation, an open Arabic number following P is used to denote serotype, an 
5
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Arabic number in brackets is used to indicate genotype; for instance, the human Wa 
strain is represented as P1A[8] (Estes and Kapikian, 2007).       
 
1.1.3 Structure of Rotavirus particle  
 
Mature infectious rotavirus particles are approximately 100nm in diameter including 
the spikes and possess a triple-layered icosahedral protein capsid, hence these are 
called triple-layered particles (TLPs). The TLP is composed of an outer layer with 
protein spikes extending from the surface, an intermediate layer and an inner core 
layer surrounding the dsRNA genome (Flewett et al., 1973). The smooth outer layer 
forming the majority of the outer capsid consists of 780 molecules of the 
neutralization antigen VP7 arranged as trimers. 60 spikes composed of dimers of 
haemagglutinin VP4 protrude to a length of around 120Å from this smooth surface 
(Prasad et al., 1990). This outer layer is lost during the uncoating process to leave 
double-layered particles (DLPs), which are described as rough particles and are 
transcriptionally active but not infectious (González et al., 1995). The intermediate 
layer is composed of 780 molecules of VP6 arranged as trimers (Bican et al., 1982). 
This VP6 layer may provide structural integrity to the rotavirus capsid by enhancing 
the morphologic homogeneity and long-term stability of the particle (Zeng et al., 
1996). Single-layered particles (SLPs or cores) are seen infrequently; they are non-
infectious and usually consist of the enzymes VP1 and VP3 together with the dsRNA 
genome, surrounded by an outer surface layer formed by 120 copies of VP2 (Labbé 
et al., 1991; Lawton et al., 1997). A distinctive feature of the viral particle is the 132 
aqueous channels that penetrate the virion to link the inner core with the outer 
surface. These channels are used to import the metabolites required for RNA 
6
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transcription and export nascent RNA transcripts during viral replication (Lawton et 
al., 1997; Estes and Kapikian, 2007).  
 
Three-dimensional reconstruction studies of the viral particle using cryo-electron 
microscopy (cryoEM) and image processing techniques have provided a detailed 
description of the structures of triple-and double-layered rotavirus particles (Li et al., 
2009). Current understanding of virions has been enhanced reaching a resolution of 
about 9.5-Å and all three layers establish an icosahedral organization (Figure 1.1).  
 
1.1.4  Rotavirus genome and gene-protein coding assignments 
 
There are 11 segments of dsRNA with sizes ranged from 3302 bps to 667 bps in the 
rotavirus genome, with around 25% of it forming a dodecahedral structure (Estes and 
Kapikian, 2007). The nucleotide sequence for all eleven RNA segments has been 
elucidated for a number of strains and general features have been described. 
 
The open reading frame (ORF) of each segment is surrounded by conserved 
untranslated regions (UTRs) of varying length dependent upon the gene segment. 
Although some of the genes possess additional in-phase (such as gene 7, 9, and 10), 
or out-of-phase (gene 11) ORFs, evidence up to date indicates that all the segments 
are monocistronic except gene 11, which encodes two non-structural proteins NSP5 
and NSP6 (Mattion et al,. 1991; Rainsford and McCrae, 2007). In general, the gene 
sequences of the dsRNA segments are A+U rich (58% to 67%) (Estes and Kapikian, 
2007). 
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Figure 1.1 Structure of mature rotavirus particle at 9.5-Å resolution.  
VP4 spikes are indicated in red, VP7 outer layer in yellow, VP6 intermediate layer in 
blue, VP2 inner layer in green and the orange colour indicates the internal density 
consisting of RNA genome and polymerase complex (figure taken from Li et al., 
2009)  
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The positive RNA strand has a conserved 5’ cap sequence m7GpppG(m)Gpy but lacks 
a 3’ poly-A tail (Imai et al., 1983; McCrae and McCorquodale, 1983); however, the 
3’ end of the positive sense strand has the conserved sequence 5’-UGUGACC-3’ as 
the minimal essential promoter for the negative RNA strand synthesis (Wentz et al., 
1996). Similar features of the RNA termini are found in the primary structures of the 
genomes of other viruses in the family Reoviridae such as orbivirus and in other 
virus families with segmented RNA genomes including Orthomyxoviridae and 
Arenaviridae (Estes and Kapikian, 2007). The use of polyacrylamide gel 
electrophoresis (PAGE) in rotavirus genome analysis is now popular for detecting 
viruses and monitoring viral outbreaks and transmissions. The electrophoretic pattern 
of group A rotavirus genomes is made up by four high-molecular-weight segments 
indicating gene 1-4, two middle-sized segments indicating gene 5 and 6, a distinctive 
triplet of segments indicating gene 7-9 and the two smallest segments indicating gene 
10 and 11(Estes and Kapikian, 2007). However, in viruses with genome 
rearrangements, these typical RNA segments are decreased in concentration or 
missing in the electrophoretic profile and are replaced by additional more slowly, or 
rarely more rapidly, migrating bands of dsRNA (Desselberger, 1996). Virus isolates 
with rearrangements in segments 5, 6, 8, 10 and 11 have been characterized; of these, 
segments 5 and 11 appear to be rearranged most frequently (Estes and Kapikian, 
2007).   
 
The rotavirus genome segments code for six structural proteins VP1-VP4, VP6 and 
VP7 that are found in virus particles and six non-structural proteins NSP1-NSP6, 
found in infected cells. The protein coding assignments for each segment were 
determined by: (a) in vitro translation using mRNA or denatured dsRNA (McCrae 
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and McCorquodale, 1983); (b) analysis of reassortant viruses (Kantharidis et al., 
1983; Mason et al., 1983; Liu et al., 1988); and (c) immunological studies with 
specific antibodies (Both et al., 1983; Greenberg et al., 1983). The eleven gene 
segments and the corresponding viral proteins are summarised in Table 1.2 (Estes 
and Kapikian, 2007).  
 
Table 1.2 Gene-protein coding assignments of rotavirus. (Adapted from Estes and 
Kapikian, 2007) 
 
Genome segment 
Protein 
product 
Location in virus 
particles 
1 VP1 Core 
2 VP2 Core 
3 VP3 Core 
4 VP4 Outer capsid 
5 NSP1 Non-structural 
6 VP6 Inner capsid 
7 NSP3 Non-structural  
8 NSP2 Non-structural  
9 VP7 Outer capsid 
10 NSP4 Non-structural  
11 
NSP5 
NSP6 
Non-structural  
 
  
1.1.5  Viral protein structure and function 
 
A characteristic feature of rotavirus-infected cells is the presence of highly 
specialized electron-dense membrane-free cytoplasmic inclusion bodies, termed 
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viroplasms (Petrie et al., 1982; Petrie et al., 1984). Viroplasm formation is typical for 
infections by several members of the Reoviridae family and these structures are sites 
of rotavirus protein accumulation, particle assembly, RNA packaging, and genome 
replication (Patton et al., 2006; Contin et al., 2010).  
 
1.1.5.1 Structural proteins 
 
VP1 has been found to be a minor (~2% of the virion mass) but consistent 
component of rotavirus complexes that has polymerase activity (Gallegos and Patton, 
1989; Zeng et al., 1996). VP1 is a nucleotide-binding protein that specifically binds 
the 3’ end of viral mRNA in the absence of any other proteins. In addition, VP1 
appears to be the RNA-dependent RNA polymerase and functions as both the viral 
replicase and transcriptase (Patton, 1996).  
 
VP2 forms the inner core layer of the viral particle and constitutes ~12% of the 
virion protein (Kumar et al., 1989). It is known to be essential for replicase activity 
and is also involved in transcriptase activity (Mansell and Patton, 1990; Estes et al., 
1983). VP2 has been shown to have sequence-independent RNA binding activity and 
to associate with both ssRNA and dsRNA, but ssRNA preferentially, which is 
thought to facilitate its role in viral replication and encapsidation (Boyle and Holmes, 
1986; Labbé et al., 1994).    
 
VP3 is found in early replication intermediates in the viroplasm and associates with 
viral mRNA at early stages in virus replication cycle (Gallegos and Patton, 1989). It 
is known to bind to proteins involved in RNA replication and transcription (Zeng et 
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al., 1998; Sandino et al., 1994). VP3 is a guanylyltransferase and has a function in 
mRNA capping by transferring GMP to the 5’ phosphate end of nascent RNAs 
(Pizarro et al., 1991; Liu et al., 1992). VP3 has also been demonstrated to have a 
sequence-independent affinity for ssRNA, but not for dsRNA (Patton and Chen, 
1999).   
 
VP4 proteins make up the spikes of the outer layer of the viral particle; it is the viral 
haemagglutinin and determines the host range and cell tropism (Offit et al., 1986; 
Estes and Kapikian, 2007). Proteolytic cleavage of VP4 to produce VP5* and VP8* 
potentiates infectivity by greatly enhancing penetration of the virus into cells, but 
does not affect absorption on to the cell surface (Kalijot et al., 1988; Fukuhara et al., 
1988).        
 
VP6, which forms the intermediate layer of the virion, is the major structural 
component of the virion, forming ~51% of the total protein content (Estes and 
Kapikian, 2007). VP6 spontaneously forms trimers which are particularly stable and 
contains several highly immunogenic epitopes (Estes et al., 1987).    
 
VP7 forms the smooth external layer of the outer capsid and constitutes ~30% of the 
virion protein (Estes and Kapikian, 2007). It is known to be the major neutralisation 
antigen and is largely responsible for serotype classification of rotaviruses (Sabara et 
al., 1985). VP7 is a glycoprotein with three potential sites for N-linked glycosylation 
although only two of these sites appear to be used in different rotavirus strains 
(Kouvelos et al., 1984). It is co-translationally glycosylated as it is inserted into the 
membrane of the endoplasmic reticulum (ER) (Stirzaker et al., 1987).  
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1.1.5.2 Non-structural proteins 
 
NSP1, the least conserved of all rotavirus proteins, is approximately 55kDa in size. 
Immunofluorescent staining of virus infected cells has shown that NSP1 is localized 
throughout the cytoplasm and also associated with the cytoskeleton (Hua and Patton, 
1994a). By contrast, all other rotavirus proteins are mostly concentrated in the 
viroplasms. NSP1 does not appear to be essential for rotavirus replication in cell 
culture since viable virus mutants only able to encode a highly truncated form of the 
protein can still replicate, although they give smaller virus plaques (Taniguchi et al., 
1996). NSP1 has been suggested as a virulence determinant for rotavirus. This was 
initially reported from studies in a mouse model using rotavirus reassortants (Broome 
et al., 1993). Moreover, NSP1 functions as an antagonist of the interferon (IFN) 
signalling pathway (Arnold and Patton, 2009). Since this thesis is focused on NSP1, 
a more detailed discussion of this protein will be presented later in this chapter. 
 
NSP2 accumulates predominantly in the viroplasm in rotavirus-infected cells (Petrie 
et al., 1984). It has been shown to interact with NSP5 and to form the viroplasm 
structure without the presence of other viral proteins (Fabbretti et al., 1999). 
Furthermore, NSP2 is able to interact with the viral polymerase VP1 and it possesses 
nucleoside triphosphatase (NTPase), RNA triphosphatase (RTPase) and helix-
destabilizing activity (Kattoura et al., 1994; Taraporewala et al., 1999; Aponte et al., 
1996; Vasquez-Del Carpió et al., 2006).   
 
NSP3 is found in the cytoplasm and associates with cytoskeleton in infected cells 
(Mattion et al., 1992). Both monomeric and multimeric forms of NSP3 have 
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rotavirus mRNA binding activity (Poncet et al., 1993). NSP3 has also been shown to 
interact with the scaffold translation initiation factor eIF4G (Piron et al., 1998). 
eIF4G can bring the initiation factor 4E (eIF4E) and the poly A binding protein 
(PABP) together to induce circularisation of cellular mRNA for efficient initiation of 
translation (Preiss and Hentze, 1998). Due to the interaction of NSP3 with eIF4G, the 
PABP and its associated mRNA are evicted from the cellular translation complex 
causing in the block of cellular protein synthesis, and suggesting that NSP3 has a role 
in ensuring efficient translation of viral mRNA (Piron et al., 1998).      
 
NSP4 is a transmembrane glycoprotein with three hydrophobic amino-terminal 
regions maintained in the ER membrane and a hydrophilic carboxy-terminus 
extended into the cytoplasm (Ericson et al., 1982; Chan et al., 1988). NSP4 is known 
to be cytotoxic and functions as a viral enterotoxin in rotavirus-induced diarrhoea by 
inducing calcium-dependent chloride secretion across the mammalian small 
intestinal mucosa (Tian et al., 1995; Ball et al., 1996; Zhang et al., 2000). In 
addition, NSP4 plays a crucial role in viral assembly and facilitates the budding of 
viral DLPs into the ER lumen to form infectious TLPs (Estes and Kapikian, 2007).  
 
NSP5 is the product of the 5’ proximal ORF in gene 11 and is 26 kDa in size. It is a 
phosphoprotein that exists in several different phosphorylated forms (Afrikanova et 
al., 1996). NSP5 forms homo-dimers and is known to interact with NSP2 to form the 
viroplasm (Poncet et al., 1997). Recent studies demonstrated that the interactions of 
NSP5-NSP2 and NSP5-VP2 are able to recruit all other viral proteins found in the 
viroplasms, suggesting that NSP5 plays an important role in the assembly of 
viroplasms and recruitment of viroplasmic proteins (Contin et al., 2010). Moreover, 
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NSP5 has also been shown to be involved in viral replication (Campagna et al., 
2005).    
 
NSP6 is encoded by a second out-of-phase ORF in gene 11 with a protein size of 12 
kDa. A relatively low level expression of NSP6 is observed in infected cells and the 
protein co-localizes with NSP5 in viroplasms (Mattion et al., 1991; Torres-Vega et 
al., 2000). It has been suggested that NSP6 may play non-essential roles in regulation 
of the viral replication cycle based on the findings that two viable rotaviruses, the 
lapine Alabama strain and the porcine OSU strain, encode truncated NSP6 (Gorziglia 
et al., 1989; González and Burrone, 1989).     
 
1.1.6 Rotavirus replication cycle 
 
Rotavirus has a rapid replication cycle in permissive cells with a maximum yield of 
virus after 10-12 hours (McCrae and Faulkner-Valle, 1981). Although the natural cell 
tropism for rotavirus is the differentiated enterocyte in the small intestine, suggesting 
that specific receptors for rotavirus are expressed in these cells, recent investigations 
have also recognised extraintestinal spread of rotavirus (Azevedo et al., 2005; Blutt 
et al., 2006; Kim et al., 2011). Studies of the initial stages of rotavirus replication 
have been primarily conducted in continuous cell cultures derived from MA104 
(monkey kidney epithelial cell line) and Caco-2 (polarized human colon carcinoma 
cell line). Both of the cell lines are highly permissive for most of the mammalian 
rotavirus infection and Caco-2 cells in particular are thought to reflect the in vivo 
situation of the infection (Estes and Kapikian, 2007; Ciarlet and Estes , 2001).  
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The general features of rotavirus replication based on studies in cultures of MA104 
are summarised as follows (Estes and Kapikian, 2007), and a schematic 
representation of the virus replication cycle (Figure 1.2) demonstrates the process 
known so far (Trask et al., 2012).  
 
(a) Cultivation of most rotavirus strains requires the addition of exogenous 
proteases to the culture medium to ensure the activation of viral infectivity by 
cleaving the outer capsid protein VP4. 
(b) Replication is entirely cytoplasmic and occurs within cytoplasmic viroplasms. 
(c) Host cells do not contain enzymes to replicate dsRNA; thus rotavirus supplies 
the necessary enzymes. 
(d) Viral mRNA transcripts are used both to produce proteins, and as a template 
for negative stranded RNA synthesis.  
(e) Replication occurs in nascent subviral particles and during the replication, 
both parental dsRNA remain associated with the partially uncoated viral 
particle, free dsRNA or free negative stranded RNA is never found in 
infected cells. 
(f) Subviral particles are produced in association with viroplasms and the 
progeny virus particle matures by budding through the membrane of the ER 
and is then released by cell lysis.  
(g) Intracellular calcium levels are important for controlling virus assembly and 
integrity. 
 
16
Chapter 1. Introduction 
 
 
 
 
 
Figure 1.2 The rotavirus replication cycle.  
The rotavirus virion first attaches to the target cell followed by virion delivery to the 
early endosome. The incoming TLP is then uncoated by losing the VP7 outer layer 
partially and subsequently releases the DLP into the cytosol. This activates the 
internal polymerase VP1 and VP3 complex to transcribe capped positive-sense 
RNAs, which then serve either as mRNAs or as templates for synthesis of negative-
sense RNAs. When VP1 and VP3 bind the viral positive-sense RNAs, the genome 
packaging is initiated. Condensation of VP2 triggers dsRNA synthesis. VP6 then 
assembles onto the nascent core to form the progeny DLP, followed by the assembly 
of the outer capsid. Through an undefined mechanism, the DLP-VP4-NSP4 complex 
buds into the ER. Subsequent removal of the ER membrane and NSP4 permits 
assembly of the ER-resident outer capsid protein VP7, thus the formation of the TLP. 
Release from the infected cell exposes the virion to trypsin-like proteases, resulting 
in the specific cleavage of VP4 to produce the fully infectious virion (figure taken 
from Trask et al., 2012).   
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1.1.6.1     Virus attachment and entry 
 
Viral proteins and host cell surface molecules are essential for rotavirus infections. A 
broad range of cells can be infected by rotaviruses with different efficiencies 
(Crawford et al., 2006). The current opinion on rotavirus cell entry is that it is a 
coordinated, multistep process involving sequential interactions with several ligands 
and a series of conformational changes in the capsid proteins VP4 and VP7 (Estes 
and Kapikian, 2007). It has been demonstrated that the proteolytic cleave of VP4 and 
the glycosylation of VP7 are not essential for the initial binding process (Fukuhara et 
al., 1988). A variety of cellular receptors have been reported to be involved in the 
binding process: N-acetylneuraminic acid (sialic acid), which functions as an 
attachment receptor for some rotavirus strains; the heat shock cognate protein hsc70, 
and four integrins namely α2β1, ανβ3, α4β1 and αxβ2 (Lόpez and Arias, 2006).  
 
Observations on cells pre-treated with neuraminidase (NA), or pre-incubation of 
virus with sialic acid-containing compounds, showed reduced infectivity of some 
viral strains, indicating that sialic acid is able to mediate the initial viral attachment 
to susceptible cells (Lόpez and Arias, 2006). However, most human rotavirus isolates 
are not affected by prior NA treatment of cells; they can still use sialic acid located in 
the internal regions of oligosaccharide structure such like ganglioside GM1 for viral 
recognition (Lόpez and Arias, 2006;  Haselhorst et al., 2009). To date four integrins 
including α2β1, ανβ3, α4β1 and αxβ2, have been identified to function at the post-
attachment level (Lόpez and Arias, 2006). Studies have shown that VP4 from a 
number of rotavirus strains, including those from humans, monkeys and calves, was 
the viral protein interacting with integrin α2β1 (VLA-2) (Graham et al., 2003). The 
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viral protein responsible for ανβ3 integrin binding was identified to be VP7 (Graham 
et al., 2003; Zárate et al., 2004). In addition, integrins α4β1 and αxβ2 have also been 
reported to promote post-attachment steps in infections by interactions with both 
VP4 and VP7, and VP7 alone respectively (Graham et al., 2005; Fleming et al., 
2007; Graham et al., 2003). Furthermore, studies on Hsc70 have shown that it 
promotes viral entry at a post-attachment step by interacting with VP4 and VP6 
(Gualtero et al., 2007). 
 
The entry of the viral particles into host cells is driven by the interaction between the 
virus and its receptors on the cell surface. Observations made with EM of rotavirus-
infected cells suggested that the virus internalization was achieved via endocytosis 
(Ludert et al., 1987). It has been reported that an inhibitor of the vacuolar proton-
ATPase pump, bafilomycin A, is able to block rotavirus infectivity, supporting the 
endocytotic mechanism for virus entry (Chemello et al., 2002). However, studies 
have also revealed that rotavirus infectivity is not inhibited by either preventing the 
acidification of endosomes or by treatment with drugs that block the intracellular 
traffic of the endocytic vesicles, these results suggested that the endocytotic pathway 
might not to be universal for cell entry of all rotaviruses (Lόpez and Arias, 2006). 
Instead, another possible mechanism by direct penetrating of cell membrane was 
proposed for rotavirus internalization. This was based on the observation that 
rotavirus infection induced a rapid permeabilization of the cell membrane (Estes and 
Kapikian, 2007). In summary, it is possible that different viral strains may utilize 
different mechanisms for their internalization and the precise mechanisms for each 
pathway still remain unclear (Sánchez-San Martín et al., 2004; Gutiérrez et al., 
2010).               
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The uncoating process of rotaviruses includes the removal of the outermost layer 
made from VP4 and VP7. It has been proposed that these proteins are solubilized 
within an endocytic vesicle because of the low calcium concentration, and this was 
supported by the inhibition of uncoating of the porcine rotavirus strain OSU in 
MA104 cells by the calcium ionophore A23187 (Ludert et al., 1987). However, 
different observation have been made by Cuadras et al, who showed that the 
uncoating of rhesus rotavirus strain RRV and monkey rotavirus strain SA11 were not 
affected by the use of compounds which increased the intracellular calcium level 
(Cuadras et al., 1997). Therefore, the importance of calcium levels for viral entry 
might also vary between the different viral strains used in different studies.  
 
1.1.6.2     Transcription and translation 
 
The virus-associated transcriptase in TLPs can be activated in vitro by treatment with 
a chelating agent or by heat shock treatment (Cohen and Dobos, 1979; Spencer and 
Arias, 1981). Such treatments result in the conversion from TLPs to DLPs by losing 
the outer capsid proteins and subsequently permit transcription to proceed (Estes and 
Kapikian, 2007).  
 
Synthesis of viral transcripts is initiated by the endogenous viral RNA-dependent 
RNA polymerase VP1 which utilizes viral dsRNA as template to generate positive 
sense ssRNA (Lawton et al., 1997). The nascent RNA transcripts are capped at their 
5’ end by the virion-associated guanylyl and methyltransferase activities present in 
the virion core protein VP3 and possess a methylated structure, m
7
GpppGm (Imai et 
al., 1983). As the elongation process proceeds, newly transcribed RNA exits the core 
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through channels in the VP2 and VP6 layers; multiple mRNA transcripts can be 
released simultaneously from an actively transcribing particle (Lawton et al., 2001). 
Each genome segment is transcribed by a specific polymerase complex, and the 
resulting transcripts exit through the channel system at the axis adjacent to their site 
of synthesis. The positive-stranded RNA transcripts encode the rotavirus proteins and 
also serve as templates for the negative stranded RNAs synthesis to make progeny 
dsRNAs (Estes and Kapikian, 2007).   
 
Viral mRNAs released from DLPs are not polyadenylated but capped, and the 
cellular translation machinery is used to translate viral proteins, with cellular 
ribosomes being recruited for synthesis of all 12 viral proteins (Patton et al., 2006). 
Viral protein translation is facilitated by the action of NSP3, which has been shown 
to have an important role in shutting off cellular protein synthesis and enhancing 
viral protein synthesis by interacting with eIF4G and with RoXaN (rotavirus X 
protein associated with NSP3). RoXaN is a novel cellular protein containing at least 
five zinc binding domains, a paxillin leucine-aspartate repeat (LD) motif facilitating 
protein-protein interactions, and another protein-protein interaction domain called the 
tetratricopeptide repeat region (TRR) (Vitour et al., 2004). Complex consists of 
NSP3, RoXaN and elF4G can be detected in rotavirus-infected cells, indicating that 
RoXaN is involved in translation regulation (Patton et al., 2006; Harb et al., 2008). It 
has been shown that viral proteins are neither synthesized in equal amounts nor are 
the amounts in each case similar to those of their corresponding gene transcripts 
(Johnson and McCrae, 1989). VP6 and NSP4 were found to be synthesized in the 
largest quantities compared to the other 9 viral proteins, whereas NSP5 and NSP6 
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were the least actively produced (Johnson and McCrae, 1989; Rainsford and 
McCrae, 2007).   
           
1.1.6.3     Genome replication 
 
The viroplasm structures provide the sites for synthesis of viral RNAs and formation 
of DLPs (Petrie et al., 1984; Fabbretti et al., 1999). The kinetics of RNAs synthesis 
in infected cells showed that positive- and negative- stranded RNAs were initially 
detected 3 hours after infection (Stacy-Phipps and Patton, 1987). It is assumed that 
rotavirus RNA replication takes place in a conservative manner; both strands of 
parental dsRNA remain within partially uncoated particles, after synthesis, dsRNA 
remains associated with subviral particles, and free dsRNA is not found in cells 
(Patton et al., 2006). Studies in SA11 infected cells revealed that the replicase 
complexes consist of the core proteins (VP1 and VP3), small amounts of VP6, large 
amounts of NSP3, and relatively less amounts of NSP1 and NSP2 (Helmberger-
Jonew and Patton, 1986) however, the role of individual proteins in RNA genome 
replication will be understood better if they are studied in vivo with pure species of 
native rotavirus proteins (Estes and Kapikian, 2007). siRNA knock down 
experiments demonstrated that NSP4 plays a role in regulating mRNA synthesis and 
possibly genome encapsidation although the mechanism remains to be determined 
(Silvestri et al., 2005). In addition, a recent study showed that the replication 
efficiency of rotavirus RRV in MA104 cells is dependent on the ubiquitin-
proteasome system (López et al., 2011). 
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1.1.6.4     Virus assembly and release 
 
Rapid assembling of DLPs serves as an intermediate stage in the formation of TLPs 
(Estes and Kapikian, 2007). Viral cores including VP1, VP2 and VP3, are 
accumulated in viroplasms (Korolev et al., 1981). The assembly of VP1 and VP2 is 
dependent on both their high affinity for ssRNA and their interaction with NSP2 and 
NSP5 (Patton et al., 2006; Arnoldi et al., 2007). VP2 forms the structural basis of the 
viral core and its simultaneous association with VP1 and VP3 directs the formation 
of a functional viral core (Zeng et al., 1998). During DLP formation in infected 
mammalian cells, VP6 has been observed in the exterior region of viroplasms, which 
allows VP6 to associate with newly assembled viral cores to form DLPs as they 
move toward the periphery of viroplasms (López et al., 2005). The glycoproteins 
VP7 and NSP4 are synthesised on ribosomes associated with the membrane of the 
ER. NSP4 acts as an intracellular receptor on the ER membrane; it binds newly made 
DLPs released from viroplasms and mediates the budding of DLPs into the ER 
lumen. A receptor role for NSP4 is supported by the observation that DLPs bind to 
ER membranes containing only NSP4 (Meyer et al., 1989; Au et al., 1989), 
suggesting that NSP4 alone was sufficient to drive DLPs into the ER lumen.     
 
It has been observed that rotavirus maturation is calcium-dependent. Studies revealed 
decreased rotavirus production in cells maintained in calcium-depleted medium, and 
these viruses do not bud into the ER (Shahrabadi and Lee, 1987; Poruchynsky et al., 
1991). In undifferentiated cells such as MA104, EM studies have shown that the 
infectious cycle terminates when progeny virus is released by host cell lysis 
(Musalem and Espejo, 1985; Estes and Kapikian, 2007). However in differentiated 
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cells like Caco-2, progeny virions are selectively released through the apical 
membrane involving actin and lipid rafts (Jourdan et al., 1997; Chwetzoff and 
Trugnan, 2006; Gardet et al., 2007).    
 
1.1.7  Rotavirus pathogenesis 
 
Rotavirus replicates in non-dividing, mature enterocytes near the tips of the villi. 
Pathologic changes of infections caused by rotaviruses are mainly limited to the 
small intestine; nevertheless, the severity of infection varies among animal species 
across different studies (Burke and Desselberger, 1996). The current understanding 
of rotavirus pathogenesis is based primarily on working with different animal 
models, in which rotavirus infection is associated with several of disease including 
no visible lesions, slight lesions such as enterocyte vacuolization and larger lesions 
such as crypt hyperplasia and villus blunting (Ramig, 2004).  
 
Pathogenesis of rotavirus infection is multifactorial, both host and viral factors can 
affect the consequences of infection. There are some major host factors recognised to 
affect the severity of rotavirus-associated disease: (i) the age of the animals at 
infection can result in different clinical symptoms including biliary atresia, diarrhea 
and some extraintestinal replication of virus (Estes and Kapikian, 2007); (ii) 
increased severity of rotavirus diarrhea can be caused by malnutrition as this delays 
the recovery of the small intestines (Ramig, 2004); and (iii) the expression of 
intestinal mucins and the rate of epithelial cell replacement can affect rotavirus 
infection in the host (Ramig, 2004). Furthermore, the enteric nervous system (ENS) 
in the intestinal wall has also been shown to be involved in rotavirus-induced watery 
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diarrhoea (Lundgren et al., 2000). A recent study analysed the total gene expression 
profile of HT29 cells infected with either simian (SA11), bovine (A5-13) or human 
(Wa) rotavirus strains using microarrays. 131 genes involved in innate immune 
responses, stress responses, apoptosis and protein metabolism were similarly induced 
by all three strains (Bagchi et al., 2012). In terms of the viral factors, studies on 
rotavirus-infected intestinal epithelial cells showed that the infection is different 
depending on whether or not the virus requires sialic acid for initial binding (Estes et 
al., 2001).  
 
1.1.8  Rotavirus vaccines 
 
Three live rotavirus vaccines have been developed, Rotashield (Wyeth), RotaTeq 
(Merck) and Rotarix (GSK). Both Rotashield and RotaTeq are reassortant viruses 
based on simian and bovine rotaviruses respectively with gene segments encoding 
VP4 and VP7 derived from human rotaviruses (Estes and Kapikian, 2007). By 
contrast, Rotarix is a human rotavirus that was attenuated by passaging in cell 
culture. RotaShield was the first of these vaccines to be licensed in the United States 
in 1998 although was withdrawn subsequently because the detection of a temporal 
association between vaccine administration and gut intussusception (Simonsen et al., 
2005). The other two rotavirus vaccines were released in 2006 and no similar link 
with intussusception has been observed (Angel et al., 2007). Ongoing vaccination 
programs in general show great reductions in clinical burden by both of the vaccines. 
However, despite the success of vaccination programs in the US, Australia and some 
European countries, only a limited number of other countries have introduced RV 
vaccination probably due to the cost barrier. Additional live and inactivated vaccines 
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from emerging manufacturers may be on the market for the next decade, providing 
competition and potentially reducing the cost of the program (Weycker et al., 2009; 
Lopman et al., 2012).  
 
1.2 Innate immune system 
 
1.2.1 Overview 
 
The body is protected from infection by a variety of effector cells and molecules 
involved in the immune system. An adaptive immune response has its specificity as 
the production of antibodies is against a definite pathogen or its products; and an 
adaptation to infection with that pathogen is developed through the lifetime of an 
individual. On the other hand, the innate immune response can be immediately 
activated against a wider range of pathogens but has no specificity for any individual 
pathogen and does not lead to lasting immunity (Biron et al., 2002). The studies 
included in this thesis are mainly focused on innate immunity.  
 
The first line of defence against an invading pathogen is the innate immune response. 
Synthesis and secretion of type I interferons (IFN) can exhibit antiviral, anti-
proliferative and immunomodulatory functions and provide a vital aspect of the 
antiviral innate immune response (Honda et al., 2005). Innate immunity is based on 
an intricate system of host pattern recognition receptors (PRRs) that specifically 
recognize pathogen-associated molecular patterns (PAMPs) (Janeway, 1989; Akira et 
al., 2006; Unterholzner and Bowie 2008). PRRs are germline-encoded, non-clonal, 
and expressed constitutively in the host cells. PRRs can react with specific ligands 
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leading to different anti-pathogen responses. Four different classes of PRRs found to 
date include Toll-like receptors (TLRs), retinoic acid-induced gene-1 (RIG-I)-like 
receptors (RLRs), nucleotide oligomerization domain (NOD)-like receptors (NLRs) 
and C-type lectin receptors (CLRs). The first three of these PRRs are able to 
recognise viral nucleic acids (Geijtenbeek et al., 2009a; Ting et al., 2005; Eisenächer 
and Krug, 2012) and among them, TLRs and RLRs are important for producing 
various cytokines and type I interferns (IFNs), while NLRs are able to regulate 
interleukin-1b (IL-1b) maturation by activating caspase-1 (Pétrilli et al., 2007a). 
Figure 1.3 illustrates these three PRRs for RNA virus recognition (Takeuchi and 
Akira, 2009).    
 
Toll-like receptors (TLRs) are transmembrane proteins and they are the mammalian 
homologs of Toll, which was discovered to mediate recognition of pathogens by the 
innate immune system in Drosophila species (Lemaitre et al., 1996). There are at 
least 13 identified mammalian TLRs that share similar extracellular and intracellular 
domains (Brikos and O’Neil, 2008). The molecular basis of TLR signalling is 
dependent on the conserved part of their intracellular domain called the 
Toll/interleukin-1 receptor (TIR) domain, which functions as a linker to connect to 
the membrane. The glycosylated extracellular domain consists of leucine-rich repeats 
(LRRs) and they are connected to the cytoplasm by a hydrophobic transmembrane 
sequence (Gay and Gangloff, 2008). Although historically the role of TLRs in the 
host immune response to bacteria and fungi was initially more apparent, the more 
significant role of TLRs to virus infections has been established as several viral 
structural entities have been identified to be the TLR recognition targets (Brikos and 
O’Neil, 2008).  
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Based on the similarities on the sequence, structure and function, a subgroup of 
TLRs including TLR3, TLR7, TLR8 and TLR9 has been identified to recognize 
nucleic acids (Hornung et al., 2008). ssRNA, anti-viral drugs and short dsRNA 
containing certain sequence motifs can be sensed by both TLR7 and TLR8 (Heil et 
al., 2004; Hornung et al., 2005; Diebold et al., 2004; Uematsu and Akira, 2008). 
dsRNA viruses and synthetic analogues of dsRNA (Poly(I:C)) are recognised by 
TLR3 (Alexopoulou et al., 2001; Beutler et al., 2007), and the ligand for TLR9 is the 
DNA-containing CpG motifs (Hemmi et al., 2000).  In addition, a number of specific 
viral structural proteins have been shown to activate signal transduction through 
other TLRs, for instance, envelope proteins of Measles virus can activate the signal 
transduction through TLR2 and F protein of respiratory syncytial virus can trigger 
this pathway via TLR4 (Uematsu and Akira, 2008).  
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Figure 1.3 Three classes of PRRs for RNA virus recognition.  
ssRNA from viruses is recognized by TLR7 in plasmacytoid dendritic cells (pDCs), 
whereas dsRNA is detected by TLR3 in conventional dendritic cells (cDCs). TLR7 
and TLR3 trigger signaling cascades via the myeloid differentiation factor 88 
(MyD88) and Toll/IL-1 receptor (IL-1R) homology domain-containing adapter 
inducing IFN- β (TRIF), respectively. RIG-I and MDA5 recruit another adapter 
protein, IFN-β promoter stimulator-1 (IPS-1). TRIF and IPS-1 share signaling 
molecules for phosphorylation of IRF3 and IRF-7 by TBK1/IKK-i. MyD88-
dependent signaling directly activates IRF-7 in pDCs. Phosphorylated IRF-3 and 
IRF-7 activate the expression of type I IFN genes. Simultaneously, TLRs and RLRs 
induce the translocation of NF-κB to induce the expression of cytokine genes. 
NALP3, one of the NLR proteins, detects the presence of dsRNA and induces the 
catalytic activity of caspase-1 via an adapter, apoptosis-associated speck-like protein 
containing a CARD (ASC) (figure taken from Takeuchi and Akira, 2009).  
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In 2005, a new pathway was identified when the retinoic acid-induced gene-1 (RIG-
I)-like receptors (RLRs) was discovered. This pathway recognizes viral nucleic acids 
exclusively in the cytoplasm of infected cells and it has been shown to be 
independent of the TLR system (Rothenfusser et al., 2005). The RLRs consist of 
three cytosolic RNA helicases namely RIG-I, MDA5 (melanoma differentiation-
associated gene 5) and LGP2 (laboratory of genetics and physiology-2), which are all 
capable of unwinding dsRNA molecules (Andrejeva et al., 2004; Tanner and Linder, 
2001). RIG-I can bind both Poly (I:C) and viral dsRNA and is activated only in the 
presence of dsRNA although over-expression of the N-terminal region of RIG-I 
containing two tandem caspase recruitment domains (CARDs) is sufficient to 
activate IRF3 and NF-κB without viral infection (Seth et al., 2006). In contrast, the 
nature of RNAs for MDA5 activation is less understood although it shares the N-
terminal CARDs structure with RIG-I and can also activate the IFNβ promoter 
(Meylan et al., 2005). LGP2 doesn’t contain the N-terminal CARDs, but has a 
repressor domain at the C-terminus. This domain is able to not only facilitate the 
binding of dsRNA but also to inhibit multimerization and the signalling of RIG-I, but 
not MDA5, thus to act as a negative regulator of the RIG-I pathway (Yoneyama et 
al., 2005; Saito et al., 2007; Pippig et al., 2009).          
  
The transcriptional activation of type I interferon (IFN) genes is a key step in the 
mammalian antiviral response. IFN genes include multiple IFNα isoforms, IFNβ and 
other members of the type I interferon family such like IFN-ω, ε, and κ (Der et al., 
1998). In humans there are at least 13 subtypes of IFNα (Randall and Goodbourn, 
2008), though only a single gene exists for IFNβ. Both IFNα and IFNβ are produced 
by many types of cells, including macrophages, fibroblasts, lymphocytes, endothelial 
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cells and epithelial cells. The activation of IFN regulatory factors (IRFs) and/or 
NFκB is triggered by the engagement of PRRs by PAMPs, which subsequently 
induce the production and secretion of type I IFN proteins. The binding of these type 
I IFN proteins to their receptors on the surface of both infected and uninfected cells 
prompts a cascade of signalling events involving signal transducers and activators of 
transcription (STAT) and Janus kinases (JAK) molecules, which can translocate to 
the nucleus after phosphorylation. They then induce the expression of many IFN-
stimulated genes (ISG) that encode proteins with antiviral properties to establish an 
antiviral state. Importantly, this occurs in both infected and uninfected cells and so is 
responsible for helping to control the spread of infection (Takeuchi and Akira, 2007; 
Randall and Goodbourn, 2008).  
 
1.2.2 Interferon regulatory factors regulated pathway 
 
Nine interferon regulatory factors (IRF1-9) have been established and are 
characterized by a conserved DNA-binding domain near the N-terminus of the 
protein (Taniguchi et al., 2001). IRF3-9 have an IRF-associated domain (IAD) 
within the carboxy terminus which is important for protein-protein interactions upon 
phosphorylation-mediated activation (Taniguchi et al., 2001). The IAD typically 
promotes either homodimer or heterodimer formation among IRF family members, 
but they can also interact with other protein families such as members of the STAT 
family (Taniguchi et al., 2001). Several IRFs have been implicated in type I IFN 
induction including IRF1, IRF3, IRF5, and IRF7. Nevertheless, studies in IRF1
-/-
 and 
IRF5
-/-
 mice indicate that these transcription factors are dispensable for type I IFN 
induction (Takaoka and Yanai, 2005).  
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Early studies identified that the main steps in the activation of IRF3 and IRF7 are 
similar (Servant et al., 2002a). IRF3 is localized to the cytoplasm in a monomeric 
and inactivated form in uninfected cells (Mercurio et al., 1997). Subsequent to viral 
infection, IRF3 becomes phosphorylated and dimerized (Honda et al., 2006). The 
dimers accumulate in the nucleus, bind consensus DNA sequences, recruit histone 
acetyltransferases (HATs) to promote gene induction, and then are degraded in a 
proteasome-dependent manner (Sato et al., 1998; Yoneyama et al., 1998). 
Hyperphosphorylation of serine and threonine residues near the C-terminus of IRF3 
by TBK1 and IKKi is necessary for IRF3 activation (Hemmi et al., 2004). 
Hyperphosphorylated IRF3 dimers form a complex with histone acetyltransferases 
such as CREB-binding protein (CBP) or p300 (Yoneyama et al., 1998; Lin et al., 
1998). Binding both DNA and CBP or p300 results in nuclear retention of IRF3 
dimers (Kumar et al., 2000); while in the nucleus, IRF3 is targeted for proteasome-
mediated degradation dependented on a peptidyl-prolylisomerase, PIN1 (Saitoh et 
al., 2006). The E3 ubiquitin ligase that directs IRF3 polyubiquitination to signal its 
degradation is likely to be a Skp1-Cull1-F-box multiprotein complex, based on the 
requirement of cullin 1 for IRF3 degradation (Bibeau-Poirier et al., 2006). 
 
IRF7 has a short half-life, and is only present in high concentrations when a viral 
infection is in progress (Taniguchi and Takaoka, 2002). Sequence alignments show 
that IRF7 has serine and threonine residue spacing near its C-terminus similar to that 
found in IRF3 (Servant et al., 2002b). IRF7 is also activated by 
hyperphosphorylation mediated by TBK1 and IKKi similar to IRF3 (Sharma et al., 
2003). The expression of IRF7 in most cells is low and the expression is upregulated 
by IFN signalling (Sato et al., 1998). It was originally thought that IRF3, but not 
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IRF7, was essential for the early phase of type I IFN induction since IRF3
-/-
 mice 
have an impaired type I IFN response (Sato et al., 1998). However, it has also been 
demonstrated that IRF7
-/-
 mice completely lost the ability to express type I IFN 
(Honda et al., 2005). Therefore, a revised model suggests that IRF3/IRF7 
heterodimers or IRF7 homodimers are important for the initial induction of type I 
IFN (Honda et al., 2005). Following induced expression of IRF7 by IFN signalling, 
IRF7 is the major driver of a positive feedback mechanism that upregulates the 
expression of a wide range of type I IFN genes and it is considered the ‘master 
regulator’ of the IFN response, as it also induces the expression of IFNα (Honda et 
al., 2005).  
 
1.2.3 NFκB regulated pathway 
 
NFκB is a dimeric transcription factor made up with members of the Rel family 
including NFκB1 (p105/p50), NFκB2 (p100/p52), Rel (c-Rel), RelA (p65) and RelB. 
NFκB is required for the optimal expression of IFN-β (Takeuchi and Akira, 2009). 
The activity of NFκB is tightly regulated by the inhibitor IκB. Phosphorylation of 
IκB by IκB kinases (IKK) leads to its rapid ubiquitination by the E3 ligase 
Skp1/Cull/F-box complex named SCF
β-TrCP 
and subsequent degradation by the 26S 
proteasome. This in turn leads to the translocation of NFκB subunits to the nucleus 
and promotes binding and transcription of NFκB target genes (Holloway et al., 2009; 
Kroll et al, 1999).   
 
IKK activation is initiated with the phosphorylation of key serine residues in the 
kinase domains of the IKKα and IKKβ subunits in the IKK complex (Häcker and 
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Karin, 2006). As a negative feedback loop, activated IKK also phosphorylates the 
IKKγ regulatory subunit; this leads to dissociation of IKKγ and conformational 
changes in IKKα and IKKβ, which allows for the recognition and dephosphorylation 
of the kinase domain serine residues to inactivate the IKK complex (Kray et al., 
2005; Palkowitsch et al., 2008). Once activated, the IKK complex can phosphorylate 
three NFκB inhibitor (IκB) proteins, IκBα, IκBβ, and IκBε (Didonato et al., 1997). 
Phosphorylated IκB is recognized by the SCFβ-TrCP E3 ubiquitin ligase complex 
leading to polyubiquitination of IκB, which is subsequently degraded by the 
proteasome (Kroll et al., 1999).  
 
The most common NFκB dimer is composed of the p65 and p50 subunits and is 
usually inhibited by association with IκBα (Hayden et al., 2008). IκBα in complex 
with p65:p50 normally shuttles between the cytoplasm and the nucleus, but is 
predominantly found in the cytoplasm (Baeuerle and Baltimore, 1988). The 
inhibitory activity of IκBα was initially recognised as a function of maintaining the 
cytoplasmic localization of p65:p50, however it was then found that the p65:p50 still 
remains mostly cytoplasmic in cells deficient in all three IκB proteins (Tergaonkar, 
2006). Robust nuclear accumulation of p65:p50 free from IκB inhibition occurs 
when the DNA binding of this dimer is enhanced by phosphorylation of the p65 
subunit on serine 276 (Vermeulen et al., 2003). This phosphorylation has been 
shown to be essential for p65:p50 interaction with the histone acetyltransferases, 
CBP and p300 (Chen et al., 2005). CBP/p300 then acetylates p65 to maximize 
transcriptional activity of this complex (Chen et al., 2005). Figure 1.4 summarises 
the signalling pathways triggered by viral infection (Kawai and Akira, 2006).  
 
34
Chapter 1. Introduction 
 
 
 
 
 
Figure1.4 Signalling pathways triggered by viral infection.  
Antiviral signalling is initiated by the recognition of dsRNA in the cytoplasm, 
followed by the activation of IRF3 and IRF7 via TBK1-and IKKi-dependent 
phosphorylation, and the activation of NFκB via stimulation of phosphorylated IκB. 
After translocation of these proteins to the nucleus, the type I interferon promoters 
are activated (adapted from Kawai and Akira, 2006). 
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The IFN response also leads to general antiviral responses other than those described 
above. Treatment of cells with type I IFNs sensitizes them to apoptosis upon viral 
infection (Stetson and Medzhitov, 2006). p53, a tumour suppressor which promotes 
apoptosis, is directly induced by interferon and is thought to confer antiviral activity 
through this function (Stetson and Medzhitov, 2006). This hypothesis is supported by 
the observation that a number of viruses, including poliovirus and adenovirus, 
actively degrade p53 during the course of infection (Pampin et al., 2006, Weitzman 
and Ornelles, 2005). 
 
1.3  Non-structural protein NSP1 
 
1.3.1 NSP1 shows high levels of primary sequence variability  
 
It is common for some viral proteins, such as neutralization antigens, to exhibit a 
high level of sequence divergence among different virus isolates as a result of the 
selective pressure supplied by the host adaptive immune system. This selection 
facilitates viral spread by providing the opportunity for the virus to escape from 
previously established immunity. By contrast, non-structural proteins tend to be 
relatively more conserved as they are not part of the virus particle and therefore not 
subjected to selection pressure from antibody-based immunity. However, NSP1 
shows very high levels of divergence in its primary sequence between different virus 
isolates (Mitchell and Both, 1990; Xu et al., 1994).  
 
The sequence of a bovine rotavirus (RF) NSP1 was the first gene 5 sequence to be 
published (Bremont et al., 1987). When the corresponding gene sequence from the 
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UKtc strain of bovine rotavirus was determined, it showed a high level of sequence 
conservation with the RF sequence (Tian and McCrae unpublished observation). By 
contrast the simian rotavirus SA11 strain showed a high level of sequence divergence 
in its gene 5, revealing 50% conservation at the nucleotide level and only 39% at the 
amino acid level with the bovine isolates (Mitchell & Both, 1990). It was thought 
that this diversity might be linked to the species of origin of the virus until the gene 5 
sequence from a second simian virus isolate (RRV) was found to show very high 
sequence divergence from that of the SA11 isolate (Xu et al., 1994). Therefore 
sequence variability in NSP1 is not entirely related to species of origin as was 
initially postulated (Table 1.3 Xu et al., 1994).  
 
Table 1.3. Levels of nucleotide and amino acid conservation across gene 5 and 
NSP1 sequences (table taken from Xu et al., 1994) 
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Although the C-terminal half of NSP1 is highly diverse between strains, the N-
terminal region is much more conserved. As an example, analysis of the first three 
NSP1 sequences including two bovine strains and one simian strain showed that the 
first 150 amino acids have a higher sequence similarity than the carboxy terminus, 
and from these sequences, a cysteine-rich region within the amino terminus was 
identified, which is not only conserved in group A rotaviruses but also in a group C 
rotavirus (Mitchell & Both, 1990; Bremont et al., 1993). The consensus sequence for 
this domain is C-X2-C-X8-C-X2-C-X3-H-X-C-X2-C-X5-C and subsequently these 
structures were proposed to be a C4HC3 two finger sequence based on comparisons 
to known zinc binding motifs (Hua et al., 1993; Freemont et al., 1991; Arnold and 
Patton, 2009). 
 
The first 81 amino acids of NSP1 were demonstrated to be essential for dsRNA-
binding activity, and the binding to the 5’ ends of rotavirus mRNAs was also shown 
to be specific as the interaction could be competitively inhibited by unlabelled 
rotavirus mRNA but not by control yeast RNA however, the specific target of the 
binding activity and the role of RNA binding remains undefined (Brottier et al., 
1992; Hua et al., 1994b). Mapping studies using deletion mutants suggested that a 
region of around 100 amino acids immediately downstream of the cysteine-rich 
region was responsible for the localization of NSP1, which is demonstrated in the 
cytoplasm, using immunofluorescence staining and cellular fractionation studies 
(Hua et al., 1994a). The more detailed sequence comparison between different 
rotavirus strains used in this project will be illustrated in Chapter 3 (Figure 3.1).  
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Despite the high levels of primary sequence divergence seen in NSP1, conservation 
was observed when predicted secondary structures of 17 strains of NSP1 from 
different species were aligned as shown in figure 1.5 (Hua et al., 1993; Xu et al., 
1994). This strongly suggests that the higher-ordered structure of NSP1 may be 
maintained despite sequence divergence, consistent with a unified, conserved role for 
this protein in the virus life cycle.  
 
1.3.2 NSP1 can interact with Interferon Regulatory Factors (IRFs) 
 
When MA104 cell cDNA library was screened in a yeast two hybrid system using 
the NSP1 of B641 (bovine rotavirus strain) as bait, IRF3 was identified as a primary 
cellular interaction partner of NSP1 (Graff et al., 2002). A gluthathione S-transferase 
(GST) pull-down assay provided further evidence that NSP1 synthesized in 
rotavirus-infected cells (MA104) was also able to bind IRF3 (Graff et al., 2002). In 
the same study,  NSP1 of the murine EW strain, which only shares 37%  amino acid 
identity with B641 NSP1, was also shown to interact with murine IRF3 (Graff et al., 
2002).  
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Figure 1.5 Conservation of predicted secondary structure across rotavirus 
NSP1.  
E indicates positions predicted to have β-sheet structure, H denotes positions 
predicted as being α-helix and L denotes positions predicted to be in loops. Positions 
at which no prediction with an acceptable level of confidence could be made are 
indicated by ‘-’ and gaps introduced to optimize the alignment by a ‘.’ (figure taken 
from Xu et al., 1994).   
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The interaction between NSP1 and IRF3 has also been tested in virus-infected cells 
using the simian rotavirus SA11-4F strain. Immunoprecipitates made from SA11-4F 
infected MA104 cells showed co-precipitation of IRF3 with NSP1 indicating that an 
NSP1-IRF3 complex is formed during the viral replication cycle (Barro and Patton, 
2005). By contrast, in a yeast two-hybrid screen, no interaction was seen between the 
NSP1 of the porcine strain OSU and MA104 cellular IRF3; furthermore in a GST 
pull-down assay, binding between these two proteins was less than 10% of that seen 
with the bovine B641 NSP1 (Graff et al., 2007). This specific interaction between 
NSP1 and IRF3 has also been studied in some other cell lines with other rotavirus 
strains: NSP1 from simian strain RRV and murine strain ETD have been shown to 
interact and degrade IRF3 in both COS7 (simian kidney fibroblast-like cells) and 
MEF (mouse embryonic fibroblast) cells (Feng et al., 2009; Sen et al., 2009). Bovine 
strain UKtc NSP1 has been demonstrated to have the same effect in Cos7 but not in 
MEF (Sen et al., 2009) while porcine strain OSU NSP1 has no such ability in either 
MA104 nor HEK293 (human embryonic kidney) cells (Graff et al., 2009). All these 
investigations indicated that the interaction between NSP1 and IRF3 is dependent on 
the virus strain type and cell line being used. 
 
A series of mutations in NSP1 have been made to try to identify the IRF3 binding 
domain in the protein. It has been found that there is at least one point of contact with 
IRF3 in the C-terminal domain of NSP1 (Graff et al., 2002). Meaningful site directed 
mutagenesis within the C-terminal of NSP1 is problematic due to the high variability 
of the primary sequence. Consequently point mutations have to-date only been made 
within the zinc finger motif, and the mutants abolished the NSP1-IRF3 interaction, 
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suggesting that the zinc finger motif is important for NSP1-IRF3 interaction. 
However, because of the earlier mutagenesis results from the same group, at present 
the only conclusion that has been possible is that this region of NSP1 is involved in, 
but is not sufficient for, the interaction between the two proteins (Graff et al., 2002, 
2007).  
 
When NSP1 was found to interact with a key transcription factor (IRF3) required for 
activation of the innate immune system (Barro and Patton, 2005; Graff et al., 2002), 
it was suggested that the selection force driving NSP1 divergence could be the ability 
to interrupt the host’s innate immune response. Further work has supported this idea, 
and suggested that the interaction between NSP1 and IRF3 functions to subvert the 
innate immune response by inducing degradation of IRF3. Immunoprecipitation 
studies with SA11-4F infected cells showed that the amount of IRF3 in infected cells 
was several-fold less than that in uninfected cells, indicating that IRF3 was being 
actively degraded during viral infection (Barro and Patton, 2005). Two naturally 
occurring viable C-terminal truncation mutants of NSP1 were also examined in this 
series of experiments. It was clear that less IRF3 degradation occurred in mutant 
infected cells than in those infected with wild type virus, providing further evidence 
that the region of NSP1 responsible for promoting degradation of IRF3 is near to the 
C-terminus of the protein (Barro and Patton, 2005). Studies using the proteasome 
inhibitor MG132 showed the level of IRF3 was maintained in cells cotransfected 
with wtNSP1 in the presence of the drug. By contrast a 50% reduction in the level of 
IRF3 was observed in the absence of MG132, indicating that the interaction of NSP1 
with IRF3 triggers the latter’s degradation through a proteasome-dependent pathway 
(Barro and Patton, 2005).  
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The current position is therefore that there appears to be two different areas of NSP1 
involved in its interaction with IRF3, the highly variable C-terminal region 
responsible for the possible binding of IRF3, and the conserved zinc finger motif 
near the N-terminus of the protein. However, it is likely that mutation of the zinc-
binding motif caused significant misfolding of NSP1 that inactivates the ability of 
NSP1 to degrade IRF3. This indicates that a better understanding of the overall 
structure of NSP1 is required to clearly define the molecular details of its interaction 
with IRF proteins.  
 
1.3.3 NSP1 can induce proteasome-dependent degradation of β-TrCP 
 
β-transducin repeat containing protein (β-TrCP), a component of the cellular E3 
ubiquitin ligase complex SCF
β-TrCP 
, has been shown to be a target of NSP1 from a 
porcine rotavirus strain OSU for proteasome-dependent degradation (Graff et al, 
2009). Cells transfected with plasmids encoding either OSU NSP1 or NCDV NSP1 
(which was shown to degrade IRF3 in early studies, Graff et al, 2002), together with 
a reporter plasmid encoding firefly luciferase under control of the IFNβ promoter 
were analysed. When the cells were stimulated with a PAMP, it was found that the 
reporter expression in cells transfected with OSU NSP1 was inhibited ~20 fold 
compared to cells transfected with an empty vector, similar to that caused by NCDV 
NSP1, which could be attributed to IRF3 degradation (Graff et al., 2002).  Therefore 
OSU NSP1 might utilize a different mechanism to inhibit IFNβ promoter-driven 
gene expression without a viral infection since it had previously been shown not to 
interact with IRF3 to cause its degradation (Graff et al., 2007).  
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Like IRF3, NFκB can also stimulate the expression of IFNβ and consequently Graff 
et al examined NFκB activation. Using an NFκB-responsive reporter, they showed 
that OSU NSP1 caused a 20-fold inhibition of NFκB driven reporter gene expression 
relative to cells transfected with the empty vector, which NCDV NSP1 only caused a 
5-fold inhibition (Graff et al., 2009). These results suggest that the interference with 
activation of NFκB seem to be the predominant mechanism of IFN antagonism in 
OSU-infected cells. Additionally, the group tested the functionality of the SCF
β-TrCP 
E3 ligase complex in the presence of NSP1, as it mediates proteasome-dependent 
degradation of IκBα and NFκB subunits which subsequently has an effect on NFκB 
activation. The results showed that, in contrast to uninfected cells, β-TrCP was 
detected only in cells infected with rotavirus strain A5-16, which encodes a truncated 
NSP1 (Taniguchi et al, 1996), not in those infected with OSU or NCDV. This result 
suggested that both OSU and NCDV NSP1s can target β-TrCP for degradation, even 
though the latter has a significantly reduced effect on NFκB signalling. When cells 
were transfected with Flag-β-TrCP then infected in the presence of MG132 with 
OSU and NCDV, β-TrCP levels remained stable, indicating that, as for IRF3, this 
degradation is also proteasome-dependent. The interaction between NSP1 and β-
TrCP was eventually confirmed in OSU infected cells by co-immunoprecipitation of 
NSP1 with β-TrCP from cells expressing Flag-β-TrCP proteins (Graff et al, 2009). 
Studies on interactions between NSP1 and β-TrCP have been done in human cell 
lines with some other virus strains including murine strain ETD, simian strain SA11, 
canine strain K9, lapine strain 30-96, bovine UKtc and human Wi61. The results 
suggested that only the NSP1 from Wi61 has a similar effect on β-TrCP as that 
previously demonstrated for porcine strain OSU (Arnold and Patton, 2011).  
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1.3.4 Other NSP1 targets 
 
Because the fact that there are shared multiple structural features in the IRF family, it 
is possible that by interacting with one of the common domains, the cellular targets 
for rotavirus NSP1 may not be limited to IRF3 and β-TrCP. Apart from the 
conserved DNA-binding domain near the N-terminal of all the IRF family members, 
some members have a serine-rich activation domain at the C-terminal region for 
phosphorylation, and others have a protein-protein interaction domain for mediating 
IRF dimerization (Barnes et al., 2002). It has been shown that NSP1 of SA11 can 
degrade IRF5 and IRF7 in addition to IRF3 (Barro and Patton, 2007), furthermore, 
murine strain ETD, rhesus strain RRV and lapine strain 30-96 also have the ability to 
induced degradation of IRF3, IRF5 and IRF7 (Arnold and Patton, 2011). Although 
the biological significance of this additional activity remains unclear, the degradation 
of IRF7 suggests that some rotaviruses may be particularly efficient in infecting 
specialized cells such like pDCs (plasmacytoid dendritic cells) which constitutively 
express IRF7 (Izaguirre et al., 2003). IRF5 is primarily detected in certain 
specialized cells such as DCs and B cells (Barnes et al., 2001); the ability of NSP1 to 
degrade IRF5 provided further evidence that NSP1 may support the virus in infecting 
specialised cells, which allows infections beyond the gut (Barro and Patton, 2007). 
Furthermore, it has also been reported that NSP1 from strains SA11 and OSU is able 
to inhibit RIG-I mediated activation of IFN-β in a dose-dependent way by interacting 
with RIG-I and causing subsequent RIG-I down regulation in a proteasome-
independent manner (Qin et al., 2011), suggesting that RIG-I might be another target 
for NSP1 in antagonizing the innate immune system.   
        
45
Chapter 1. Introduction 
 
 
 
1.4 Aims of the study 
 
Whilst there is considerable amount of evidence that NSP1 has evolved a number of 
ways to target components involved in the host innate immunity pathway, the 
complete nature of its IFN antagonist activity has yet to be revealed. Therefore the 
identification of the determinant of NSP1 sequence variations which influence its 
target specificity and activation efficiency may help to complete the mechanisms of 
NSP1 in rotavirus pathogenesis. The aim of this thesis is to gain a better 
understanding of the molecular determinant of NSP1 specificity for targeting the 
interferon production pathway by mapping the regions in NSP1 sequences 
responsible for specific host cellular targets.  
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2.1 Materials 
 
This section includes the complete collection of suppliers, cell lines, virus strains, 
bacterial strains, antibodies, primers and plasmids that were used in this study. 
 
Table 2.1.1 List of suppliers used in this study 
 
 
Supplier Address 
BD Biosciences Edmund Halley Road, Oxford Science Park, Oxford, UK 
Biorad 
Bio-Rad Laboratories Ltd. Bio-Rad House, Maxted Road, 
Hempstead, UK 
Cell Signaling 
Technology 
Cell Signaling Technology, Inc, 3 Trask Lane, Danvers, 
MA 01923, USA 
Clontech 
Clontech Laboratories, Inc. A Takara Bio Company 
1290 Terra Bella Ave. Mountain View, CA 94043, USA 
Eppendorf 
Eppendorf UK Ltd. Endurance House, Chivers Way, 
Histon, Cambridge, UK 
Fermentas Opelstrasse 9, St. Leon-Rot 68789, Germany 
Fisher Scientific 
Fisher Scientific UK Ltd. Bishop Meadow Road, 
Loughborough, UK 
FUJIFILM 
FUJIFILM UK Ltd. Unit 10A, St Martins Business 
Centre, St Martins Way, Bedfordshire, UK 
GE Healthcare 
GE Healthcare Life Sciences, Amersham Place, Little 
Chalfont, UK 
Invitrogen 
Life Technologies Ltd. 3 Fountain Drive, Inchinnan 
Business Park, Paisley, UK 
Melford 
Laboratories Ltd 
Melford Laboratories Ltd. Bildeston Road, Chelsworth, 
Ipswich, Suffolk, UK 
New England 
Biolabs Inc 
New England Biolabs (UK) Ltd. 
75/77 Knowl Piece, Wilbury Way, Hitchin, Herts, UK 
48
 Chapter 2. Materials and Methods 
 
 
 
 
PEQLAB Ltd. Building 34, Universal Marina, Sarisbury Green, UK 
Promega 
Promega UK, Delta House, Southampton Science Park, 
Southampton, UK 
Qiagen QIAGEN HOUSE, Fleming Way, Crawley, UK 
Santa-Cruz 
Biotechnology 
Santa Cruz Biotechnology, Inc. Bergheimer Str. 89-2 
69115 Heidelberg, Germany 
Sigma-Aldrich Sigma-Aldrich Company Ltd. Dorset, UK 
Stratect Scientific 
Ltd 
Acorn Business Centre, Oaks Drive, Suffolk, UK 
Thermo Scientific 
Building 2B, 28 Schenck Parkway, Suite 400 Asheville, 
NC 28803, USA 
Vector Laboratories 
Ltd 
Vector Laboratories Ltd, 3 Accent Park, Bakewell Road, 
Orton Southgate, Peterborough, UK 
 
 
Table 2.1.2 List of cell lines used in this study 
 
 
Cell 
Line 
Origin/Description Culture medium 
BSC-1 
African green monkey kidney cells 
(Supplied by Prof. M. A. McCrae, 
University of Warwick) 
GMEM NEAA + 5% (v/v) 
Fetal Bovin Serum (FBS)  
HEK293 
Human embryonic kidney cells 
(Supplied by Dr. K. N. Leppard, 
University of Warwick) 
DMEM + 10% (v/v) 
Newborn Calf Serum 
(NBCS)  
MA104 
African green monkey kidney cells 
(Supplied by Prof. M. A. McCrae, 
University of Warwick) 
GMEM NEAA + 5% (v/v) 
FBS  
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Table 2.1.3 List of Rotavirus strains used in this study 
 
 
Strain Phenotype 
UKtc Wild type tissue culture adapted Group A bovine RV  
OSU Wild type tissue culture adapted Group A porcine RV 
P9Δ5 NSP1 Frame-shift deletion tissue culture adapted Group A feline RV  
 
 
Table 2.1.4 List of bacterial strain used in this study 
 
 
Escherichia coli 
strain 
Genotype  
DH5α 
F
-
 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK
-
 
mK
+), λ–  
 
 
Table 2.1.5 List of primary antibodies used in this study 
 
 
Antibody Detail/Supplier 
Dilution for 
Western Blotting 
Rabbit anti-IRF3 
Polyclonal FL-425 Santa 
Cruz Biotechnology 
1:1000 
Rabbit anti-β-TrCP 
Polyclonal H-300  
Santa Cruz Biotechnology 
1:1000 
Rabbit anti-HA epitope 
Polyclonal Y-11 
Santa Cruz 
Biotechnology 
1:5000 
Mouse anti-FLAG 
epitope 
Monoclonal F3165 Sigma-
Aldrich 
1:100000 
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Rabbit anti-β-actin 
Rabbit monoclonal #4970  
Cell Signaling Technology 
1:2000 
Rabbit anti-p53 
Polyclonal FL-393 Santa 
Cruz Biotechnology 
1:10000 
Rabbit anti-Gal4 
Polyclonal SC-577 Santa 
Cruz Biotechnology 
1:1000 
Mouse anti-VP16 
Monoclonal SC-7546 
Santa Cruz Biotechnology 
1:1000 
 
 
Table 2.1.6 List of secondary antibodies used in this study 
 
 
Antibody Detail/Supplier 
Dilution for 
Western Blotting 
Goat anti-Mouse 
Horseradish peroxidase 
conjugate Sigma-Aldrich 
1:100000 
Goat anti-Rabbit 
Horseradish peroxidase 
conjugate Santa Cruz 
Biotechnology 
1: 100000 
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Table 2.1.7 List of primers used in this study  
 
 
Primer name Sequence 5’-3’ Application 
mpCR2.1_PstI 5’ GTCCGGTGCCCTGAATGAACTCCAGGACGAGGCAGCGCGGCTA Mutation of Pst I site in mpCR2.1vector  
mpCR2.1_PstI 3’ CGATAGCCGCGCTGCCTCGTCCTGGAGTTCATTCAGGGCACCG Mutation of Pst I site in mpCR2.1vector 
UKtc-EcoI 5’ GCGCGAATTCATGGCTACGTTCAAAGACGC 
PCR primer for cloning UKtcNSP1 into 
mpCR2.1 vector 
UKtc-XhoI 3’ GCGCCTCGAGTTATTCAACATCTGAAAGTTCTAAGTCG 
PCR primer for cloning UKtcNSP1 into 
mpCR2.1 vector 
OSU-BamHI 5’ GCGCGGATCCATGGCTACTTTTAAGGATGC 
PCR primer for cloning OSUNSP1 into 
mpCR2.1 vector 
OSU-XhoI 3’ GCGCCTCGAGTTATTCAACATCAGATATACCG 
PCR primer for cloning OSUNSP1 into 
mpCR2.1 vector 
UKtc-StuI 5’ GCAAATGATGAATGGAGGCCTGCACCAGTGACAAAATACAAAGGG 
Mutagenesis PCR primer for UKtcNSP1 to 
create Stu I site 
UKtc-StuI 3’ CCCTTTGTATTTTGTCACTGGTGCAGGCCTCCATTCATCATTTGC 
Mutagenesis PCR primer for UKtcNSP1to 
create Stu I site 
UKtc-PmlI 5’ GGATGTGCTTTGTACCACGTGTGTCAGTGG 
Mutagenesis PCR primer for UKtcNSP1to 
create Pml I site 
UKtc-PmlI 3’ CCACTGACACACGTGGTACAAAGCACATCC 
Mutagenesis PCR primer for UKtcNSP1to 
create Pml I site 
UKtc-AclI 5’ CGGAAACGTTGGGCAGTGTTCG 
Mutagenesis PCR primer for UKtcNSP1to 
create Acl I site 
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UKtc-AclI 3’ CGAACACTGCCCAACGTTTCCG 
Mutagenesis PCR primer for UKtcNSP1to 
create Acl I site 
UKtc-HpaI 5’ GGACTATGAAGTTAACTGGGAAGTGAGAGG 
Mutagenesis PCR primer for UKtcNSP1to 
create Hpa I site 
UKtc-HpaI 3’ CCTCTCACTTCCCAGTTAACTTCATAGTCC 
Mutagenesis PCR primer for UKtcNSP1to 
create Hpa I site 
UKtc-PstI 5’ GCCAATAACACTGCAGGCATTAACTATAAAACTTGAAGATAGC 
Mutagenesis PCR primer for UKtcNSP1to 
create Pst I site 
UKtc-PstI 3’ GCTATCTTCAAGTTTTATAGTTAATGCCTGCAGTGTTATTGGC 
Mutagenesis PCR primer for UKtcNSP1to 
create Pst I site 
UKtc-HindIII 5’ GGGATTATATCAAAGCTTGTAAAGCC 
Mutagenesis PCR primer for UKtcNSP1to 
create Hind III site 
UKtc-HindIII 3’ GGCTTTACAAGCTTTGATATAATCCC 
Mutagenesis PCR primer for UKtcNSP1to 
create Hind III site 
OSU-StuI 5’ GGAGTTAATGATACATGGAGGCCTTCACCTCCAACTAAATACAAAG 
Mutagenesis PCR primer for OSU to create 
Stu I site 
OSU-StuI 3’ CCTTTGTATTTAGTTGGAGGTGAAGGCCTCCATGTATCATTAACTCC 
Mutagenesis PCR primer for OSU to create 
Stu I site 
OSU-PmlI 5’ GGCTGTACCATGTATCACGTGTGTCAATGGTGTAGTCAATATGG 
Mutagenesis PCR primer for OSU to create 
Pml I site 
OSU-PmlI 3’ CCATATTGACTACACCATTGACACACGTGATACATGGTACAGCC 
Mutagenesis PCR primer for OSU to create 
Pml I site 
OSU-AclI 5’ CGAGCTTTAGTTAAATCAAACGTTAATGTTGG 
Mutagenesis PCR primer for OSU to create 
Acl I site 
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OSU-AclI 3’ CCAACATTAACGTTTGATTTAACTAAAGCTCG 
Mutagenesis PCR primer for OSU to create 
Acl I site 
OSU-PstI 5’ GCCAATAACACTGCAGTCTCTGTCAATTGAATTGG 
Mutagenesis PCR primer for OSUNSP1to 
create Pst I site 
OSU-PstI 3’ CCAATTCAATTGACAGAGACTGCAGTGTTATTGGC 
Mutagenesis PCR primer for OSUNSP1to 
create Pst I site 
OSU-HindIII 5’ GCGCAAACTCAAAATAGCATCTAAGCTTATAAAACC 
Mutagenesis PCR primer for OSUNSP1to 
create Hind III site 
OSU-HindIII 3’ GGTTTTATAAGCTTAGATGCTATTTTGAGTTTGCGC 
Mutagenesis PCR primer for OSUNSP1to 
create Hind III site 
UKtc-Flag 5’ AATTCACCATGGATTACAAGGATGACGACGATAAGC 
PCR primer for addition of Flag tag at 
UKtcNSP1 N-terminal 
UKtc-Flag 3’ GTGGTACCTAATGTTCCTACTGCTGCTATTCGTTAA 
PCR primer for addition of Flag tag at 
UKtcNSP1 N-terminal 
OSU-Flag 5’ GATCCACCATGGATTACAAGGATGACGACGATAAGCC 
PCR primer for addition of Flag tag at 
OSUNSP1 N-terminal 
OSU-Flag 3’ GTGGTACCTAATGTTCCTACTGCTGCTATTCGGCTAG 
PCR primer for addition of Flag tag at 
OSUNSP1 N-terminal 
IRF3-EcoRI 5’ GCGCGAATTCATGGGAACCCCAAAGCCACGGATCC 
PCR primer for cloning IRF3 into 
PM/PVP16 vector 
IRF3-EcoRI 3’ GCGCGGATTCTCAGCTCTCCCCAGGGCCCTGGAAATCC 
PCR primer for cloning IRF3 into 
PM/PVP16 vector 
β-TrCP-BamHI 5’ GCGCGGATCCAAATGGACCCGGCAGAGGCGGTGC 
PCR primer for cloning β-TrCP into 
PM/PVP16 vector 
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β-TrCP-BamHI 3’ GCGCGGATCCTTATCTGGAGATGTAGGTGTATGTTCG 
PCR primer for cloning β-TrCP into 
PM/PVP16 vector 
PM seq F primer  GCGGCTTCAGTGGAGACTGATATGCC 
Sequencing primer for PM vector 
associated genes 
PM seq R primer  GCGCGGTTCAGGGGGAGGTGTGG 
Sequencing primer for PM vector 
associated genes 
PVP16 seq F primer  GCCGGGATTTACCCCCACGACTCCG 
Sequencing primer for PVP16 vector 
associated genes 
PVP16 seq R primer GCATTCATTTTATGTTTCAGGTTCAGGG 
Sequencing primer for PVP16 vector 
associated genes 
M13 F primer GTAAAACGACGGCCAG 
Sequencing primer for pCR2.1 vector 
associated genes 
M13 R primer CGAGAAACAGCTATGAC 
Sequencing primer for pCR2.1 vector 
associated genes 
UKtc CMV seq primer GCTCCTAGTTTAAGTACTAAGC Sequencing primer for CMV promoter 
OSU CMV seq primer GGT CTC CAT GTA TCA TTA ACT CC Sequencing primer for CMV promoter 
RT_common F primer GCGCTAACGCAGTCAGTGCTTCTGAC 
Common forward PCR primer for UKtc and 
OSUNSP1 to detect RT reaction 
RT_UKtc R primer GCCCATTCATCATTTGCTCC 
PCR reverse primer for UKtcNSP1 to 
detect RT reaction 
RT_OSU R primer GCCCATGTATCATTAACTCC 
PCR reverse primer for OSUNSP1 to detect 
RT reaction 
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Table 2.1.8 List of plasmids used in this study 
 
 
Plasmid Description 
mpCR2.1 vector Modified pCR2.1 vector with altered Acl I (p2315 and 2688), Pst I (p1499) and Hind III (p235) sites 
mpCR2.1-UKtcNSP1 UKtcNSP1 cloned into mpCR2.1 vector between restriction enzyme sites EcoR I and Xho I 
mpCR2.1-OSUNSP1 OSUNSP1 cloned into mpCR2.1 vector between restriction enzyme sites BamH I and Xho I 
mpCR2.1-UKtc-StuI UKtcNSP1expressing plasmid with Stu I site generated 
mpCR2.1-UKtc-PmlI As mpCR2.1-UKtc-StuI with Pml I site generated 
mpCR2.1-UKtc-HpaI UKtcNSP1expressing plasmid with Hpa I site generated 
mpCR2.1-UKtc-AclI As mpCR2.1-UKtc-HpaI with Acl I site generated 
mpCR2.1-OSU-StuI OSUNSP1expressing plasmid with Stu I site generated 
mpCR2.1-OSU-PmlI As mpCR2.1-OSU-StuI with Pml I site generated 
mpCR2.1-OSU-AclI OSUNSP1expressing plasmid with Acl I site generated 
mpCR2.1-UKtcNSP1-4RE UKtcNSP1expressing plasmid with Stu I, Pml I, Acl I and Hpa I sites generated 
mpCR2.1-OSUNSP1-4RE OSUNSP1expressing plasmid with Stu I, Pml I and Acl I sites generated 
pM-53 
4.6 kb positive control plasmid expressing a fusion of the GAL4 DNA-BD to the mouse p53 
protein(Clonetech) 
pVP16-T 
5.3 kb positive control plasmid expressing a fusion of the VP16 AD to the SV40 large T-antigen which is 
known to interact with p53(Clonetech) 
pVP16-CP 
4.5 kb negative control plasmid expressing a fusion of the VP16 AD to a viral coat protein which does not 
interact with p53(Clonetech) 
pM-OSUNSP1 OSUNSP1 expression plasmid fused to the GAL4 DNA-BD 
pM-UKtcNSP1 
UKtcNSP1 expression plasmid fused to the GAL4 DNA-BD (Provided by Dr K.T.Chung, University of 
Warwick) 
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pVP16-UKtcNSP1 UKtcNSP1 expression plasmid fused to the VP16 AD (Provided by Dr K.T.Chung, University of Warwick) 
pVP16-OSUNSP1 OSUNSP1 expression plasmid fused to the VP16 AD 
pEFplink2-IRF3 IRF3 expression plasmid (Provided by Dr S Goodbourn, University of London) 
pcDNA3.1-HA-IRF3 IRF3 expression plasmid with 3 HA epitope sequence tagged at C-terminal of IRF3 
pM-IRF3 IRF3 expression plasmid fused to the GAL4-DNA-BD 
pVP16-IRF3 IRF3 expression plasmid fused to the VP16 AD 
pcDNA3.1-HA- β-TrCP1a β-TrCP expression plasmid with HA tagged (Provided by Dr A Stephanou, University of London) 
pM-β-TrCP β-TrCP expression plasmid fused to the GAL4-DNA-BD 
pVP16-β-TrCP β-TrCP expression plasmid fused to the VP16 AD 
pcDNA3.1- UKtcNSP1-4RE Expression plasmid for UKtcNSP1 with 4 selected RE sites generated 
pcDNA3.1- OSUNSP1-4RE Expression plasmid for OSUNSP1 with 4 selected RE sites generated 
pcDNA3.1- Flag_UKtcNSP1-4RE 
As pcDNA3.1- UKtcNSP1-4RE with a FLAG epitope sequence (MDYKDDDDK) tagged upstream of the 
NSP1 translation initiation codon 
pcDNA3.1- Flag_OSUNSP1-4RE 
As pcDNA3.1- OSUNSP1-4RE with a FLAG epitope sequence (MDYKDDDDK) tagged upstream of the 
NSP1 translation initiation codon 
pCIneo- Flag_UKtc NSP1-4RE Expression plasmid for UKtc NSP1-4RE 
pCIneo- Flag_OSU NSP1-4RE Expression plasmid for OSU NSP1-4RE 
pA 
Expression plasmid for NSP1 with the sequences between RE sites Stu I and Acl I came from OSUNSP1 and 
the rest from UKtcNSP1 
pB 
Expression plasmid for NSP1 with the sequences between RE sites Stu I and Acl I came from UKtcNSP1 and 
the rest from OSUNSP1 
pC 
Expression plasmid for NSP1 with the sequences between RE sites EcoR I and Pml I came from UKtcNSP1 
and the rest from OSUNSP1 
pD 
Expression plasmid for NSP1 with the sequences between RE sites EcoR I and Pml I came from OSUNSP1 
and the rest from UKtcNSP1 
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pE 
Expression plasmid for NSP1 with the sequences between RE sites Hpa I and Xho I came from OSUNSP1 
and the rest from UKtcNSP1 
pF 
Expression plasmid for NSP1 with the sequences between RE sites Hpa I and Xho I came from UKtcNSP1 
and the rest from OSUNSP1 
pG 
Expression plasmid for NSP1 with the sequences between RE sites Eco I and Stu I came from UKtcNSP1 and 
the rest from OSUNSP1 
pH 
Expression plasmid for NSP1 with the sequences between RE sites Eco I and Stu I came from OSUNSP1 and 
the rest from UKtcNSP1 
pI 
Expression plasmid for NSP1 with the sequences between RE sites Acl I and Hpa I came from OSUNSP1 and 
the rest from UKtcNSP1 
pJ 
Expression plasmid for NSP1 with the sequences between RE sites Acl I and Hpa I came from UKtcNSP1 
and the rest from OSUNSP1 
pK 
Expression plasmid for NSP1 with the sequences between RE sites Acl I and Xho I came from OSUNSP1 and 
the rest from UKtcNSP1 
pL 
Expression plasmid for NSP1 with the sequences between RE sites Acl I and Xho I came from UKtcNSP1 and 
the rest from OSUNSP1 
pIFNβ-Luc 
A firefly luciferase reporter plasmid of the Homo sapiens interferon β promoter. The promoter lies upstream 
of the firefly luciferase gene. (King & Goodbourn, 1994) 
pPRDI/III-Luc 
ptk-Luciferase reporter plasmid ( Promega) containing the PRDI/III element of the IFN β promoter (Provided 
by Dr Y Ke, Peking University College of Oncology) 
pConA-Luc 
A firefly luciferase reporter driven by the NFkB sites in the Concanavalin A promoter (Mankouri et al. 2010 
PLoS Pathogens) 
pcDNA3.1-HisB::lacZ β-galactosidase expression plasmid driven by the CMV IE promoter region (Invitrogen) 
pUAST-hrGFP-neo 
GFP expression plasmid under the control of a Gal4-responsive promoter (Provided by Dr K.T.Chung, 
University of Warwick) 
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2.2 Methods 
 
2.2.1  Bacteriological techniques 
 
2.2.1.1 Growth of bacteria 
 
The bacteria were grown in liquid LB medium containing appropriate antibiotics 
(100µg/ml of ampicillin or 25 µg/ml of kanamycin) in a sterile vessel with 
approximately four times the volume of the liquid culture at 37°C and shaken 
vigorously. 
 
2.2.1.2 Preparation of competent cells 
 
DH5α was used as competent cells throughout the entire study. 2ml of fresh 
overnight bacterial culture was inoculated into 200ml of pre-warmed liquid LB 
medium and shaken vigorously at 37°C until OD600 of the culture reached 0.39. The 
culture was then put on ice for 5 minutes followed by centrifugation (Beckman 
Coulter Allegra
TM 
X-12R Centrifuge) at 6,000rpm for 10 minutes at 4°C. The pellet 
was resuspended in 80ml of ice-cold transformation buffer I (10Mm RbCl2, 30mM 
potassium acetate, 10mM CaCl2, 50Mm MnCl2 and 15% (v/v) glycerol, pH 5.8) and 
then left on ice for 5 minutes. Centrifugation was repeated at 6,000rpm for another 
10 minutes at 4°C; the pellet was subsequently resuspended in 8ml of ice-cold 
transformation buffer II (75mM CaCl2, 10mM RbCl2, 10mM MOPS and 15% (v/v) 
glycerol, pH 6.5) and left on ice for 2 hours. The competent cells were transferred 
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into 100µl aliquots for use or frozen with dry ice before storage at -70°C (up to three 
months).   
 
2.2.1.3 Transformation of competent bacterial cells by heat shock 
 
Ligation product or plasmid DNA (typically 50ng) was added into 100µl of thawed 
competent cells and left on ice for 30 minutes. Cells were heat shocked for 45 
seconds in a 42°C water bath followed by immediate incubation on ice for another 2 
minutes. 400µl of pre-warmed liquid LB medium was added to the competent cell 
mixture and incubated at 37°C in a shaking incubator for 1 hour; the cells were then 
plated onto LB plates containing appropriate selection of antibiotics and incubated at 
37°C overnight. 
 
2.2.1.4 Transformation of competent bacterial cells by electroporation 
 
Competent bacterial cells for electroporation were prepared as described previously 
until the OD600 reached around 0.39. Cells were then pelleted and washed in equal, 
half and a quarter volumes of ice-cold H2O containing 10% glycerol, cells were 
finally resuspended in 3ml of ice-cold H2O containing 10% glycerol. The 
resuspended cells were aliquoted into 100µl and used immediately or stored at -70°C 
until used. The entire electroporation procedures were carried out on ice. Pre-cooled 
0.2cm cuvettes containing competent cells and DNA (typically total volume of 50µl) 
were inserted into the cuvette slides of Bio-Rad Gene Pulser system which was 
previously set with voltage at 2.5 kV, capacitance at 25µFD, capacitance extender at 
150 µFD and pulse controller at 200 Ohms resistance. The time constant value was 
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used to monitor electroporation with a reading above 4.6 being considered as a 
successful electroporation. Cells were then incubated in liquid LB medium for 1 hour 
at 37°C and then plated on LB agar plates containing appropriate antibiotics.      
 
2.2.1.5 Extraction of plasmid DNA (Mini Prep, Midi Prep and Maxi Prep) 
 
Plasmids were extracted using Qiagen MiniprepKit
TM
, Promega Pureyield
TM
 Plasmid 
Midiprep System or Sigma GenEluteTM Plasmid Maxiprep Kit according to specific 
requirements for the utility of the plasmids; all the protocols were obtained from the 
manufacturers’ instructions. 
 
2.2.1.6 Quantification of nucleic acid 
 
The concentration of DNA and RNA samples was quantified using Nanodrop-
ND1000 spectrophotometer (Thermo Scientific) by measuring OD260. The purity of 
DNA and RNA was indicated by the absorbance ratio of OD260 to OD280, where a 
ratio of 1.8 indicates pure DNA and a ratio of 2 indicates pure RNA. 
 
2.2.1.7 Blue/white selection of bacterial colonies 
 
LB plates containing appropriate antibiotics were aseptically covered with 40µl of 
20mg/ml X-Gal (Melford Laboratories Ltd.) in DMF and 4µl of IPTG (Melford 
Laboratories Ltd.). The plates were then left to dry at 37°C for 1 hour and ready for 
inoculation overnight. On the next day, plates were examined for white colonies as 
these indicate the ones containing the plasmid carrying the inset of interest. Selected 
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white colonies were transferred to 5ml of pre-warmed liquid LB medium containing 
appropriate antibiotics and incubated overnight in a 37°C shaking incubator for 
plasmid DNA extraction. 
 
2.2.2  Manipulation of DNA 
 
2.2.2.1 Standard Polymerase Chain Reaction (PCR) 
 
Standard PCR amplifications were carried out in a final volume of 50µl in 0.5ml 
microcentrifuge tubes using a Primus 96 advanced Gradient Innovative PCR 
Technology (PeQLab). The reaction mixture usually included 50ng of template 
DNA, 100ng of each primer, 0.25µM of each dNTP, 5µl of 10X PCR Buffer, 1.5mM 
of MgCl2 and 2 units of Taq polymerase (Invitrogen). The mixture was incubated at 
94°C for 1 min and subjected to 40 PCR cycles as follows: denaturing at 94°C for 1 
min, annealing at 55-60°C for 1 min and extending at 72°C for 1 min/kb of amplicon. 
The annealing temperature was adjusted depending on the GC content of the specific 
primers used in order to reduce non-specific amplification in some individual PCR 
reactions.  
 
2.2.2.2 Site-Direct Mutagenesis PCR   
 
All mutagenesis PCR was performed with Platinum Pfx DNA polymerase 
(Invitrogen) to ensure higher fidelity. According to the manufacture’s instruction, 
MgSO4 was used as a source of magnesium. The reaction mixture (typically 50µl) 
containing 100ng of template DNA, 100ng of each primer, 0.25µM of each dNTP, 
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5µl of 10X PCR Buffer, 1.5-3mM of MgSO4 and 2 units of Platinum Pfx DNA 
polymerase was incubated at 94°C for 1 min followed by 30 cycles of 94°C for 1 min, 
55-58°C for 1 min and 68°C for 1 min/kb of amplicon. The annealing temperature 
was adjusted depending on the GC content of the specific primers used and the final 
concentration of magnesium was adjusted in some individual PCR reactions for 
optimization. The mutagenesis PCR product was digested with Dpn I to remove 
methylated template before ligating into the appropriate vectors.     
 
2.2.2.3 Restriction Enzyme Digest 
 
Typically up to 1µg of plasmid DNA or PCR product was digested in a total reaction 
volume of 50µl. Restriction enzymes were used with recommended reaction buffers 
according to the manufacturer’s instructions. In reactions requiring multiple 
restriction enzyme digests, reaction buffer selected was the most optimal for all 
enzymes; in which this was not possible, sequential digestions were carried out, with 
DNA being purified after each reaction with a GFX PCR DNA and gel band 
purification kit (GE Healthcare) according to the manufacturer’s instructions.  
 
2.2.2.4 De-phosphorylation of vector DNA 
 
Removal of 5’ phosphate groups from DNA was achieved by adding 1 unit of shrimp 
alkaline phosphatise (SAP) (Fermentas) to per µg of DNA treated according to the 
manufacturer’s instructions. SAP was inactivated by incubating the reaction mixture 
at 65°C for 15 minutes. 
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2.2.2.5 Conversion of 5’ overhangs restriction enzyme ends to blunt ends 
 
5’ overhangs generated in a restriction enzyme digestion were filled in using large 
fragment of DNA polymerase I (1unit/µg DNA treated) (Invitrogen) in the supplied 
buffer together with 0.5mM of each dNTP at room temperature for 15 minutes. The 
fill-in reaction was subsequently terminated by phenol extraction. 
 
2.2.2.6 Phenol/Chloroform extraction 
 
An equal volume of Phenol/Chloroform/iso-amyl alcohol solution was added to the 
DNA sample followed by vortexing for 1 minute, the mixture was centrifuged at 
16,000 x g in a micro-centrifuge for 2 minutes. The upper layer was then transferred 
to a clean tube and an equal volume of chloroform/iso-amyl alcohol was added. The 
mixture was vortexed and centrifuged again as before. The upper layer was 
transferred to a clean tube containing distilled H2O making the final volume of 250µl 
and stored at -20°C until needed.  
 
2.2.2.7 Ethanol precipitation of DNA 
 
DNA in aqueous solution was precipitated by adding 1/10 volume of 3M sodium 
acetate pH 5.2 and 2.5 X volume of 100% ice-cold ethanol. After incubation at -70°C 
for 1 hour, precipitated DNA was collected by centrifuging at 13,200rpm at 4°C for 
10 minutes using a tabletop microcentrifuge. Pellets were washed in 80% ice-cold 
ethanol followed by drying in a vacuum dessicator for 20 minutes. Pellets were then 
resuspended in 50µl of sterile distilled water. 
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2.2.2.8 Agarose gel electrophoresis of DNA 
 
DNA molecules were typically separated by elecreophoresis on 1% (w/v) agarose in 
1X TBE buffer (89mM Tris base, 89mM Boric acid and 2mM EDTA) containing 
0.5µg/ml ethidium bromide. DNA samples were loaded onto the gel in 1X loading 
buffer (5% (w/v) glycerol, 0.04% (w/v) bromophenol blue and 0.04% (w/v) xylene 
cyanol). Electrophoresis was carried out in 1X TBE buffer at 70V for 1 hour. DNA 
fragments were visualised under UV light and imaged using a BioRad Gel/Chemi 
Doc system with associated software. 
 
2.2.2.9 Agarose Gel Extraction of DNA 
 
DNA bands of interest were excised from the agarose gel using a clean scalpel under 
UV light. The DNA was recovered using a Qiagen Gel Extraction Kit or a GFX PCR 
DNA and gel band extraction kit under the instructions recommended by the 
manufacturers. 
 
2.2.2.10 DNA Ligation 
 
Ligation of DNA molecules was performed in a final reaction volume of 20-50µl. A 
3:1 molar ratio of insert DNA to vector DNA was typically used. This ratio was 
changed to 5:1 in some particular reactions to increase ligation efficiency. T4 DNA 
ligase was used according to the manufacturer’s instructions with supplied buffers 
under recommended conditions.  
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2.2.2.11 DNA Sequencing 
 
All DNA sequencing was done in-house by the Molecular Biology Service at 
University of Warwick using an automated ABI PRISM 3130xl Genetic Analyse. 
Sequencing data were viewed using Chromas Lite 2.0 and analysed using Clone 
Manager, SciEd Central, v7.04 software. 
 
2.2.2.12 Transfection of plasmid DNA 
 
Lipofectamine 2000 (Invitrogen) was used for liposome-mediated transfection of 
plasmid DNA throughout the entire study. A ratio of 2µl of reagent per µg of 
plasmid DNA transfected was used, and this ratio was applied to all transfections in 
all cell lines used during this study.  
 
All transfections were performed in 12 or 24-well plates. Cells were seeded about 24 
hours before the procedure to allow approximately 60-70% of cell confluence by the 
time of transfection. Transfection reagent and DNA mixture was prepared in pre-
warmed OptiMEM medium to make a total volume of 100µl (24-well plate) or 200µl 
(12-well plate) per well. After incubation for 20 minutes at room temperature the 
complex mixtures were gently pipetted onto the cells containing serum medium. 
Cells were then incubated at 37°C in a 5% CO2 incubator for 24 or 40 hours 
depending on different requirements for individual experiment.   
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2.2.3  Manipulation of RNA 
 
2.2.3.1 Extraction of RNA from cultured 293 cells 
 
RNA sample was extracted from one well of confluent cells in 12-well plates. Cells 
were washed twice with 500µl of ice-cold sterile TBS and harvested by centrifuging 
at 3,000rpm for 3 minutes at 4°C. The pellets were resuspended in 40µl of ice-cold 
isotonic buffer (150mM NaCl, 10mM Tris/HCl and 1.5mM MgCl2, pH 7.6) 
containing 10% NP40 (200µl of 10%NP40 per 3ml of isotonic buffer). 250µl of TRI 
reagent (Sigma-Aldrich) was added to the cell suspension and left at room 
temperature for 2 minutes. 50µl of chloroform was then added and left at room 
temperature for another 10 minutes. The mixture was subsequently centrifuged at 
13,000rpm for 10 minutes at 4°C. The upper aqueous layer of the mixture was 
carefully removed into a fresh tube containing 200µl of ice-cold isopropanol, and the 
mixture was left at -20°C overnight or longer for storage until required.  
 
When RNA was needed, the mixture was centrifuged at 13,000rpm for 10 minutes at 
4°C. The pellet was washed with 75% ice-cold ethanol and centrifuged again at 
13,000rpm for 10 minutes at 4°C. The pellet was then air-dried for 15 minutes and if 
required, it can be left to dry for another 20 minutes in a vacuum dessicator.  Finally 
the pellet was resuspended in 50µl of RNAse-free water and used for analysis 
immediately or stored at -20°C until required.  
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2.2.3.2 Reverse-Transcription (RT) PCR 
 
1µg of RNA was used per reaction for reverse transcription. Reactions were 
performed in a total volume of 50µl using SS-Reverse Transcriptase (Fermentas) 
according to the manufacturer’s instructions. Reactions were left to proceed for 1 
hour at 42°C before incubation at 70°C for 15 minutes to terminate reverse 
transcriptase activity. 0.5µl of RNase H was added to the reaction followed by 
incubation at 37°C for 20 minutes. 2.5µl of the final reaction volume was used for 
subsequent PCR analysis. 
 
2.2.3.3 Transfection of cells by poly (I:C) 
 
Lipofectamine 2000 (Invitrogen) was used for transfecting cells with poly (I:C) with 
a ratio of 2µl of transfecting reagent per µg of poly(I:C) throughout the entire study. 
The mixtures were prepared in pre-warmed OptiMEM medium to make a total 
volume equivalent to 100µl (24-well plate) or 200µl (12-well plate) per well. The 
mixture was left for incubation at room temperature for 20 minutes and gently 
pipetted into the cells containing serum medium. Cells were incubated for 16 hours 
before being harvested for further analysis.  
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2.2.4  Mammalian cell culture techniques  
 
2.2.4.1 Maintenance of tissue culture cells 
 
Mammalian cell lines were maintained at 37°C in a 5% CO2 incubator in a 
humidified atmosphere using appropriate medium (Table 2.1.2). Cells were passaged 
every 3 to 4 days based on different demands. When confluent, the cells were 
detached by rinsing the cell monolayer with versene (0.02% EDTA in PBS) followed 
by incubation with trypsin/versene (1:5 v/v) for cell disaggregation; cell suspensions 
were then centrifuged at 13,000rpm for 3 minutes to form pellet; cell pellets were 
resuspended and reseeded at appropriate ratios (1:4 for 293, BSC-1 and MA104 
cells). All manipulations were carried out under sterile conditions in a Class II 
Laminar Flow Cabinet using standard aseptic techniques. 
 
2.2.4.2 Growth of rotavirus 
 
Cell monolayers were washed twice with serum-free medium and inoculated with 
pre-treated rotavirus (10μg of trypsin per μl of virus inoculum) diluted in serum-free 
medium with an m.o.i of 0.5 for 40 minutes at 37°C. The inoculum was then 
removed by aspiration and serum-free medium was replaced, the cells were 
incubated at 37°C until the cytopathic effect (CPE) reached about 80% after typically 
5-6 days. A sterile rubber policeman was used to harvest the infected cell. The 
infected cells were treated with three freeze-thaw cycles, aliquoted and stored at -
70°C until required. 
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2.2.4.3 Titration of virus stocks 
 
Serial ten-fold dilutions of pre-trypsin treated virus stock were prepared in serum-
free GMEM, and 0.2ml of each virus dilution was added to confluent BSC-1 cell 
monolayers in 12-well plates. After incubation at 37°C for 40 minutes, the inoculum 
was removed by aspiration and 2ml of serum-free GMEM overlay containing 1μg/μl 
trypsin was added to each well and incubated at 37°C for 4-5 days for development 
of virus plaques. The cells were then fixed with formal-saline (30% (v/v) 
formaldehyde in PBS) overnight. The virus plaques were visualised by staining the 
remaining cells with 0.1% (w/v) crystal violet. 
 
2.2.4.4 MG132 treatment 
 
293 cells were transfected with plasmid DNA as described previously. 40 hours post 
transfection, the medium was replaced with 1ml of 10% FBS DMEM containing 
50µM MG132 (Sigma-Aldrich or Stratect Scientific Ltd). Cells were left to incubate 
at 37°C for a further 8 hours before harvest.  
 
2.2.4.5 Mammalian two-hybrid assay 
 
Mammalian two-hybrid assay was performed using Matchmaker
TM
 Mammalian 
Assay Kit according to the manufacturer’s instructions and recommended protocol. 
pUAST-hrGFP-neo expressing green fluorescent protein (provided by Dr K.T.Chung, 
University of Warwick) was used as the reporter plasmids and cells were visualised 
under UV microscopy. 
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2.2.5  Protein expression and analysis 
 
2.2.5.1 Coupled Transcription/Translation system 
 
Coupled transcription/translation was performed using TNT T7 Quick Coupled 
Transcription/Translation system (Promega) according to the manufacture’s 
recommended protocol with 
35
S methionine incorporated for visualization. 
 
2.2.5.2 Determination of protein concentration 
 
The Bio-Rad protein assay
TM
 was used according to the manufacture’s instructions 
using bovine serum albumin (BSA) generating a standard curve for comparison of 
protein concentrations. 
 
2.2.5.3 Harvesting of total cellular protein 
 
Cell monolayers were washed once with PBS before incubation with 100μl of 1X 
sample buffer with DTT (50μl of 2X sample buffer (2ml 10% SDS stock solution, 
1ml glycerol, 250μl of 1M Tris-HCl pH6.8, 1.75ml of dH2O and grains bromophenol 
blue), 10μl of DTT and 40μl of dH2O) per well in a 24-well plate at room 
temperature for 5 minutes. The cell lysates were collected and boiled for 10 minutes 
to denature the proteins and used immediately or stored at -70°C for future analysis. 
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2.2.5.4 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
Denatured protein samples were separated by SDS-PAGE. Gels were made of a 5% 
acrylamide stacking gel and a 10% acrylamide resolving gel. Typically, 
electrophoresis was performed for 1.5 hours at 120V in 1X running buffer (25mM 
Tris, 192mM glycine and 0.1%SDS, pH8.3) at room temperature. All SDS-PAGE 
performed in this study utilised the Bio-Rad mini-PROTEIN III systems according to 
the manufacturer’s instructions. 
 
2.2.5.5 Transfer of proteins onto nitrocellulose membranes 
 
Prior to transfer the stacking gel was removed, and the separated proteins from the 
resolving gel were transferred onto nitrocellulose membranes. Transfers were 
performed in 1X transfer buffer (25mM Tris base, 192mM glycine and 20% 
methanol) at 4°C at 350mA for 1.5 hours or 80mA overnight using the Bio-Rad Mini 
Trans-Blot Electrophoretic Transfer Cell system according to the manufacturer’s 
instructions. All transfers utilised Hybond
TM
  ECL
TM
 nitrocellulose membranes 
throughout this study.  
 
2.2.5.6 Western Blotting 
 
Nitrocellulose membranes were incubated for 1.5 hours in 20ml of blocking solution 
(2% milk in PBS containing 0.05% (v/v) Tween-20 or 5% BSA in TBS containing 
0.1% (v/v) Tween-20) at room temperature on an orbital shaker. Membranes were 
then probed with 3ml of selected primary antibody against the protein of interest 
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diluted in appropriate blocking solution for 1 hour at room temperature on the shaker. 
The dilution of the primary antibody was dependent upon the protein of interest 
(Table 2.1.5). Membranes were then washed for 1 hour on the shaker with PBS 
containing 0.05% (v/v) Tween-20 or TBS containing 0.1% (v/v) Tween-20 with the 
washing buffer replaced every 8-10 minutes. The membranes were then probed with 
3ml of the appropriate secondary antibody (Table 2.1.6) diluted in blocking solution 
for 1 hour. Membranes were then washed for 1 hour again with the washing buffer 
replaced every 8-10 minutes. The blots were developed using ECL
TM
 Advance 
according to the manufacturer’s instructions and exposed to FUJI superRX X-Ray 
Film and developed using an AGFA Curix60 developer.  
 
2.2.5.7 Co-Immunoprecipitation 
 
Co-Immunoprecipitation was performed using ANTI-FLAG M2 Affinity Gel (Sigma) 
according to the manufactures’ instruction. All transfection were performed in 
duplicates on sub-confluent (70%-80%) 293 cell monolayers in 6 well plates. Each 
well of cells was transfected with 2.5µg of total DNA including 1.25µg of each of 
the two plasmids transfected. 40 hours post transfection; the samples were mock-
treated or treated with MG132 for another 8 hours. The cell harvesting procedure 
was performed on ice. Cells were washed twice with 2ml of ice-cold PBS-
pic1(Protease Inhibitor Cocktail) before harvested in 500µl of Guccionne buffer 
(25mM HEPES pH7, 0.1% NP40, 0.5M NaCl, 1mM Nabutyrate) in combination 
with 1% pic1 per well. Cell lysates were left on ice for 20 minutes, sonication 
treatment was performed for 10 seconds and cells were centrifuged at 12,000 x g for 
20 minutes in a pre-cooled tabletop centrifuge at 4°C. Supernatant was transferred 
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into a new chilled tube and diluted with an equal volume of 50mM salt buffer to get a 
final solution of 275mM salt. 10% of the input at this stage was removed and added 
into equal volume of 1 x SB for direct western blotting analysis. 100µl of 1 x SB was 
added to the pellet. The supernatant samples were stored on ice until the binding step.  
 
ANTI-FLAG M2 Affinity Gel was resuspended thoroughly before use, suspended 
gel was transferred in bulk and 20µl of resin was used per reaction. The resin was 
centrifuged for 5 seconds at 10,000 x g and settled on ice for 2 minutes. 23G needles 
and syringe on aspirator were used to remove the supernatant. The resin was washed 
twice with 0.2ml of TBS-pic1 per 20µl of resin, and the resin was washed again with 
0.2ml of 1.1M Gly-HCl pH2.8, supernatant was discarded and the resin was then 
washed twice with TBS-pic1. The third TBS-pic1 wash was applied and the resin 
was thoroughly suspended. 220µl of suspension of each sample was aliquoted into 
pre-cooled tubes, centrifuged and aspirated. Cell lysate supernatant was added to the 
washed affinity gel-containing tubes. Samples were agitated by strapping to rotary 
mixer in cold room for 3 hours or overnight. The resin was centrifuged again for 5 
seconds at 10.000 x g and the supernatant was removed. The resin was then washed 6 
times with 500µl of TBS-pic1. Elution of the FLAG fusion protein was performed at 
room temperature. 40µl of 2 X SB was added to each sample, the samples were then 
boiled for 5 minutes followed by centrifuging at 10,000 x g for 5 seconds to pellet 
any undissolved gel. The supernatants were transferred to fresh tubes using needles 
and syringes and 10µl of DTT was added to each sample. Samples were stored at -
70°C until required in SDS-PAGE and immunoblotting.     
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2.2.6  Luciferase reporter assay 
 
2.2.6.1 Preparation of cell lysates 
 
All transfections were performed in triplicate on sub-confluent (50%-60%) 293 cell 
monolayers in 24 well plates. Each well of cells was transfected with 500ng of total 
DNA, in which 250ng of the expression plasmid of interest and 250ng of a 
combination of reporter plasmids of inducible reporter (pIFNβ-Luc, pPRDI/III-Luc 
or pConA-Luc) to autonomous reporter (pcDNA3.1-hisB::lacZ) with a ratio of 9:1. 
24 hours later cells were mock-transfected or transfected with 1μg of poly (I:C) per 
well. Cells transfected with poly (I:C) were then incubated for a further 16 hours 
before harvest. Cells were washed with 200μl of PBS and subsequently harvested in 
100μl of 1X passive lysis buffer (Promega) per well, after shaking the plates for 1 
hour at room temperature, cells lysates were collected and used immediately or 
stored at -20°C for short-term storage until used.  
 
2.2.6.2 β-Galactosidase Assay 
 
All β-Galactosidase assays were performed in clear 96-well plates (BD Falcon). 20μl 
of cell lysate was mixed with 130μl of Z-buffer (60mM Na2HPO4.7H2O, 40mM 
NaH2PO4.H2O, 1mM KCl and 1mM MgSO4.7H2O), 32μl of ONPG and 0.382μl of β-
mercaptoethanol in each well. The plates were then incubated at 37°C until the 
reaction mixture became visibly yellow in colour, at which point reactions were 
stopped by adding 80μl of 1M Na2CO3. The OD405nm was measured using a 
colorimeter (Labsystems Multiskan RC) and associated software. 
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2.2.6.3 Bright-Glo Luciferase Assay 
 
All assays were performed in opaque, half-volume 96-well plates (Greiner). 20μl of 
cell lysates were mixed with 25μl of Bright-Glo Luciferase Assay Substrate 
(Promega) in each well. Luciferase activities were measured using a Luminoskan 
Ascent microplate luminometer and associated software.  
 
2.2.6.4 Luciferase Assay Data Analysis 
 
Relative Luciferase Activity (RLA) for each sample was calculated in order to 
normalise luciferase activity to the general transfection efficiency of the cells. This 
was achieved by dividing the value of luciferase activity by the value of the activity 
of β-Galactosidase reporter for each sample. All RLA values were calculated 
independently for each sample either treated or untreated with Poly (I:C). Finally all 
the RLA values were normalised to the respective control with the control sample 
having the value of 1. Within each experiment the standard deviation from the mean 
of the ratios obtained from each set of triplicates was calculated. As the experiment 
was repeated three to four times under the same condition, a two-tailed Student’s t-
test analysis was performed to all the values to investigate whether or not the datasets 
were significantly different from the subjected control values.  
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3.1 Introduction 
 
In a yeast two-hybrid interaction screen of an MA104 cDNA library, that employed 
NSP1 of a bovine rotavirus (strain B641) as bait, the interferon regulatory factor 3 
(IRF3) was identified as the primary cellular interaction partner of NSP1 (Graff et 
al., 2002). The same research group also found that NSP1 synthesized in infected 
MA104 cells interacted with host cellular IRF3 in a GST pull-down assay suggesting 
that the interaction was not unique to the yeast two-hybrid system (Graff et al., 
2002). Similarly, NSP1 of another bovine rotavirus (strain UKtc) has also been 
shown to interact with IRF3 in a yeast two-hybrid assay (Goodbourn et al., 
unpublished results) and in addition, this interaction caused IRF3 degradation in a 
proteasome dependent manner (Barro and Patton, 2005). Despite these results with 
bovine rotavirus strains, in MA104 cells infected with a porcine rotavirus (strain 
OSU), the cellular IRF3 levels remained stable, little interaction between OSU NSP1 
and IRF3 was observed in a GST pull-down assay. From these results it was 
concluded that the binding between OSU NSP1 and IRF3 was less than 10% of that 
seen with the bovine B641 NSP1 (Graff et al., 2007).  
 
The porcine NSP1 was however shown to interact and promote degradation of a 
second component involved in the innate immune response, namely the β-transducin 
repeat containing protein (β-TrCP), which functions as part of an E3 ligase 
Skp1/Cull/F-box complex (SCF
β-TrCP
) involved in the ubiquitination of inhibitor 
kappa B (IκBα) (Graff et al., 2009). By contrast UKtcNSP1 has been shown to have 
little effect on β-TrCP (Arnold and Patton, 2011). Therefore, based on the fact that 
UKtcNSP1 and OSUNSP1 were able to interact and degrade different cellular 
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proteins and they share only 59.3% and 66% conservation at the amino acid and the 
nucleotide sequence levels respectively (Xu et al., 1994), it was decided to use these 
two NSP1s for generating chimeric NSP1 hybrid constructs to map the important 
regions in NSP1 responsible for their specific interactions with the different cellular 
proteins. Figure 3.1 illustrated the amino acid sequence comparison between a few 
NSP1 proteins from different rotavirus strains including the selected bovine UKtc, 
porcine OSU strains used in this study and some other strains analysed in others’ 
studies (Figure 3.1).   
 
The strategy employed was to select or create by site directed mutagenesis restriction 
enzyme (RE) sites spread at intervals across both UKtc and OSU NSP1 sequences to 
facilitate the swapping of cDNA fragments between the two parental molecules to 
generate a series of reciprocal hybrid gene constructs. A total of seven possible 
restriction enzyme sites spread across the two sequences were initially identified 
although a Nru I site (at UKtcNSP1 nucleotide position 669) was eliminated as it is 
the only RE site of those identified that was sensitive to dam methylation. Six RE 
sites finally chosen to be generated in the two parental NSP1 sequences are shown 
(Figure 3.2A). These positions were selected on the basis that the generation of the 
RE sites should not cause any change in the amino acid sequence in order to 
eliminate the possibility that their introduction would change the structure of the 
NSP1 proteins. The predicted secondary structures of both proteins were also taken 
in consideration when selecting these potential RE sites (Figure 3.2B) to ensure that 
the higher order structure of the protein was maintained as much as possible in the 
hybrids being generated.  
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Figure 3.1 Sequence comparision between NSP1s of different rotavirus strains. 
Sequence alignment was generated using DNASTAR’s Lasegene Core Suite 
software. The three NSP1s from the bovine strains (B641, NCDV and UKtc) showed 
over 90% of sequence identity among themselves. However the NSP1 of the porcine 
strain OSU showed only around 60% of sequence identity with bovine NSP1, but 
around 85% with the NSP1 from the human strain Wa. The NSP1 from the simian 
stratin SA11 showed less than 40% sequence identity with the porcine OSU NSP1, 
the human Wa NSP1 and all the bovine NSP1s.  
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Figure 3.2 Schematic diagrams illustrating the selected restriction enzyme (RE) 
sites to be generated in both UKtc and OSU NSP1 sequences.  
 
(A). Schematic diagram of six selected RE sites including Stu I, Pml I, Pst I, Hind 
III, Acl I and Hpa I to be generated in both UKtc and OSU NSP1 sequences (Hpa I 
already exists in OSUNSP1). The amino acid positions of the corresponding sites in 
UKtcNSP1 are indicated. The nucleotides highlighted in red indicate those in both 
NSP1 sequences mutated to generate the RE site without changing the amino acid 
sequence of the protein.  
 
(B). Predicted secondary structures of the two NSP1 proteins (adapted from Xu et 
al., 1994) with the selected RE sites highlighted indicating that the overall structure 
of the NSP1 proteins was maintained mostly in the hybrids constructed while 
introducing the six RE sites. E indicates positions predicted to have β-sheet structure, 
H represents positions predicted as being α-helix and L denotes positions predicted to 
be in loops. Positions at which no prediction with an acceptable level of confidence 
could be made are indicated by ‘-’ and gaps introduced to optimize the alignment by 
a ‘.’. 
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3.2 Cloning vector preparation for generating chimeric NSP1 hybrid cDNAs 
 
The experimental plan was that the NSP1 hybrids should be analysed for their 
interaction first in a mammalian two-hybrid assay. However, because the mammalian 
two-hybrid vectors pM and pVP16 contain several of the RE sites chosen for use in 
generating hybrid constructs, including Stu I, Pst I, Hind III, Acl I and Hpa I; the 
cloning vector pCR2.1 was used as the vehicle for introducing RE sites into the two 
NSP1 genes. However as indicated in Figure 3.3 two Pst I sites (position 309 and 
1499), two Acl I sites (position 2315 and 2688) and one Hind III site (position 235) 
are also present in the pCR2.1 vector sequence and consequently the vector was 
modified prior to its use in these experiments to remove these RE sites.   
 
The preparation of the pCR2.1 cloning vector is illustrated in Figure 3.4. It was first 
digested with each of the six restriction enzymes selected for use in NSP1 hybrid 
construction and the digestion outcomes were those expected from the vector 
sequence (Figure 3.4A). These two Acl I sites in pCR2.1 were destroyed by filling-in 
the 5’ overhangs generated by digestion and ligating the blunt ends to re-circularise 
the plasmid. The deletion of the nucleotides between the two Acl I sites within the 
ampicillin persistence gene of the vector destroyed the ampicillin selectivity marker. 
This was confirmed by transforming re-circularised plasmid into DH5α competent 
cells and plating onto LB plates containing either Ampicillin or Kanamycin, and as 
expected colonies were only seen from the Kan
+
 plates, DNA extracted from 
colonies obtained on Kan
+
 plates were then transformed again and re-plated on plates 
containing ampicillin, and no colonies were observed, confirming that the ampicillin 
selectivity has been destroyed. 12 colonies were picked from Kan
+
 plates, DNA was 
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extracted with Qiagen mini-prep kit and digested with Acl I again, no cutting of the 
plasmid occurred (Figure 3.4B), indicating that the Acl I sites in the starting pCR2.1 
vector plasmid had been destroyed. One of the 12 clones was selected to use for 
subsequent manipulations.  
 
A similar procedure was repeated to remove the Hind III site present in the starting 
vector plasmid (Figure 3.3). Although the situation of the two Pst I sites in pCR2.1 
differed, the site at position 1499 was within the Kanamycin ORF, therefore in order 
to maintain kanamycin resistance marker for colony selection, mutagenesis PCR was 
applied to alter this restriction enzyme site without changing the amino acids 
encoded (from CTGCAG to CTCCAG). The second Pst I site at position 309 did not 
require alteration as EcoR I/Bam HI (position 283, 252) and Xho I (position 332) 
digestion was going to be used for insertion of UKtcNSP1 and OSUNSP1 
respectively. This being the case, the sequences between these sites, including the 
second Pst I site, were going to be replaced by NSP1 gene. Following mutagenesis 
PCR, digestion with Pst I confirmed that only one Pst I site remained in the vector, 
named mpCR2.1, and it was ready for use. 
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Figure 3.3 Illustration of the cloning vector pCR2.1 indicating the selected RE 
sites already exist in the vector sequence.  
The selected RE sites already exist in the cloning vector are labelled.  
 
 
 
3.3  Cloning of the UKtcNSP1 and OSUNSP1 genes into mpCR2.1 vector 
 
The UKtcNSP1 gene was amplified from plasmid pVP16-NSP1 (provided by Dr 
K.T.Chung, University of Warwick) by PCR using primers UKtc-EcoRI 5’ and UKtc 
-XhoI 3’ (Table 2.1.7). The modified vector mpCR2.1 was digested with EcoR I and 
Xho I and dephosphorylated with shrimp alkaline phosphatase (SAP). The amplified 
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UKtcNSP1 was also digested with the same restriction enzymes and ligated into the 
prepared vector to generate the mpCR2.1-UKtcNSP1 construct. Recombinant clones 
carrying the inserted UKtcNSP1 gene were selected using blue/white colony 
screening and six of them confirmed to be correct by double digestion with EcoR I 
and Xho I. Two of the clones (S2 and S5) (Figure 3.5A) were sequenced across the 
inserted gene and S5 was confirmed to have been inserted accurately and to have the 
correct orientation (Figure 3.5B).  
 
In a similar fashion, OSUNSP1 gene (provided by Prof M.A.McCrae, University of 
Warwick) was amplified by PCR using primers OSU BamHI 5’ and OSU XhoI 3’ 
(Table 2.1.7). The modified vector mpCR2.1 was digested with BamH I and Xho I 
followed by dephosphorylation with SAP. The PCR amplicon was digested with the 
same restriction enzymes and ligated into the prepared vector to generate the 
mpCR2.1-OSUNSP1 construct. 12 recombinant clones were selected using 
blue/white colony screening and confirmed by double digestion with BamH I and 
Xho I. Four clones containing NSP1 inserts, S1, S2, S4 and S5 were identified 
(Figure 3.6A). S1 was sequenced across the NSP1 insert which confirmed that the 
gene had been inserted accurately in the correct orientation with respect to the 
promoter in mpCR2.1 (Figure 3.6B). 
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Figure 3.4 Modification of the pCR2.1 cloning vector for use in generating NSP1 
hybrids.  
 
(A). pCR2.1 was digested with the 6 restriction enzymes indicated; and the products 
were analysed by electrophoresis on a 1% TBE agarose gel as described in Materials 
and Methods. Stu I, Pml I and Hpa I (indicated lane 1, 2 and 4) were unable to digest 
the vector and showed the same pattern as the undigested vector control (indicated as 
lane C) whereas the other enzymes were able to digest this vector. The sizes of the 
markers used are given down the left hand side of each gel in base pairs.   
  
(B). Through filling-in and site directed mutagenesis, selected RE sites were 
destroyed and the modified vector was subjected to corresponding enzyme digestion 
again. The products were analysed by electrophoresis on a 1% TBE agarose gel as 
described in Materials and Methods. It indicates that the vector could no longer be 
digested by the selected restriction enzymes. The sizes of the markers used are given 
down the left hand side of each gel in base pairs.   
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Figure 3.5 Cloning of UKtcNSP1 into mpCR2.1 vector.  
 
(A). Plasmid DNA from 6 independent clones, generated following the ligation 
reactions between mpCR2.1 and PCR amplified UKtcNSP1, was prepared and 
double-digested with EcoR I and Xho I. The products were analysed by 
electrophoresis on a 1% TBE agarose gel as described in Materials and Methods. The 
inserted UKtcNSP1 was released by this double digestion resulting in a band of 1579 
bps with a 3900 bps vector band also being generated, as indicated by arrows on the 
right side of the gel. Lane M was loaded with 1Kb DNA ladder and the sizes of the 
markers are given in base pairs down the left hand side of the gel.  
 
(B). Clone S5 was sequenced using M13 reverse and forward primers (Table 2.1.7) 
and the sequence of the vector-insert junction regions are illustrated. The sequencing 
confirmed that the UKtcNSP1 gene was inserted without any additional nucleotide 
changes having been introduced and in the correct orientation in the mpCR2.1 
vector.    
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Figure 3.6 Cloning of OSUNSP1 into mpCR2.1 vector.  
 
(A). Plasmid DNA from 5 independent clones, generated following the ligation 
reactions between mpCR2.1 and PCR amplified OSUNSP1, was prepared and 
double-digested with BamH I and Xho I. The products were analysed by 
electrophoresis on a 1% TBE agarose gel as described in Materials and Methods. The 
inserted OSUNSP1 was released by the double digestion resulting in a band of 1567 
bps with 3900 bps vector band also being generated, as indicated by arrows on the 
right side of the gel. Lane M was loaded with 1Kb DNA ladder and the sizes of the 
markers are given in base pairs down the left hand side of the gel.  
 
(B). Clone S1 was sequenced using M13 reverse and forward primers and the 
sequence of the vector-insert junction regions are illustrated. The sequencing 
confirmed that the OSUNSP1 gene was inserted without any additional nucleotide 
changes having been introduced and in the correct orientation in the mpCR2.1 
vector.    
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3.4  Sequential mutagenesis PCR of mpCR2.1-UKtcNSP1 and mpCR2.1-
OSUNSP1 
 
Site direct mutagenesis PCR was performed to create the desired restriction enzyme 
sites in both mpCR2.1-UKtcNSP1 and mpCR2.1-OSUNSP1. The RE sites were 
generated sequentially starting from both 5’ and 3’ ends of the genes to minimise the 
possibility of creating unwanted mutations through the PCR process. Consequently 
Stu I, Pml I and Pst I were generated sequentially from the 5’ end of both genes and 
Hind III, Acl I and Hpa I from the 3’ end of the genes (as the Hpa I site already 
existed in OSUNSP1, it would only need to be created in UKtcNSP1). Subsequently, 
modified UKtcNSP1 constructs, one containing the 3 RE sites near the 5’ end and the 
other one containing the 3 RE sites near the 3’ end, were digested with SanB I to 
generate the final mutated version of the gene carrying all six inserted RE sites 
(Figure 3.7). The same strategy was followed to generate the equivalent OSUNSP1 
construct.  
 
Stu I was the first RE site to be generated in each case via mutagenesis PCR using 
primers UKtc-StuI 5’ and UKtc-StuI 3’ for mpCR2.1-UKtcNSP1 or OSU-StuI 5’ and 
OSU-StuI 3’ for mpCR2.1-OSUNSP1 (Table 2.1.7). Ten colonies for each NSP1 
gene were selected and DNA was extracted via mini-prep, these constructs were then 
subjected to Stu I digest and one clone from each NSP1 was selected and sequencing 
analysis was performed to confirm the correct restriction enzyme site had been 
generated and that no other change had been made during the PCR process (Figure 
3.8).  
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Figure 3.7 The cloning strategy employed for constructing NSP1 genes 
containing six selected RE sites.  
The aim was to create three selected RE sites in both the 5’ end and 3’ end portions 
of the NSP1 gene via site directed PCR based mutagenesis. The two constructs 
should then be digested with SnaB I (for UKtcNSP1) and EcoR I (for OSUNSP1) 
and ligated to form the final constructs containing all six RE sites. 
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The newly generated constructs were then used as the template in the next step to 
generate Pml I sites using the appropriate primers (Table 2.1.7). The selected clones 
were subjected to Pml I digestion and sequencing analysis to ensure the correct 
creation of the desire restriction enzyme sites and that the rest of the sequences were 
intact (Figure 3.8).  
 
Using the same strategy starting from the 3’ end of the gene, the Hpa I site for 
mpCR2.1-UKtcNSP1 and the Acl I site for mpCR2.1-OSUNSP1 were generated via 
mutagenesis PCR using appropriate primers (Table 2.1.7). The selected clones were 
subjected to digestion and sequencing analysis to ensure the correct creation of the 
desire restriction enzyme sites and that the rest of the sequences were intact (Figure 
3.8). Subsequently, this UKtcNSP1 construct containing the Hpa I site was used as 
the template to generate the Acl I site in UKtcNSP1 employing the same protocol.  
 
In the cases of the Pst I and Hind III sites several unsuccessful attempts were made 
to generate these RE sites into the relevant cDNA clones. It was therefore decided 
that creation of these last two domain swap proteins should be abandoned. This left 
four RE sites to be utilised for further manipulations in plasmids designated 
OSUNSP1-4RE and UKtcNSP1-4RE.    
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A      mpCR2.1-UKtcNSP1 
 
 
 
 
 
 
B    mpCR2.1-OSUNSP1 
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Figure 3.8 Analysis of RE sites generated in UKtcNSP1 and OSUNSP1 cDNA 
clones.  
 
(A). Confirmation of four RE sites generated in mpCR2.1-UKtcNSP1. 
Four RE sites generated in mpCR2.1-UKtcNSP1 were confirmed by restriction 
enzyme digestions and subsequent sequencing. Following each mutagenesis PCR, 
plasmid DNA from a selection of clones prepared by mini-prep was digested with the 
appropriate restriction enzyme and the products of the digest were analysed by 
electrophoresis on a 1% TBE agarose gel as described in Materials and Methods. 
Lanes C contain the wild type mpCR2.1-UKtcNSP1 which does not contain the RE 
sites. The numbered lanes contain the digestions of DNA made from different clones; 
those highlighted in red indicate the correct clone selected for subsequent 
sequencing. The results of sequence analysis carried out to confirm the introduced 
mutational change are shown below each gel.  
 
(B). Confirmation of three RE sites generated in mpCR2.1-OSUNSP1. 
Three RE sites generated in mpCR2.1-OSUNSP1 were confirmed by restriction 
enzyme digestions and subsequent sequencing. Following each mutagenesis PCR, 
plasmid DNA from a selection of clones prepared by mini-prep was digested with 
appropriate restriction enzymes and the products of the digest were analysed by 
electrophoresis on a 1% TBE agarose gel as described in Materials and Methods. 
Lanes C contain the wild type mpCR2.1-OSUNSP1 which does not contain the RE 
sites. The numbered lanes contain the digestions of DNA made from different clones; 
those highlighted in red indicate the correct clone selected for subsequent 
sequencing. The results of sequence analysis carried out to confirm the introduced 
mutational change are shown below each gel.  
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3.5  Generating chimeric NSP1 hybrid constructs using mutated UKtcNSP1 
and OSUNSP1 cDNAs 
 
NSP1 hybrid genes were generated by ligating together different sections of the 
NSP1 sequences from both UKtcNSP1-4RE and OSUNSP1-4RE produced by 
digestion at combinations of newly generated RE sites. Constructs pA and pB 
(Figure 3.10) were obtained by digesting both UKtcNSP1-4RE and OSUNSP1-4RE 
with Stu I and Acl I. The products of the digests were then fractionated on a 1% TBE 
agarose gel and the relevant DNA bands were extracted using Qiagen Gel Extraction 
Kit. The larger DNA bands containing the mpCR2.1 vector and part of the UKtc or 
OSU NSP1 gene were dephosphorylated and then ligated to the smaller DNA bands 
containing the remainder of the NSP1 gene sequence from the other strain of virus. 
Colonies were selected, DNA extracted was then sequenced to confirm the correct 
domain swap had occurred (Figure 3.9). In a similar fashion other pairs of restriction 
enzymes were selected and used to generate other chimeric NSP1 hybrids. Due to 
continuous unsuccessful swaps using other RE combinations and time limitation, 12 
NSP1 hybrids in total were generated, as shown in Figure 3.10. 
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A. 
 
 
B.  Construct A: pA 
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Figure 3.9 Analysis of the chimeric NSP1 hybrid pA.  
 
(A). OSUNSP1-4RE and UKtcNSP1-4RE were digested with both Stu I and Acl I 
and the digests were analysed on 1% TBE agarose gel as described in Materials 
and Methods. The positions of the vector DNA and released cDNA fragment in 
each case are indicated by arrows on the right hand side of each gel. Vector and 
insert bands were separately eluted from the gel using the procedure described in 
Materials and Methods. DNA from the insert band from OSUNSP1 was then 
ligated into the DNA extracted from the vector band from UKtcNSP1 and vice 
versa to generate constructs pA and pB respectively.  
 
(B). The complete cDNA insert of hybrid pA was sequenced and this revealed that 
the sequences between restriction enzyme sites Stu I and Acl I was identical with 
the original OSUNSP1 sequence whereas the rest of the sequence matched the 
UKtcNSP1 sequence as shown in this partial sequence alignment.   
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Figure 3.10 Schematic illustrations of the chimeric NSP1 hybrid protein 
sequences generated with UKtcNSP1 and OSUNSP1.  
Six pairs of chimeric NSP1 hybrids were generated in the mpCR2.1 vector and 
designated A-L. Black bars indicate the sequences derived from UKtcNSP1 and 
red bars indicate the sequences derived from OSUNSP1. In all cases the 
constructs were sequenced to confirm the correct swaps at these restriction 
enzyme junctions (Appendix).  
 
  
103
 Chapter 3. Generation of chimeric rotavirus NSP1 hybrids 
 
 
3.6  Discussion 
 
The DNA constructs described in this chapter were intended for use in a range of 
key assays to map the interaction sites on viral NSP1 proteins responsible for 
interacting with and promoting the degradation of cellular proteins involved in the 
host innate immune system. The hybrid constructs were originally designed 
primarily for a mammalian two-hybrid assay, the vector was therefore modified to 
avoid multiple desire restriction enzyme sites present in both pCR2.1 and the 
mammalian two-hybrid vectors.  
 
Difficulties were encountered with selecting the correct clones from the PCR 
cloning products initially. White and blue screening technique was applied to 
increase the possibility of selecting the correct clones as the plasmid containing 
bacteria lacZ gene can produce β-gal if its ORF is not interrupted by any foreign 
DNA, the functional β-gal can be produced by transforming this lacZ containing 
plasmid into E.coli which expresses the α peptide, the β-gal is able to turn the X-
gal into a blue coloured product. If a foreign DNA is inserted within the lacZ 
gene, the ORF of lacZ is therefore changed and no β-gal can be produced which 
makes the recombinant colony to be in white colour (Messing et al., 1977). 
However, there were still white colonies appearing that were subsequently 
identified as incorrect clones. The reason for this might be that only part of the 
desired DNA was inserted. As a result, a number of colonies (typically 20-50) 
were picked each time and DNA was extracted for analysis separately. 
Mutagenesis PCR conditions were also optimised for this reason, the magnesium 
concentration used was higher than standard PCR as the standard 1.5mM of 
104
 Chapter 3. Generation of chimeric rotavirus NSP1 hybrids 
 
 
MgSO4 could not give any detectable PCR product at the end of the reaction. 
However, increased magnesium concentration might bring reduction of the 
fidelity and unwanted product and this might be the reason why selected colonies 
sometimes contain undesired clones.  
 
Several attempts were made to generate Hind III and Pst I sites within the NSP1 
genes but no mutated clones were isolated. On average, approximately 50 
colonies have been analysed in each attempt, various adjustments including 
changing the annealing temperature, the Mg
2+
 concentration, the elongation time, 
still revealed no correct mutation clones. PCR control was carried out alongside 
each time and transformation control was also included at the same time to ensure 
the PCR and transformation process was working. It remained unclear that the 
reason for the unsuccessful mutagenesis. Therefore due to time limitation these 
two sites were left in this study.  
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4.1 Introduction 
 
The rotavirus NSP1 protein is expressed at relatively low levels from early in the 
virus replication cycle and may well function at an early stage in the viral replication 
process (Johnson and McCrae, 1989). It has been shown that NSP1 from the bovine 
UKtc strain of rotavirus is able to interact with and promote the degradation of IRF3 
in a proteasome-dependent manner whereas the protein from the porcine OSU strain 
of rotavirus interacts with and promotes the degradation of a different component of 
the innate immune response namely β-TrCP (Goodbourn et al., unpublished 
observation, Graff et al., 2009; Arnold and Patton, 2011). In a follow-up study from 
the Graff lab an initial attempt was made to localise the IRF3 interaction site(s) in 
NSP1 of the bovine B641 strain, which shares ~88% sequence identity with the UKtc 
protein (Graff et al., 2002; Xu et al., 1994). Three deletion mutants of B641NSP1 
were constructed and examined for interaction with human IRF3 in a yeast two-
hybrid assay. The results of these deletion studies suggested that there is at least one 
point of contact with IRF3 in the C-terminal half of NSP1 (Graff et al., 2002). The 
C-terminal half of NSP1 is the most highly variable region of the protein (Xu et al., 
1994) and so subsequent point mutations were made within the conserved N-terminal 
zinc finger motif at positions 29, 54 and 57 (H29L, C54A and C57A in B641NSP1), 
all of these point mutants abolished the NSP1-IRF3 interaction, suggesting that is the 
second region of the protein also important for this particular interaction (Graff et al., 
2007).  
 
By contrast no data have been published as yet on the interaction site(s) of the OSU 
NSP1 with β-TrCP. Against this background the strategy pursued in this study was to 
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use chimeric UKtc/OSU NSP1 hybrid genes in different assays to determine the 
site(s) responsible for interactions between NSP1 and these two cellular proteins. 
The two assay systems chosen initially to study these interactions were mammalian 
two-hybrid assays and co-immunoprecipitation analysis.  
 
The mammalian two-hybrid system is a development of the original yeast two hybrid 
system which is a sensitive assay for detecting protein-protein interactions in vivo 
(Luo et al., 1997). To set up the assay, one of the two potentially interacting proteins 
is fused to the Gal4 DNA-binding domain and its potential partner protein is fused to 
a transcriptional activation domain, in this case from herpes simplex virus VP16 
protein. Plasmids encoding these two fusion proteins are then transfected into 
mammalian cells together with a suitable reporter gene plasmid. If there is an 
interaction between the two proteins under analysis, it will bring the DNA binding 
and activation domain together and result in the activation of reporter gene 
expression. In this study the reporter chosen was a green fluorescent protein which 
can be easily visualised under a UV microscope. If the two proteins under analysis 
do not interact with each other, the reporter gene will not be switched on and no 
fluorescent signal will be detected (Figure 4.1).  
 
The second assay system chosen to complement the mammalian two hybrid assay for 
studying the physical protein-protein interaction between NSP1 and IRF3/ β-TrCP 
was co-immunoprecipitation. This technique relies on the fact that a specific 
antibody against NSP1 can precipitate the protein from a complex mixture. Any 
proteins that are complexed to the target protein should also be precipitated and can 
then be identified in subsequent analysis of the precipitate. For the purposes of this 
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study, a FLAG epitope was added to the N-terminal of the parental and hybrid NSP1 
proteins to ensure constant efficiency of precipitation of the different variants, and 
FLAG-Sepharose was used to isolate the antibody-antigen complexes. It is important 
to bear in mind that one shortcoming of co-immunoprecipitation studies is that on 
their own they do not necessarily show the existence of a direct protein-protein 
interaction with the protein targeted by the precipitating antibody as they may be one 
component of a large complex that is held together by a complex set of protein-
protein interactions.  
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Figure 4.1 Schematic representation of the mammalian two-hybrid assay. 
Regular transcription of the reporter gene under the control of a GAL4 responsive 
promoter is triggered when the Activation domain (AD) and the DNA-binding (BD) 
domain are intact. In the two-hybrid system, these two domains are physically 
separated and fused to the two genes of interest (here, UKtc/OSU NSP1 hybrid and 
IRF3/β-TrCP), then transfected into cells with the reporter plasmid (here, GFP 
expression plasmid). When the two genes of interest interact with each other, the two 
domains come into proximity to each other initiating reporter gene transcription, as 
GFP expression plasmid is used, the cells can be visualised under UV microscopy. In 
the case of two non-interacting proteins, the two domains remain separated and there 
is no reporter gene transcription.  
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4.2 Molecular cloning of protein coding sequences for interaction studies in 
the mammalian two-hybrid assay system 
 
The human IRF3 coding sequence was obtained from the pEFplink2-IRF3 (kindly 
provided by Prof S Goodbourn) via restriction enzyme digestion with Nco I and Xba 
I (Figure 4.2). As one of the host cellular proteins previously shown to interact with 
rotavirus NSP1, the IRF3 coding sequence had to be cloned into the mammalian two-
hybrid vectors pM and pVP16 for subsequent analysis and RE sites EcoR I and Hind 
III have been selected for this cloning (Figure 4.3). These two RE sites were 
generated in IRF3 plasmid via PCR using primers listed in table 2.1.7. The EcoR I 
site was generated just before the start codon of IRF3 ORF, whereas the Hind III site 
was created at the end of the coding sequence before the stop codon, in which case 
the gene will be using the stop codon from the vector (Figure 4.4). Positive colonies 
were selected via Blue/White screening and the DNA extracted was subjected in 
restriction enzyme double digestion followed by sequencing (Figure 4.5A). However 
this analysis revealed that the original design of the primer used for IRF3 cDNA 
amplification had made IRF3 protein to be out of frame with the upstream DNA 
binding and transcription activation domains of the fusion protein. To overcome this 
oversight the fusion construct plasmid was digested with EcoR I, the staggered ends 
of the EcoR I site were filled in using Klenow DNA polymerase I and the plasmid 
was re-circularised to give a construct in which the two halves of the fusion protein 
were joined to each other in frame (Figure 4.5B).  
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Figure 4.2 IRF3 obtained from vector pEFplink2.  
IRF3 expression plasmid was obtained by double digestion with restriction enzymes 
Nco I and Xba I from the pEFplink2-IRF3 plasmid, which is ready for the 
subsequence re-amplification with PCR to add other restriction enzyme sites for 
cloning into the mammalian two-hybrid vectors.  
 
 
Figure 4.3 Experimental strategies for re-amplifying IRF3 coding sequence into 
the mammalian two-hybrid vectors.  
EcoR I and Hind III sites are generated using PCR with appropriate primers at both 
the 5’ and 3’ end of the IRF3 coding sequence for re-amplifying IRF3 coding 
sequence into the mammalian two-hybrid vectors.   
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Figure 4.4 Schematic diagrams of the mammalian two-hybrid system cloning 
vectors pM and pVP16, showing the multi-cloning site sequence and unique 
restriction enzyme sites.  
Schematic diagrams of the main features of vectors pM (panel A) and pVP16 (panel 
B) are shown. pM expresses the DNA binding domain (amino acids 1-147) of the 
GAL4 protein. pVP16 generates the transcriptional activation domain (amino acids 
446-490) of the HSV VP16 protein. These plasmids have unique RE sites located in 
the multi-cloning site (MCS) region at the 3’ end of the open reading frame for either 
the GAL4 DNA binding domain or the VP16 activation domain. The gene encoding 
the protein of interest is ligated into the MCS in the correct orientation and reading 
frame, such that fusion proteins with the GAL4 or VP16 domains are expressed. The 
unique restriction sites that chosen to be used for cloning both IRF3 (EcoR I and 
Hind III) and β-TrCP (BamH I and Xba I) in the MCS of these vectors are indicated 
below each plasmid diagram (This figure is adapted from the Clontech Matchmaker 
Mammalian Assay Kit User Manual). 
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Figure 4.5 Confirmation of the constructs pM-IRF3 and pVP16-IRF3.  
(A) DNAs of the pM-IRF3 and pVP16-IRF3 constructs were amplified in E.coli and 
purified by maxi-prep as described in Materials and Methods. Plasmid DNA was 
then double digested with EcoR I and Hind III and fractionated on a 1% agarose gel 
as described in Materials and Methods. The position of the expected 1300bp IRF3 
insert band is indicated down the right hand side of each gel. Lanes labelled D 
indicate the samples after double digestion and lanes labelled U indicate the 
undigested samples, lanes labelled M indicate the 1kb DNA marker and the sizes of 
the markers are given in base pairs.  
 
(B) Sequencing analysis was performed to confirm the correct orientation and open 
reading frame of IRF3 at the junction with the Gal4 domain in the pM vector, or the 
VP16 domain in the pVP16 vector.  
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Similarly, β-TrCP, the other possible interaction partner for rotavirus NSP1, was also 
cloned into pM and pVP16 vectors. The β-TrCP coding region from a plasmid 
carrying HA-tagged human β-TrCP (TRcP 1a/Fbw 1a) (Kindly provided by Dr A 
Stephanou) was amplified with primers listed in table 2.1.7 and cloned into the 
mammalian two-hybrid vectors between RE sites BamH I and Xba I for pM or only 
BamH I in the case of pVP16 (Figure 4.3). BamH I and Xba I sites were created at 
respectively the 5’ end of the β-TrCP coding sequence upstream of the start codon 
and the 3’ end of the ORF following the stop codon for cloning into the pM vector. 
For cloning into pVP16 activation domain vector, BamH I sites were generated at 
both ends of the β-TrCP ORF. Positive colonies were selected via Blue/White 
screening, and plasmid DNA extracted was subjected to restriction enzyme double 
digestion (Figure 4.6A). Selected clones were then sequenced to confirm the correct 
joining points in both vectors (Figure 4.6B).  
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Figure 4.6 Confirmation of the constructs pM-β-TrCP and pVP16-β-TrCP.  
(A) DNAs of the pM- β-TrCP and pVP16- β-TrCP constructs were amplified in 
E.coli and purified by maxi-prep as described in Materials and Methods. Plasmid 
DNA was then double digested with BamH I and Xba I or digested with BamH I 
alone, and fractionated on a 1% agarose gel as described in Materials and Methods. 
The position of the expected 1800bp β-TrCP insert band is indicated down the right 
hand side of each gel. Lanes labelled D indicate the samples after digestion and lanes 
labelled U indicate the undigested samples, lanes labelled M indicate the 1kb DNA 
marker and the sizes of the markers are given in base pairs.  
 
(B) Sequencing analysis was performed to confirm the correct orientation and open 
reading frame of β-TrCP at the junction with the Gal4 domain in the pM vector, or 
the VP16 domain in the pVP16 vector.  
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The parental UKtcNSP1 and OSUNSP1 cDNAs were also cloned into the two 
mammalian two-hybrid vectors. The UKtcNSP1 coding sequence was cloned in 
between EcoR I and Hind III restriction enzyme sites using the same strategy as that 
employed for IRF3. The OSUNSP1 coding sequence was cloned in between BamH I 
and Hind III restriction enzyme sites again using the strategy described earlier for 
their putative interaction partners, i.e: IRF3 and β-TrCP. The expected insert bands 
were detected as indicated (Figure 4.7A, Figure 4.8A) and the sequencing results of 
the corresponding junctions in all constructs confirmed the correct construction of 
these plasmids (Figure 4.7B, Figure 4.8B).  
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Figure 4.7 Cloning of UKtcNSP1 into mammalian two-hybrid vectors pM and 
pVP16.  
 
(A) Around 500ng of DNA sample were digested with EcoR I and Hind III and 
correct sized bands were released indicating the correct insert of the UKtcNSP1. U 
indicates the undigested product and D indicates the products after digestion, 1kb 
DNA marker on the left hand side indicates the sizes of the bands.  
 
(B) Selected clones were sequenced using pM and pVP16 sequencing primers (Table 
2.1.7) and the junction regions are illustrated. Sequencing analysis confirmed that the 
UKtcNSP1 gene was inserted correctly with correct orientation in both pM and 
pVP16 vectors. 
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Figure 4.8 Cloning of OSUNSP1 into mammalian two-hybrid vectors pM and 
pVP16. 
  
(A). Around 500ng of DNA sample were digested with BamH I and Hind III, and 
correct sized bands were released indicating the correct insert of the NSP1. U 
indicates the undigested product and D indicates the products after digestion, 1kb 
DNA marker on the left hand side indicates the sizes of the bands.  
 
(B). Selected clones were sequenced using pM and pVP16 sequencing primers 
(Table 2.1.7) and the junction regions are illustrated. Sequencing analysis confirmed 
that the OSUNSP1 gene was inserted correctly with correct orientation in both pM 
and pVP16 vectors.    
 
 
 
4.3  Protein-Protein interaction studies using the mammalian two-hybrid 
assay system 
 
Positive and negative control reactions were included in each mammalian two-hybrid 
assay. The positive control plasmids used for the assay were pM-p53, which 
expresses a fusion of the GAL4DNA-BD to the mouse p53 protein, and pVP16-LT, 
which expresses a fusion of the VP16 AD to the SV40 large T-antigen. Mouse p53 
and SV40 large T-antigen have been shown to interact (Lane and Crowford, 1979) 
and the purpose of this positive control was to verify that the system was detecting an 
expected protein-protein interaction between the two known interacting proteins. 
pVP16-CP plasmid encodes and expresses a fusion of the VP16 AD to a viral coat 
protein, which does not interact with p53. The transfection with pM-p53 and pVP16-
CP was therefore used as a negative control indicating no interaction is detected. The 
reporter gene chosen for these studies was GFP, because its expression could be 
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easily and rapidly screened for living cells by UV microscopy. The plasmid pUAST-
hrGFP-neo (kindly provided by Dr K.T.Chung, University of Warwick) which 
contains a GFP gene under the control of a Gal4-responsive promoter (Figure 4.9) 
was the reporter plasmid actually used in the series of experiments. 
 
 
 
 
 
Figure 4.9 Reporter gene plasmid used in the mammalian two-hybrid system.  
pUAST-hrGFP-neo contains the green fluorescent protein (GFP) gene positioned 
downstream of the Gal4 responsive element and a minimal promoter from the 
Adenovirus E1b gene. It is used as a qualitative reporter in this mammalian two-
hybrid assay as the GFP expression can be easily visualised under the UV 
microscope in live cells.  
 
125
Chapter 4. Analysis of protein-protein interactions between rotavirus NSP1 and host cellular proteins 
 
 
 
 
 
To establish the utility of the mammalian two hybrid assay in attempts to map 
protein-protein interaction sites, the two parental NSP1 plasmids, i.e: those from 
UKtc and OSU were analysed first. Highly transfectable human embryonic kidney 
cells (293) were mock transfected or co-transfected with a combination of a Gal4-BD 
fusion protein plasmid, a VP16-AD fusion protein plasmid and the reporter GFP 
plasmid, 48 hours later, the cells were visualised under UV microscopy to monitor 
reporter gene expression. In initial tranfections, not even samples co-transfected with 
the positive control plasmids showed any evidence of reporter gene expression. 
Therefore a variety of changes were made to the transfection protocol, including 
changing of the ratio of the total amount of DNA to the transfection reagent, 
changing cells and making new batches of plasmid DNA. These changes proved 
successful with ~ 50% of the 293 cells showing positive GFP expression with the 
control plasmids (Figure 4.10B). Despite the positive control giving good reporter 
gene expression in the experimental samples, few fluorescent cells were observed 
(Figure 4.10 D-G). A positive signal was observed in one of the experimental 
samples in Figure 4.10D. However control transfections with individual plasmids 
and reporter plasmid revealed that the positive signal was due to self-activation by 
pM-IRF3 (Figure 4.11). The failure to demonstrate protein-protein interaction 
between the parental NSP1 proteins used in this study and IRF3 or β-TrCP in the 
mammalian two-hybrid assay was particularly surprising as UKtc and IRF3 have 
been shown to interact in a yeast two-hybrid assay (Goodbourn et al., unpublished 
observations).   
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Figure 4.10 NSP1-host protein interaction analysed in mammalian two-hybrid 
assay.  
3.6 x10
5
 293 cells were mock transfected or co-transfected with a combination of 
Gal4-BD fusion protein plasmid, VP16-AD fusion protein plasmid and reporter GFP 
plasmid. 48 hrs post transfection, cells were visualised under UV microscope as 
described in Materials and Methods. (A). Cells mock transfected, showing no 
fluorescent cells as expected. (B). Cells co-transfected with positive control 
plasmids, around 50% of the cells exhibit fluorescent cells indicating the expected 
interaction between p53 and large T-antigen. (C). Cells co-transfected with negative 
control plasmids, little GFP expression is observed indicating no interaction between 
p53 and CP. (D). Cells co-transfected with pVP16-UKtcNSP1 and pM-IRF3, a few 
fluorescent cells were observed although they only account around 10% of the total 
cell number. (E). Cells co-transfected with pM-UKtcNSP1 and pVP16-IRF3, no 
obvious GFP expression is observed. (F+G). Cells co-transfected with pM-
OSUNSP1 and pVP16-β-TrCP; pM-β-TrCP and pVP16-OSUNSP1 respectively, no 
obvious GFP expression is observed.       
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Figure 4.11 selected individual transfection analysing self-activated GFP 
expression.  
3.6 x10
5
 293 cells were mock transfected or co-transfected with individual Gal4-BD 
or VP16-AD fusion protein plasmid, accompanied with the empty pVP16 or pM 
vector, and reporter GFP plasmid. 48 hrs post transfection, cells were visualised 
under UV microscope as described in Materials and Methods. (A). Cells mock 
transfected, showing no fluorescent cells as expected. (B). Cells co-transfected with 
one of the positive control plasmid, pM-p53, and empty pVP16 vector, less than 1% 
of the cells exhibit fluorescent cells. (C). Cells co-transfected with pM-IRF3 and 
pVP16 empty vector, less than 10% of cells showed GFP expression indicating the 
ability of self-activation of this pM-IRF3 plasmid. (D). Cells co-transfected with 
pVP16-UKtcNSP1 and pM empty vector, no obvious GFP expression is observed.  
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4.4  NSP1 expression in transfected cells  
 
Given the previously demonstrated interaction between UKtcNSP1 and IRF3, one 
possible explanation for the failure to detect it in the mammalian two-hybrid assay 
system was that the proteins might not be expressed correctly in the transfected 293 
cells. To investigate this possibility 293 cells were transfected with a number of 
plasmids including pM vector, pM-p53, pM-UKtcNSP1, pM-OSUNSP1, pVP16 
vector, pVP16-LT, pVP16-UKtcNSP1 and pVP16-OSUNSP1 individually. Cell 
extracts at 48 hours post transfection were examined via SDS-PAGE followed by 
western blot using anti-Gal4 and anti-VP16 antibodies respectively to detect the 
fusion proteins (Figure 4.12). No obvious protein expression was detected using 
these two antibodies; the experimental samples exhibited the similar appearance as 
the mock-transfected samples. No obvious difference in band pattern between the 
one transfected with vector only and the ones transfected with the fusion protein 
plasmids. The size of Gal 4 is around 40kDa and therefore the expected bands in the 
lanes should appear around 95-105kDa region, since the NSP1 is around 55kDa in 
size, therefore it is similar to p53, suggesting similar bands should appear in all 
transfected samples (Figure 4.12A), however, these bands are absent in this blot. 
Blot probed by anti-VP16 antibody shows no obvious difference between the cells 
transfected with pVP16 vector only and cells transfected with VP16 fusion proteins, 
the size of VP16 is around 30kDa and therefore the expected band in each lane 
transfected with NSP1 fusion protein plasmid should be around 85-95kDa, whereas 
the lane transfected with the control plasmid pVP16-LT should have a band around 
120kDa as the SV40 large T antigen has a molecular weight around 90kDa (Figure 
4.12B), none of the band was observed.   
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Figure 4.12 Protein expression analysis from mammalian two-hybrid vectors.  
2 x 10
5
 293 cells were transfected with individual Gal4 and VP16 fused protein 
plasmids. 48 hrs later, cell lysate were collected and proteins were separated on SDS-
PAGE and probed with anti-Gal4 (A) or anti-VP16 (B) respectively as described in 
Materials and Methods. Protein molecular weight markers are indicated on the left 
hand side in both figures.  
 
 
    
The fact that levels of positive control protein that were undetectable could 
nevertheless give a positive result in the two-hybrid assay suggested that even low 
level of the protein expression are still able to give a result. Therefore, we considered 
whether or not the constructs were actually able to expression the intended proteins.  
     
 
4.5  Expression of NSP1 proteins in pCDNA3.1 vector 
 
In order to confirm the unsuccessful results of the reporter assay was due to the 
poorly expressed NSP1 proteins in 293 cells, further analysis was carried out. 
Rotavirus NSP1 is normally expressed in the cytoplasm of its permissive cells; 
therefore it is possible the NSP1 cDNA expression was limited as it took place in the 
nucleus. Subsequently, both parental NSP1 cDNAs were cloned into another 
mammalian vector pCDNA3.1, which contains a powerful CMV promoter to 
enhance expression (Figure 4.13). Proteins encoded by open reading frames cloned 
downstream of this promoter are routinely expressed to high levels in transient 
translation experiments.    
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Figure 4.13 Cloning of NSP1 genes into vector pcDNA3.1.  
Parental UKtcNSP1 cDNA was cloned into the vector between sites EcoR I and Xho 
I while OSUNSP1 cDNA was cloned into the vector between sites BamH I and Xho I 
via PCR. 
 
 
 
A FLAG epitope was added at the N-terminus of both UKtc and OSU NSP1 cDNAs 
via PCR with appropriate primers (Table 2.1.7) for conventional detection using 
anti-FLAG antibody. Constructs pCDNA3.1-FLAG-UKtcNSP1 and pCDNA3.1-
FLAG-OSUNSP1 were therefore generated. The aim of this was to make the protein 
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product reading detectable via an antibody that was fully validated in our hands. The 
expression of NSP1 proteins from these plasmids was determined using anti-FLAG 
antibody in western blot (Figure 4.14). Despite the background of the blot, it is 
evident that only the positive control FLAG-PML plasmid (Beech et al,. 2005) 
expressed a detectable product; a strong band at around 100kDa in lane C was clearly 
observed overlaying a weaker background band present in all samples. Both 
pCDNA3.1-FLAG-UKtcNSP1 and pCDNA3.1-FLAG-OSUNSP1 showed very 
similar patterns to the mock-transfected negative control, suggesting that neither of 
the NSP1 plasmids expressed detectable products. 
 
 
 
 
 
Figure 4.14 pCDNA3.1-FLAG-NSP1s cannot be detected in 293 cells.  
2 x 10
5
 293 cells were mock-transfected or transfected with a positive control FLAG-
PML plasmid, pCDNA3.1-FLAG-UKtcNSP1 or pCDNA3.1-FLAG-OSUNSP1 
individually. 48 hours later, cells were harvested and the total lysates were subjected 
to 10% SDS-PAGE and western blotting as described in Materials and Methods. The 
blot was probed by a polyclonal anti-FLAG antibody. Protein sizes of marker 
proteins are indicated in kDa on the left hand side of the blot.    
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4.6 Protein interaction studies via co-immunoprecipitation 
 
With the intention of optimising the expression of NSP1 cDNAs, FLAG-tagged 
parental NSP1 genes were cloned into a pCI-neo vector between sites Nhe I and Sal I 
(Figure 4.15). pCI-neo vector contains a chimeric intron, upstream the inserted 
cDNA sequence, to facilitate RNA splicing. Early studies with SV40 virus 
demonstrated that splicing is a prerequisite for stable cytoplasmic 16S mRNA 
production (Hamer and Leder, 1979). It was subsequently shown that the addition of 
a splice to the 5’ –untranslated leader can dramatically increase protein expression 
from a vector that contains no introns (Callis et al., 1987). Furthermore, splicing has 
been confirmed to lead to an increased level of both nuclear and cytoplasmic poly 
(A)-containing RNA (Buchman and Berg, 1988). Huang and Gorman using two 
expression vectors which differ only in the presence of absence of an intron reported 
that transient transfection into four mammalian cell lines resulted in up to 50 fold 
increased levels of the indicator protein from the vector carrying an intron, and that 
cytoplasmic RNA concentration corresponded directly to the resultant protein levels 
(Huang and Gorman, 1990). Therefore, the problem with the undetectable NSP1 
proteins in transfected cells might be resolved by cloning it to the pCI-neo vector, 
and this was subsequently tested in the co-immunoprecipitation assay. 
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Figure 4.15 Map of cloning vector pCI-neo.  
Both UKtcNSP1 and OSUNSP cDNAs were cloned into the vector between 
restriction enzyme sites Nhe I and Sal I. 
 
 
Co-immunoprecipitation is a frequently used method of studying protein-protein 
interactions. An initial study was performed to determine if transfected pCI-neo-
FLAG-UKtcNSP1 and pCI-neo-FLAG-OSUNSP1 were co-immunoprecipitated with 
IRF3 protein from transfected pCDNA-IRF3 in the presence or absence of 
proteasome inhibitor MG132, as it has been shown that UKtcNSP1 degrade IRF3 in 
a proteasome dependent manner. Cells mock-transfected or co-transfected with IRF3 
and an empty vector or corresponding NSP1 plasmids were processed and 
precipitated using FLAG-Sepharose to isolate the antibody bound complex; samples 
before and after passing the resin were probed with anti-IRF3 and anti-FLAG 
antibodies. However, this experiment showed little co-precipitation of IRF3 with 
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either UKtcNSP1 or OSUNSP1. Figure 4.16 panel A and B showed the detection 
before the precipitation. Anti-IRF3 antibody detected a similar amount of the 
endogenous IRF3 in the mock transfected and FLAG control adenovirus 33kDa 
(Ad33) transfected samples,  and much stronger bands were observed when 
additional IRF3 was transfected into the cells (Figure 4.16A); anti-FLAG antibody 
only detected the positive control Ad 33 at around 33kDa position before binding, 
none of the UKtcNSP1 or OSUNSP1 were probed (Figure 4.16B); however after 
binding to the FLAG-Sepharose, the elution detected by anti-IRF3 or anti-FLAG 
respectively showed no clear distinguish band across the blot, the expected band 
should appear on the samples transfected with UKtcNSP1 at least as it has been 
shown previously in other groups to be interacting with IRF3, and the addition of 
MG132 should restore the level of IRF3. However, bands all appeared to be the same 
with no expected binding in the UKtcNSP1 and OSUNSP1 transfected samples and 
no indication of precipitation (Figure 4.16C+D) and this observation suggested that 
the interaction between NSP1 and host cellular proteins were still very difficult to be 
detected so did the protein expression.  
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Figure 4.16 Analysis of protein interaction between NSP1 and IRF3 via co-
immunoprecipitation.  
 
(A) 293 Cell monolayer in 6-well plates were mock transfected or transfected with a 
combination of indicated plasmids in duplicates, 40 hrs later, medium was replaced 
by either fresh serum-containing medium or serum-containing medium with 50 µM 
of MG132, and the cells were incubated for a further 8 hrs (‘+’and ‘-’ indicate the 
presence and absence of MG132) as described in Materials and Methods. Cells were 
collected and samples were prepared and 10µl of the sample were kept whereas the 
rest were subjected in the next step, the kept samples were analysed in SDS-PAGE 
and detected using anti-IRF3 antibody. The protein marker on the left hand side 
indicates the corresponding protein sizes and the endogenous and transfected IRF3 
bands are illustrated.  
 
(B) Samples before passing through the Sepharose were analysed on SDS-PAGE 
followed by western blot as described in Materials and Methods. The blot was 
probed with anti-FLAG antibody and the protein marker on the left hand side 
indicates the corresponding protein sizes and the endogenous and transfected IRF3 
bands are illustrated. 
 
(C) Samples were eluted after the binding to the Sepharose and analysed on SDS-
PAGE followed by western blot as described in Materials and Methods. The blot was 
probed with anti-IRF3 antibody, and the protein marker on the left hand side 
indicates the corresponding protein sizes and the endogenous and transfected IRF3 
bands are illustrated. 
 
(D) Samples were eluted after the binding to the Sepharose and analysed on SDS-
PAGE followed by western blot as described in Materials and Methods. The blot was 
probed with anti-FLAG antibody, and the protein marker on the left hand side 
indicates the corresponding protein sizes and the endogenous and transfected IRF3 
bands are illustrated. 
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4.7  Discussion 
 
The mammalian two-hybrid assay system utilized in this study to determine protein-
protein interactions is not a quantitative assay,  if two proteins of interest interact, the 
reporter gene activation occurred, if not, no reporter protein expressed. A 
complement experiment with flow cytometry was considered to analyse the data 
quantitatively. However, as the mammalian two-hybrid assay failed to illustrate 
convincible results of the protein-protein interaction, the flow cytometry experiment 
was not carried out. The two-hybrid assays investigating potential interactions 
between UKtcNSP1-IRF3 and OSUNSP1-β-TrCP in this study all yielded negative 
results, even though direct protein interaction of IRF3 and UKtcNSP1 have been 
observed in a yeast two-hybrid assay system (Goodbourn et al., unpublished results).  
 
Several possible explanations could be put forward for these failures of detecting the 
interaction in the two-hybrid system: some proteins might not be expressed correctly 
from the plasmids, there might be weak interactions that were not able to activate the 
reporter gene above a threshold level, the lack of nuclear localisation of the proteins 
lead to insufficient expression of the NSP1 proteins, and a low transfection efficiency 
may also inhibit the detection of protein-protein interaction. The two-hybrid assays 
were carefully repeated a number of times with fresh cells, fresh batch of plasmid 
preparations, altered transfection conditions and altered incubation time. However 
the outcome remained the same that no convincible interactions between the parental 
NSP1 proteins and the targeted cellular proteins were detected. 
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As one possibility was that the proteins might not be expressed correctly from some 
or all of plasmids, anti-Gal4 and anti-VP16 antibodies were used to detect the 
expression of proteins fused to the mammalian two-hybrid vectors, however, it has 
been unsuccessful to detect any fusion proteins expressed from the mammalian two-
hybrid vectors. Nevertheless, the expression studies also revealed negative results in 
the positive control plasmids, which showed clear GFP expression in the two-hybrid 
system. Therefore the lack of detectable protein bands on the blot might due to the 
possibility that the proteins were only expressed to very limited amounts, such that 
the antibodies were not able to detect the expression.  
 
In order to enhance the expression of both NSP1 proteins, pcDNA3.1 vector was 
firstly put in use instead of the mammalian two-hybrid vectors and eventually 
changed to a pCI-neo vector containing a chimeric intron upstream of the inserted 
cDNA. A FLAG-tag was introduced to both NSP1 proteins for consistent detection 
with the anti-FLAG antibody. Similarly as the previous expression results, the 
change of vectors did not show any better detection of the NSP1 expression 
compared with the observation from the mammalian two-hybrid vectors. However in 
the functional assays employing the pCI-neo-NSP1 plasmid (Chapter 5), evidences 
had been obtained to illustrate the expression of the NSP1 in this particular vector. 
Therefore the main reason of the failure of this assay might be that the proteins have 
not been expressed to a sufficient level either to be detected or to be able to initiate 
the activation of the reporter gene.   
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5.1 Introduction 
 
There are several lines of evidence that one of the functions of rotavirus NSP1 is to 
antagonise the host innate immune system via inhibiting the production of IFNβ 
(Barro and Patton, 2005; Arnold and Patton, 2009), and that this is achieved by 
interactions between NSP1 and the host cellular proteins IRF3 and β-TrCP 
promoting their subsequent proteasome-dependent degradation (Graff et al., 2002; 
Barro and Patton, 2005; Graff et al., 2009). In this study, hybrid NSP1 genes 
consisting of different sequence domains from both UKtcNSP1 and OSUNSP1 
(Chapter 3) were first tested in functional assays in an attempt to localise the 
interaction sites responsible for the degradation of these two cellular proteins.  
 
Despite the unsuccessful outcome of these studies reported in Chapter 4, the 
biological phenotype of these NSP1 hybrid proteins could still be examined through 
the use of reporter gene assays. Three firefly luciferase reporter plasmids were used 
in this study (i) reporter expression driven by the full-length IFNβ promoter, (ii) 
reporter expression driven by a sub-element of that promoter: PRD I/III, which is 
activated specifically by IRF3-induced IFNβ production, (iii) reporter expression 
driven by a ConA promoter element that detects NFκB activity. The promoters in 
each case are activated by a signalling cascade that is induced by the detection of 
double-stranded RNA (in this case transfected PolyI:C) within the cell. This chapter 
describes the details of setting up of these reporter assays, and their use to determine 
the functionality of the various NSP1 hybrid proteins constructed in this study. 
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5.2 pcDNA3.1-NSP1 constructs do not stimulate the activation of the IFNβ 
promoter 
 
A reporter plasmid carrying the firefly luciferase gene driven by a full-length 
interferon β promoter was used initially to determine the effect of co-transfected 
NSP1 hybrid genes on the stimulation of IFNβ production by poly (I:C). Although 
the parental NSP1 proteins showed little physical interaction and undetectable 
expression in the mammalian two-hybrid vector system (Chapter 4), and expression 
of these proteins were undetectable when cloned into the CMV promoter containing 
vector pcDNA3.1 (Chapter 4), it is possible that even though the amount of protein 
expressed is undetectable, the protein can still be examined functionally. Therefore 
parental constructs pcDNA3.1-UKtcNSP1 and pcDNA3.1-OSUNSP1 were subjected 
to this reporter assay to test if a detectable signal generated by the reporter plasmid 
can be observed.   
 
293HEK cells were co-transfected with a combination of the IFNβ promoter reporter 
plasmid and parental NSP1 plasmids or an empty vector plasmid. A control plasmid 
carrying E.coli LacZ (β-galactosidase) under the control of the constitutive 
immediate early promoter of cytomegalovirus (CMV) was included in all the 
transfections as a basal control for measuring the general transfection efficiency. 24 
hrs after transfection the cells were mock transfected or transfected with poly (I:C), 
an analogue of dsRNA known to be a powerful stimulant of IFNβ production. The 
Poly (I:C) was transfected into the 293 cells as they do not have a Toll-like receptor 
expressed on their cell surface under normal culture conditions so do not respond to 
Poly (I:C) unless it’s transfected into the cells. 16 hrs after this second transfection 
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the cells were harvested, and cell lysates were analysed for firefly luciferase activity 
(Figure 5.1B).  
 
Overall, transfections with NSP1 parental gene plasmids did not cause significant 
changes in the reporter activity over the empty vector transfected control. However, 
cells transfected with a combination of the reporter gene plasmid and the empty 
vector did cause an ~70-fold stimulation of the IFNβ reporter activity when 
transfected with poly (I:C) (Figure 5.1A), indicating the reporter activity can be 
stimulated by the transfected poly (I:C); typically, in the experiments repeated in this 
chapter, stimulation of reporter activity varied from 50-fold to 80-fold. This result 
suggested that 293 cells were able to respond to poly (I:C) stimulation and 
subsequently activate the IFNβ promoter but the NSP1 genes were unable affect the 
signalling pathways to cause any reduction in IFNβ promoter activity as expected. 
The reason for this observation might be either the NSP1 genes were not expressed 
sufficiently in cells to cause any changes on the promoter activity or the expressed 
proteins were unable to cause any detectable changes in the IFNβ promoter activity. 
A new batch of 293 cells and new stocks of NSP1 plasmids were prepared and the 
assay was repeated for several times. Similar results were obtained and there was 
little effect on the level of IFNβ promoter activity caused by the pcDNA3.1-parental 
NSP1 constructs.   
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Figure 5.1 Studies on IFNβ promoter activities in 293HEK cells.  
 
2 x 10
5
 293 cells were co-transfected with 225ng pLuc-IFNβ, 25ng pcDNA3.1-
HisB::lacZ and 250ng pcDNA3.1 vector, pcDNA3.1-UKtcNSP1 or pcDNA3.1-
OSUNSP1 as described in Materials and Methods. 24 hrs after transfection cells 
were mock transfected or transfected with 1µg of poly (I:C). Cells were incubated for 
a further 16 hrs before harvested and assayed for β-galactosidase and luciferase 
activities as described in Materials and Methods. Luciferase activity was normalised 
to β-galactosidase activity generating a relative luciferase activity (RLA) value for 
each sample as described in Materials and Methods.  
 
(A) Histogram of the fold changes in RLA of mock transfected cells and cells co-
transfected with pLuc-IFNβ, pcDNA3.1-HisB::lacZ and the empty vector pcDNA3.1 
in the presence and absence of the stimulation of Poly (I:C).  
 
(B) Histogram of IFNβ promoter activity of cells co-transfected with pLuc-IFNβ, 
pcDNA3.1-HisB::lacZ and an empty vector or the pcDNA3.1-parental NSP1 
plasmids. The RLA values were expressed as a ratio of the values obtained from the 
cells transfected with the NSP1 plasmids to those from cells transfected with the 
empty pcDNA3.1 vector as described in Materials and Methods. Error bars indicate 
the approximate upper and lower 95% of confidence limits (upper and lower 95% 
limit = mean value + standard error x 1.96) from the mean value.
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One possible explanation for the failure of the transfected parental NSP1 genes to 
affect reporter gene expression from the IFNβ reporter was that insufficient NSP1 
protein was being expressed in the assay. To investigate this possibility, these 
reporter assays were carried out in which NSP1 was being expressed under ideal 
conditions i.e: following virus infection. The control employed in these experiments 
was p9Δ5 virus which had been shown in previous studies (Xu et al., 1994) to carry a 
deletion in gene 5 (NSP1) that precludes expression of anything beyond the amino-
terminal third of NSP1 which is not stable in infected cells and therefore would not 
be expected to influence IFNβ expression. 
 
293HEK cells were mock infected or infected with rotaviruses p9Δ5, UKtc or OSU 
at an m.o.i of 3. 40 mins later, virus inoculum was removed, replaced by fresh 
serum-free medium. After 8 hrs of incubation, cells were mock transfected or 
transfected with poly (I:C), and cells were harvested after 16 hrs of incubation. The 
lysates were analysed for firefly luciferase activity.  
 
Cells infected with p9Δ5 showed a similar promoter activity compared with the 
mock-infected cells. On the other hand, cells infected with UKtc showed around 40% 
reduction in the IFNβ promoter activity compared with the mock-infected cells, 
nevertheless, cells infected with OSU showed no significant effect on the promoter 
activity compared with the control as the error bar was very significant (Figure 5.2). 
This result indicated that viral NSP1 proteins expressed from UKtc was able to 
induce a decreased IFNβ promoter activity in infected 293 cells, suggesting the 
failure of the pcDNA3.1-NSP1 plasmids to achieve the same effect might due to 
insufficient expression of NSP1 proteins. 
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Figure 5.2 Studies of IFNβ reporter activity in 293 cells infected with selected 
rotaviruses. 
2 x 10
5
 293 cells were co-transfected with 225ng pLuc-IFNβ, 25ng pcDNA3.1-
HisB::lacZ. 24 hrs later cells were mock-infected or infected with p9Δ5, UKtc and 
OSU at an m.o.i of 3. 40 mins later virus inoculum were removed and free medium 
was replaced. 8 hrs after the incubation, cells were transfected with 1µg of poly (I:C) 
and were harvested and assayed after a further 16 hrs of incubation as described in 
Materials and Methods. The luciferase activity which was normalised to β-
galactosidase activity generating a RLA value for each sample whereas RLAs were 
expressed as a ratio of the values from the experimental samples to the values from 
mock infected cells. Error bars indicate the approximate upper and lower 95% of 
confidence limits (upper and lower 95% limit = mean value + standard error x 1.96) 
from the mean value. 
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5.3 pCI-neo-NSP1 constructs can cause reduction of IFNβ promoter activity  
 
Despite the fact that the co-immunoprecipitation employing parental NSP1 genes 
cloned in a pCI-neo vector failed to show any convincible precipitation (Chapter 4), 
the biological function of these two parental NSP1 constructs were tested in the 
reporter assay to examine if the proteins expressed in this particular vector could 
achieve a sufficient amount so as to affect the IFNβ promoter activity. Similar 
transfection procedures were carried out. 293HEK cells were co-transfected with a 
combination of an IFNβ promoter reporter plasmid and the two parental pCI-neo-
NSP1 genes or an empty vector plasmid together with the CMV-β-Gal control 
plasmid. 24 hrs after transfection the cells were mock transfected or transfected with 
poly (I:C), 16 hrs later cells were harvested and the lysates were analysed for firefly 
luciferase activity (Figure 5.3). 
 
Cells transfected with pCI-neo-UKtcNSP1 showed a ~60% reduction of IFNβ 
promoter activity compared with the ones transfected with the empty pCI-neo vector, 
whereas cells transfected with pCI-neo-OSUNSP1 showed more or less similar effect 
on the IFNβ promoter activity as the ones transfected with the empty vector. This 
result was expected as the reduction of IFNβ promoter activity might be caused by 
the reduced expression of IRF3 protein which can be degraded by UKtcNSP1 but not 
OSUNSP1 based on previously published literature (Graff et al., 2002, 2007). 
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Figure 5.3 Studies of IFNβ reporter activities in 293 cells transfected with 
parental pCI-neo-NSP1 plasmids.  
2 x 10
5
 293 cells were co-transfected with 225ng pLuc-IFNβ, 25ng pcDNA3.1-
HisB::lacZ and 250ng pCI-neo vector, pCI-neo-UKtcNSP1 or pCI-neo-OSUNSOP1 
individually. 24 hrs later cells were transfected with 1µg of poly (I:C). All cells were 
harvested after 16 hrs and β-glactosidase and luciferase activity of cell lysates were 
measured as described in Materials and Methods. Luciferase activity was normalised 
to β-galactosidase activity generating an RLA value for each sample as described in 
Materials and Methods. These values were then expressed as a ratio to those from 
cells transfected with pCI-neo vector. Error bars indicate the approximate upper and 
lower 95% of confidence limits (upper and lower 95% limit = mean value + standard 
error x 1.96) from the mean value. 
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5.4  Analysis of protein expression of all NSP1 hybrid genes in pCI-neo 
vector 
 
As one of the parental pCI-neo-NSP1 genes plasmids showed some functional effect 
in the reporter assay, suggesting that NSP1 in this particular vector can be expressed 
to a sufficient level for exhibiting biological functions in this assay. Therefore, the 
collection of all NSP1 hybrid genes constructed (Chapter 3) was subsequently cloned 
into this pCI-neo vector, producing constructs pCI-neo-pA to pCI-neo-pL (Figure 
5.7A). In order to confirm the expression of all NSP1 hybrid cDNAs, two 
independent experiments were conducted.  
 
An in-vitro coupled transcription translation system with labelled 
35
S methionine was 
used to demonstrate the expression of all NSP1 hybrid cDNAs in pCI-neo (Figure 
5.4). The positive control plasmid encoding the T7 luciferase showed a strong band 
at the expected position around 61kDa and the empty vector (EV) showed no 
obvious band as expected. Among all the NSP1 cDNA constructs, apart from the 
parental OSUNSP1 plasmid, all the rest showed a band at around 55kDa indicating 
that they were able to express NSP1 proteins. The pCI-neo-OSUNSP1 plasmid was 
tested twice and the same observation was revealed confirming the absence of the 
band was not due to experimental errors. 
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Figure 5.4 Expression of NSP1 hybrid gene constructs labelled with 
35
S 
methionine analysed in in-vitro transcription translation system.  
A total volume of 15µl reaction mixture including 10µl of Quick Master Mix, 3µl of 
35
S (3µCi) and 2µl of DNA plasmid was used for each sample. The reaction mixture 
was incubated at 30ºC for 90 minutes followed by analysis on SDS-PAGE. The gel 
was fixed in 25% of methanol and 7% of acidic acid overnight before drying in a gel 
dryer. The gel containing the radiolabelled 
35
S was then exposed and developed as 
described in Materials and Methods. EV indicates the pCI-neo vector and the 
positive control indicates the T7 Luciferase Control DNA included in the assay kit, 
the expected protein position is also indicated. The marker on the left hand side of 
the figure is shown in kDa. 
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The pCI-neo-OSUNSP1 was therefore re-constructed by re-generating the RE sites 
for cloning OSUNSP1 into pCI-neo vector followed by subsequent digestion and 
ligation. Another independent method: reverse-transcription (RT) PCR was used 
subsequently to test the ability of mRNA production for this newly constructed pCI-
neo-OSUNSP1 plasmid and all the rest NSP1 hybrid constructs tested in the coupled 
transcription translation system previously. 293HEK cells were transfected with an 
empty vector or the NSP1 gene plasmids individually, 24 hrs post transfection, 
cytoplasmic RNA was harvested and reverse-transcribed into cDNA. The reaction 
involved the use of a common forward primer just upstream the chimeric intron in 
the vector pCI-neo and individual reverse primers for either UKtcNSP1 or 
OSUNSP1 depending on the hybrid constructs (Figure 5.5A). The expected PCR 
product from the plasmid was around 420bps; as the size of the intron is 132bps, 
therefore a 300bp sequence was expected for amplification from cDNA after the 
intron has been cleaved (Figure 5.5B). As a positive control for RNA quality, actin 
primers were utilized in this reaction and showed similar amount of actin expression 
across all transfected cells. In addition, PCR samples with no reverse transcriptase 
added were also included as the negative control. The results revealed that all the 
NSP1 constructs were able to produce mRNA and these constructs including the 
newly constructed parental OSUNSP1 plasmid were used in all the subsequent 
assays presented in this chapter.   
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Figure 5.5 mRNA expressions analysis of all NSP1 constructs by RT-PCR. 
  
3.6 x 10
5
 293 cells were transfected with an empty vector or an NSP1 gene plasmid, 
24 hrs later cytoplasmic RNA was extracted and analysed by RT-PCR as described 
in Materials and Methods.  
 
(A) Schematic illustration of the respective primers used in this RT-PCR analysis.  
 
(B) 1µg of total cytoplasmic RNA was used as template for reverse transcriptation 
using 5’ common forward primer and 3’ reverse primers specific for UKtcNSP1 and 
OSUNSP1 in the presence (+RT) or absence (-RT) of reverse transcriptase. 2.5µl of 
the resulting cDNA was used as template in a PCR using either actin 5’ and 3’ 
primers as a control, or the combination of the primers for NSP1. PCR products were 
separated by electrophoresis through a 1% agarose gel as described in Materials and 
Methods. The arrow indicates the expected cDNA amplification from the plasmid 
(NSP1 plasmid DNA), mRNA lacking the intron (NSP1 mRNA) or the control (actin 
mRNA). DNA sizes are indicated in bps on the left hand side of the panels.   
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5.5  Mapping of the interaction sites with different pCI-neo-NSP1 hybrids 
analysed in the reporter assay 
 
As the NSP1 hybrid genes had all been shown to be able to express proteins, the 
biological function of these hybrid genes was subsequently examined in the IFNβ 
reporter assays. There are four positive regulatory domains (PRDs I-IV) responsible 
for transcriptional activation of the IFNβ gene in its promoter sequence (Figure 5.6). 
The four PRDs can induce IFNβ promoter activity independently, PRD I and PRD III 
require the binding of IRF3 or IRF1 for function, PRD II appears to require NFκB 
whereas PRD IV requires ATF-2/c-Jun (King and Goodbourn, 1994; Qing et al., 
2004).  
 
 
 
Figure 5.6 Schematic illustration of INFβ promoter sequence including four 
PRDs. 
Four positive regulatory domains in the INFβ promoter sequence are indicated. PRD 
IV requires the binding of ATF2/c-Jun, PRD I and PRD III function via binding of 
IRFs whereas NF-κB can bind PRD II (Honda et al., 2005). 
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As IRF3 has been shown to be the target for UKtcNSP1 but not OSUNSP1 for 
degradation causing reduced level of IFNβ production, a ptk-Luciferase reporter 
plasmid containing the PRDI/III element of the IFNβ promoter responsible for IRF3 
induced IFNβ activity (kindly provided by Dr Y Ke, Peking University College of 
Oncology) was used instead of the full promoter of IFNβ to ensure higher specificity 
of the subsequent results.  
 
The 12 NSP1 hybrid constructs shown in Figure 5.7A were tested in the transfection 
based reporter assay using the PRDI/III promoter. The assay was repeated four times 
under the same conditions and the results presented in Figure 5.7B are the averaged 
values from these experiments. Consistent with the results obtained previously with 
the full-length IFNβ promoter, parental UKtcNSP1 caused a >75% significant 
reduction in PRDI/III activity whereas promoter activity was not changed 
significantly in OSUNSP1 transfected cells (~10% reduction observed). Turning next 
to the NSP1 hybrid genes, constructs D and H reduced PRDI/III promoter activity by 
around 70% and 80% compared to that seen in control transfections (Figure 5.7B). 
However, the remaining hybrids all showed less than a 50% reduction in PRDI/III 
activity. Student’s T-test analysis was performed on these data to compare them 
against both the parental UKtcNSP1 and OSUNSP1 controls (Table 5.1). Table 5.1 
shows that constructs D and H had a statistically significant difference from 
OSUNSP1, whereas constructs F and L exhibited a significant difference from both 
UKtcNSP1 and OSUNSP1. This suggests that the C-terminal region of UKtcNSP1 is 
responsible for repressing IRF3 induced increase in IFNβ activity but that the last 
135 amino acids in the C-terminal region of UKtcNSP1 are not sufficient to fully 
repress activation of the PRDI/III promoter triggered by Poly (I:C). The other hybrid 
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gene constructs all showed more significant difference from UKtcNSP1 suggesting 
that similar to the OSUNSP1, the rest of the NSP1 hybrid proteins were unable to 
repress the PRDI/III promoter activity.    
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Figure 5.7 Studies of PRDI/III promoter activities in 293 cells transfected with 
NSP1 hybrid gene constructs. 
 
(A) Schematic diagram of the NSP1 hybrid constructs tested in the experiments. 
Six pairs of NSP1 hybrid constructs are shown with the restriction enzymes sites 
used to create the hybrids being indicated for each pair.  
 
(B) Histogram of effect of NSP1 hybrid genes on Poly (I:C) induced PRDI/III 
IFNβ promoter activity. 
2 x 10
5
 293 cells were co-transfected with 225ng pPRDI/III-Luc, 25ng pcDNA3.1-
HisB::lacZ and 250ng of either control empty vector, or individual NSP1 hybrid 
plasmids. 24 hours later cells were transfected with 1µg of poly (I:C). After a further 
16 hrs of incubation, cells were harvested and β-glactosidase and luciferase activity 
of cell lysates were measured as described in Materials and Methods. Luciferase 
activity was normalised to β-galactosidase activity generating an RLA value for each 
sample. Error bars indicate the approximate upper and lower 95% of confidence 
limits (upper and lower 95% limit = mean value + standard error x 1.96) from the 
mean value. 
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Construct P against UKtcNSP1 P against OSUNSP1
A 0.000139636 0.019389431
B 1.97663E-07 0.306269522
C 4.8261E-06 0.279225009
D 0.098884985 1.08875E-07
E 0.000205899 0.211828681
F 0.000325347 0.000689642
G 4.4076E-07 3.81715E-05
H 0.511396336 4.94575E-09
I 0.000950966 0.094249425
J 0.00224831 0.000606755
K 0.004056097 0.017896454
L 1.3848E-05 1.21841E-05  
 
 
Table 5.1 The P value of each NSP1 hybrid construct against parental UKtc and 
OSU NSP1 constructs. 
By applying student’s T-test to the data shown in Figure 5.7B, the P value of each 
NSP1 hybrid construct against both parental NSP1 constructs is generated. The 
Bonferroni corrected p value (0.05/sample size = 0.004167) is used to adjust the data. 
The ones indicated in red are the two constructs showing significant difference from 
OSUNSP1, i.e: constructs D and H. The ones indicated in blue are the constructs 
showing significant difference from UKtcNSP1, i.e: constructs A, B, C, E, I and K. 
The ones indicated in purple are the constructs showing significant difference from 
both UKtc and OSU NSP1s, i.e: constructs F, G, J and L. 
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5.6 The effect of NSP1 hybrid genes on NFκB activity 
 
The NSP1 of the porcine OSU strain has previously been shown to target and 
degrade β-TrCP, a component of the E3 ligase SCF β-TrCP, responsible for degrading 
inhibitor κB which in turn releases NFκB to travel into the nucleus and activate the 
IFN response. The effect of this increased degradation of β-TrCP should therefore be 
able to reduce activation of the IFNβ promoter. In order to test if this is also the case 
for some of the NSP1 hybrids. A Luciferase reporter plasmid in which the reporter 
expression was under the control of the NFκB regulated Concanavalin A promoter 
(Kindly provided Dr A Macdonald) (Mankouri et al., 2010) was used. As the 
parental OSUNSP1 should promote the degradation of β-TrCP, co-transfection of the 
parental OSUNSP1 plasmid should reduce reporter gene expression.  
 
In this particular reporter assay, Poly (I:C) was not introduced due to the results 
obtained by others in our lab (Chen’s unpublished observations) that this reporter 
plasmid did not respond to stimulation caused by Poly(I:C) in 293HEK cells. There 
was little effect on ConA promoter activity in cells co-transfected with OSUNSP1 
(Figure 5.8). The whole of the C-terminal region and part of the zing finger motif 
from the UKtcNSP1 (construct D) showed some reduction in reporter gene 
expression i.e: ConA promoter activity. Given the sizes of the error bar indicated in 
Figure 5.8, no other construct has demonstrated a significant difference in the 
promoter activity compared with the control.  
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Figure 5.8 NFκB ConA promoter activities of NSP1 hybrid constructs.  
2 x 10
5
 293 cells were co-transfected with 225ng pConA-Luc, 25ng pcDNA3.1-
HisB::lacZ and 250ng of either control empty vector, or individual NSP1 hybrid 
plasmids. 24 hours later cells were harvested and β-glactosidase and luciferase 
activity of cell lysates were measured as described in Materials and Methods. RLA 
was calculated as previously described. Error bars indicate the approximate upper 
and lower 95% of confidence limits (upper and lower 95% limit = mean value + 
standard error x 1.96) from the mean value. 
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5.7 NSP1 induced degradation of IRF3 and/or β-TrCP  
 
IRF3 is a constitutively expressed cellular protein and this has meant that 
demonstrating that NSP1 affects its level in cells, whilst straightforward in virus 
infected cells where all cells can be infected synchronously, has met with problems 
of consistency in transfected cells where NSP1 will only be expressed by a fraction 
of the cell population. To overcome this problem with transfected cells a plasmid 
construct was generated which expresses a tagged version of IRF3. To do this the 
IRF3 gene was inserted into a pcDNA3 vector containing 3 HA tags (Figure 5.9A). 
This construct allows the NSP1 induced degradation of IRF3 to be assayed using 
anti-HA antibodies. The final pcDNA3-IRF3 construct was sequenced with 
appropriate forward and reverse primers (Table 2.1.7) to confirm that the HA tags 
were in frame downsteam of IRF3 (Figure 5.9B). The β-TrCP plasmid available for 
this study was already tagged with HA and consequently anti-HA antibody could be 
used for detecting both of the cellular proteins being analysed.  
 
Western blot analysis of 293HEK cells transfected with NSP1 hybrid plasmids and 
IRF3 or β-TrCP in the presence or absence of the proteasome inhibitor MG132 
revealed the different abilities of these hybrid NSP1s to degrade the corresponding 
cellular proteins (Figure 5.10). For this analysis 293HEK cells were transfected in 
duplicates with either empty vector or individual NSP1 hybrid plasmids, 40 hrs later, 
one set of the cells were treated with 50µM of MG132 for a further 8 hrs, cell lysates 
were harvested and analysed in SDS-PAGE followed by probing for IRF3 or β-TrCP 
using anti-HA antibody.  
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Figure 5.9 Construction of HA-tagged pcDNA3-IRF3 plasmid. 
(A). Schematic illustration of the pcDNA3 vector with the Kpn I and EcoR I 
restriction enzyme sites used for insertion of the IRF3 gene sequence highlighted. 
The position of the three HA tags is also indicated on the vector map.   
 
(B). Sequencing trace confirming the correct insertion of the IRF3 gene sequence, 
and that the HA tags are in frame with the IRF3 coding sequence.  
 
 
Figure 5.10A shows that in the absence of MG132, the level of IRF3 in UKtcNSP1 
transfected cells was reduced significantly compared to vector only control whereas 
in the presence of MG132, the level of IRF3 was similar to that in the control 
transfection. This contrasted with the result seen for cells transfected with parental 
OSUNSP1 where the level of IRF3 showed little change in the presence or absence 
of MG132. In agreement with the results obtained in transfections with the luciferase 
reporter plasmid, the hybrid constructs D and H showed similar effect to the 
UKtcNSP1 parental gene, with IRF3 being degraded significantly in the absence of 
MG132 compared to when proteasomal based degradation was blocked with MG132. 
Also consistent with the luciferase reporter assay, the remaining hybrid genes had 
little effect on IRF3 expression. These results showed that the ability of NSP1 to 
promote IRF3 degradation co-incided with its effects on activation of the PRDI/III 
promoter in reporter gene assays. Furthermore the fact that only the D and H hybrids 
had a similar effect to the parental UKtcNSP1 in these IRF3 degradation assays 
suggests that the C-terminal half of the NSP1 protein is important for this function, 
although it is important to note that neither hybrid F or hybrid L which carried 
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respectively the C-terminal 88 and 135 amino acids of the UKtcNSP1 gene were able 
to mediate proteasome dependent IRF3 degradation.    
 
The results for similar degradation assays carried out on HA tagged β-TrCP are 
shown in Figure 5.10B. The parental OSUNSP1 was, as expected from previously 
published results (Graff et al., 2009; Arnold and Patton, 2011), able to stimulate 
proteasomally based degradation of β-TrCP. However in contrast to what has been 
seen previously the UKtc NSP1 was also able to promote β-TrCP degradation. In 
addition the C, D, G and H hybrid gene constructs also stimulated β-TrCP 
degradation in the absence of the MG132 proteasome inhibitor.  
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Figure 5.10 Testing of parental UKtc and OSU NSP1 genes and hybrid 
constructs between these two genes in proteasomal based degradation assays of 
IRF3 and β-TrCP.  
 
(A) Degradation studies of IRF3 employing parental UKtc and OSU NSP1 genes 
and the hybrid constructs. 
293HEK cells were co-transfected with HA-IRF3 together with either an empty 
vector control or a NSP1 gene plasmid. 40 hrs after transfection, the medium was 
replaced by either fresh serum-containing medium or the serum-containing medium 
with 50µM of MG132, cells were incubated for a further 8 hrs at 37ºC and harvested 
as described in Materials and Methods. Cell lysates were analysed on SDS-PAGE 
followed by western blot as described in Materials and Methods. The blots were 
probed using anti-HA antibody for IRF3 and anti- β-actin was used for detection of 
β-actin as a positive control. The presence or absence of proteasome inhibitor 
MG132 is indicated as (+) or (-) respectively. Protein molecular weights in kDa are 
indicated on the right hand side of the blots.  
 
(B) Degradation studies of β-TrCP employing parental UKtc and OSU NSP1 
genes and the hybrid constructs.  
293HEK cells were co-transfected with HA- β-TrCP together with either an empty 
vector control or a NSP1 gene plasmid. 40 hrs after transfection, the medium was 
replaced by either fresh serum-containing medium or the serum-containing medium 
with 50µM of MG132, cells were incubated for a further 8 hrs at 37ºC and harvested 
as described in Materials and Methods. Cell lysates were analysed on SDS-PAGE 
followed by western blot as described in Materials and Methods. The blots were 
probed using anti-HA antibody for β-TrCP and anti- β-actin was used for detection 
of β-actin as a positive control. The presence or absence of proteasome inhibitor 
MG132 is indicated as (+) or (-) respectively. Protein molecular weights in kDa are 
indicated on the right hand side of the blots.  
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5.8 Discussion 
 
The aim of the analysis described in this chapter was to investigate the biological 
function of the hybrid NSP1 genes generated in this study. The two parental genes 
were cloned initially into pcDNA3.1 vector, however when co-transfected with 
reporter gene under the control of the IFNβ promoter, they had little effect on 
reporter gene expression. When analysed using virus infected cells, the promoter 
activity was reduced significantly with UKtc infected cells, whereas in cells infected 
with OSU or p9Δ5, the promoter activity showed similar pattern with the mock 
infected cells. However, the origins of these virus strains used are all different. p9Δ5 
encoding the truncated form of NSP1 is from the feline origin, whereas UKtc and 
OSU are originated from bovine and porcine respectively. Therefore, ideally, based 
on the ability of rotaviruses to undergo reassortment, reassortant viruses containing 
either the UKtc or the OSU genome background with truncated NSP1 genes should 
be used for this analysis for increased comparability.      
 
The two parental genes were then cloned into the pCI-neo expression vector and the 
UKtcNSP1 gene cloned in this vector was able to produce a significant reduction in 
IFNβ promoter activity, in agreement with the previously published literature 
(Arnold and Patton, 2011). Consequently all of the NSP1 hybrid genes were sub-
cloned into the pCI-neo vector for functional analysis.  
 
A cell-free transcription/translation system was used for studying protein expression 
for the pCI-neo-NSP1 hybrid constructs and the expressed protein was detected using 
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incorporated 
35
S methionine labelling. This system is a convenient single-tube 
reaction for a coupled eukaryotic transcription-translation system and the reaction 
mixture is designed to give the highest expression for most expression constructs. 
With the exception of the parental OSUNSP1, all the remaining constructs tested 
including the positive control construct showed the expected protein band indicating 
the expression of proteins from these constructs. This confirmed that these hybrid 
proteins can be expressed to a detectable level and the reporter assay employing the 
pCI-neo-UKtcNSP1 has given a true reduction of promoter activity caused by 
UKtcNSP1 protein. Unfortunately, the expression of the parental pCI-neo-OSUNSP1 
construct could not be detected in this system; therefore this particular plasmid was 
re-constructed by re-generating the corresponding restriction enzyme sites on OSU 
NSP1 sequence and followed by subsequent digestion and ligation into the vector. 
Due to time limitation, this newly constructed plasmid was not tested in this 
transcription translation system. Instead, this newly constructed pCI-neo-OSUNSP1 
together with all the rest of the NSP1 gene constructs were tested in another assay to 
complement the transcription translation system assay. All of the NSP1 hybrid 
constructs including the newly-reconstructed pCI-neo-OSUNSP1 were tested in RT-
PCR and all of them showed the expected mRNA products indicating that all these 
constructs were able to make mRNA. The subsequent degradation studies also 
showed that at least some of the constructs were expressed at certain levels to induce 
the degradation of the target proteins.  
 
The functions of these NSP1 hybrids were tested in a reporter assay and the 
correlation between interaction and degradation was studied in the degradation 
investigations. The reporter plasmid initially used contains the full-length IFNβ 
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enhancer including four overlapping positive regulatory domains (PRDs) which 
contribute to the magnitude of the induction, and when multimerized, each PRD can 
induce the transcription upon a synthetic promoter independently of other IFNβ 
promoter sequences (King and Goodbourn, 1994; Sato et al., 1998; Du et al., 1992). 
Several members of the IRF family including IRF3 have been shown to bind PRD 
I/III elements (Escalanete et al., 1998; Fujii et al., 1999), NFκB p50/p65 binds PRD 
II and ATF-2/c-Jun binds to PRD IV (Berkowitz et al., 2002; Panne et al., 2004). 
Therefore, in order to increase the specificity of the reporter assay, the reporter 
plasmid employed in the assay was changed to a PRD I/III element containing 
promoter plasmid, ensuring the inducible promoter activity was caused by IRF3, 
which was expected to be degraded in cells transfected with some NSP1 constructs. 
Similarly, the ConA plasmid driven by NFκB was chosen to be used as OSUNSP1 
was expected to affect NFκB induced INFβ production.  
 
The results from the reporter assay employing PRD I/III promoter plasmid revealed 
that apart from the parental UKtcNSP1 construct, only two other constructs (D and 
H) containing the entire C-terminal region of UKtcNSP1 showed similar level of 
reduction on the promoter activity. However, in the assay employing ConA plasmid, 
no significant activity reduction was observed in any of the construct. It has to be 
noted that in the particular assay employing ConA reporter plasmid, Poly (I:C) was 
not included as it has been shown to have no significant effect on the reporter 
activity. This might be one of the reasons that most of the NSP1 constructs had 
shown no significant effect on the reporter activity. Another possible reason for this 
might be the E1A protein constitutively expressed in 293 cells has inhibited the 
NFκB pathway therefore the induction could not be detected (Cook et al., 2002). The 
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IRF3 degradation studies carried out subsequently were in agreement with the 
reporter assay results. The constructs showing most of the degradation in the absence 
of a proteasome inhibitor were the ones containing the entire C-terminal region of the 
UKtcNSP1 protein. Although it has been demonstrated by others that the IRF3 
binding domain located in the last 165 amino acids of NSP1, the results from this 
study indicated that constructs containing the last 135 or 88 amino acids of the 
UKtcNSP1 failed to show significant reduction of promoter activity in the reporter 
assay or degradation of IRF3, indicating that the sequence between 165 and 135 from 
the C-terminal of UKtcNSP1 are essential for IRF3 binding activity. 
 
Interestingly, the results observed from the β-TrCP degradation were different from 
the published literature. The OSUNSP1 transfected cells showed significant 
degradation of β-TrCP in the absence of proteasome inhibitor as expected, 
UKtcNSP1 also showed a substantial degradation of β-TrCP, among the hybrid 
constructs, two reciprocal pairs of constructs showed similar observation supporting 
the ability of UKtcNSP1 to degrade β-TrCP. One possible reason might be that the 
interaction site responsible for β-TrCP is close to the IRF3 binding site although the 
degradation studies were not analysed quantitatively therefore the exact amount of 
protein degraded was not able to be analysed.  
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Viral infection of most cells can induce the secretion of type I interferon which 
subsequently establishes an antiviral state in surrounding cells that can limit the 
spread of infection. Therefore viruses have evolved diverse mechanisms to interfere 
with this process and variation in the efficiency of this interference is a major factor 
in determining the differences in viral pathogenicity. Rotaviruses, which are of 
interest because they account for up to 50% of diarrheal illnesses worldwide in 
infants and young children and are responsible for more than half million deaths in 
this age group annually (Estes and Kapikian, 2007). Rotaviruses are able to evade 
this host antiviral response via interactions between their non-structural protein 
NSP1 and certain host cellular proteins. A better understanding of the mechanism of 
the interactions may provide insights that lead to novel strategies for antiviral 
research and live-attenuated vaccine development.  
 
At the start of this project, published data had shown that some rotavirus NSP1 
proteins target IRF3, a key transcription factor for IFN expression. Subsequently, one 
was found to target β-TrCP, which indirectly regulates a second important factor in 
this process- NFκB. In both cases, this limits subsequent IFNβ expression (Chapter 
1). Given this information, 12 NSP1 hybrid genes were constructed for analysis in 
this project, each containing sequences from UKtc (bovine rotavirus strain) and OSU 
(porcine rotavirus strain) NSP1, by swapping sequence equivalent gene segments in 
plasmid expression constructs (Chapter 3). These were intended for use in a range of 
key assays to map the sites on viral NSP1 proteins responsible for interacting with 
and promoting the degradation of cellular proteins involved in the host’s innate 
immune system. However, the cloning process took much longer than planned. There 
were problems with generating the restriction enzyme sites within both NSP1 
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sequences, and with expressing the proteins at a detectable amount in cell culture. 
Different approaches were attempted to address these problems including adding a 
FLAG tag for better antibody detection and changing the expression vector; the 
mammalian two-hybrid vectors containing the SV40 promoter was changed to 
pCDNA3.1 vector containing a more powerful CMV promoter and then the 
expression cassette was changed to use pCI-neo vector, the one containing an intron 
upstream of the inserted cDNA (Chapter 4 and Chapter 5).  
 
In retrospect, other strategies for obtaining these hybrid NSP1 genes may have been 
more efficient. For example, domain swaps for the two parental NSP1 genes could be 
achieved via a two-step PCR approach with separated primer sets. However, a 
significant time commitment had been made to the restriction enzyme site approach 
and so it was decided to carry on with it.  
 
A mammalian two-hybrid system was utilized to determine if direct protein-protein 
interactions occurred between NSP1 and cellular proteins IRF3 and β-TrCP in cells 
transfected with parental NSP1 plasmid constructs (Chapter 4). The assays 
investigating potential interactions between UKtcNSP1, IRF3 and OSUNSP1, β-
TrCP all yielded negative results. These results seemed to suggest that there might 
not be direct interactions between NSP1 and the specific cellular proteins. However, 
it had been shown in a yeast two-hybrid assay system that direct interactions of 
UKtcNSP1 with IRF3 could be observed (Goodbourn et al unpublished results). One 
obvious possibility was that the proteins might not be expressed correctly from some 
or all of the plasmids employed in Chapter 4. Anti-Gal4 and anti-VP16 antibodies, 
which should detect the fusion protein domains expressed from these constructs both 
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failed to detect any protein expression from these constructs in those mammalian 
hybrid assay vectors. Nevertheless, these expression studies also revealed negative 
results for the positive control plasmids of the mammalian two-hybrid assay, which 
had shown clear evidence of protein-protein interaction in the assay system. 
Therefore the proteins might only be expressed in very limited amounts from the 
experimental constructs, such that the antibodies were not able to pick up the 
expression, or there may indeed have been a failure to express functional levels of 
proteins from one or more of the constructs.  
 
NSP1 is normally expressed in the cytoplasm in rotavirus-infected host cells by using 
the viral polymerase. A possible reason why NSP1 cDNA did not give detectable 
expression in tissue culture cells following transfection of the plasmid might be the 
different transcription mechanisms employed by the viral genome RNA and cDNA. 
Since the rotavirus gene sequence is not normally expressed in the nucleus, it is 
never exposed to the RNA splicing machinery. RNA splicing at cryptic, unintended 
splice signals in the cDNA, might therefore cause disturbance to expression from the 
NSP1 cDNA during transcription and therefore inhibit the expression of NSP1 
protein. Alternatively, it has been shown that RNA splicing from an artificial intron 
can increase protein expression from cDNA in mammalian cells significantly (Huang 
and Gorman, 1990). In their studies, two vectors which differ only in the presence or 
absence of an intron upstream to the 5’-untranslated sequence of the fusion proteins 
were compared. The results revealed that under transient transfection conditions, 
expression with the intron-containing vector in four mammalian cell lines: 293 
(human embryonic kidney cells), Hela (cervical cancer cells), CV-1 (African green 
monkey kidney cells) and CHO (Chinese hamster ovary cells) all showed different 
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degrees of increase in protein synthesis and cytoplasmic RNA production compared 
with the expression in the intron-lacking vector (Huang and Gorman, 1990). In 
another study, it has also been shown that some sequences including β-globin cDNA 
exhibit a 400-fold increase in expression from the addition of an intron for splicing 
(Buchman and Berg, 1988), indicating that the introduction of an intron is able to 
maximize the gene expression in mammalian cells. This is thought to be due to the 
splicing event tagging the mRNA with proteins that promote mRNA export from the 
nucleus and/or its stability in the cytoplasm.  
 
Consequently, the parental and hybrid NSP1 gene sequences were cloned into pCI-
neo, a vector containing a chimeric intron upstream of the inserted cDNA sequences 
to prevent utilization of possible cryptic 5’ –donor splice sites within the NSP1 
cDNA sequence and to improve expression of full length mRNA (Chapter 4 and 
Chapter 5). In order to test for expression of NSP1 proteins from pCI-neo vector, a 
FLAG-tag was inserted at the N-terminal of the parental NSP1 gene sequences. 
However, this addition did not allow detection of expression of the parental NSP1 
proteins any better than from the other vectors used. Therefore the proteins might 
still be expressed only at a very limited level so that they were not detectable. To 
avoid any issues with splicing and to give the most sensitive detection of protein, a 
coupled transcription and translation system with labelled 
35
S methionine was used to 
analyse the expression of all the NSP1 hybrid proteins in vitro; and positive results 
were obtained with clear expression from all the hybrid NSP1 proteins and the UKtc 
parental NSP1 protein. After the re-construction of the OSU parental NSP1 plasmid, 
another assay was carried out to complement the couple transcription and translation 
system. By applying reverse transcriptase PCR using a common forward primer 
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starting upstream of the chimeric intron in the pCI-neo vector and a reverse primer 
for UKtc and OSU NSP1 respectively, all the constructs tested including the newly 
constructed OSU parental NSP1 showed the production of mRNA (Chapter 5). This 
RNA expression and processing was occurring as expected. Thus all these NSP1 
constructs in pCI-neo vector were likely able to produce proteins.  
 
Having obtained the evidence that the NSP1 proteins could be expressed, the 
function of these NSP1 hybrid constructs was then determined. The IFNβ promoter 
reporter assay applying these pCI-neo-NSP1 hybrid constructs showed evidence that 
these proteins were expressed in sufficient levels such that to have an impact on the 
promoter activity, i.e: functionally significant amount of protein were present. The 
results included analysis of these NSP1 hybrids utilizing either a full-length IFNβ 
promoter, a sub-element of that promoter: PRD I/III, which is activated specifically 
by IRF3-induced IFNβ production or a ConA promoter element that detects NFκB 
activity, in each case to test whether the NSP1 hybrid construct could inhibit 
induction of the promoter by a synthetic inducer of IFN that activates signalling via 
IRF3 and NFκB. Out of the 12 different NSP1 hybrids, constructs D and H (Figure 
3.9/5.6A) containing the last 430 and 460 amino acids of the UKtc NSP1 
respectively, showed similar level of reduction of PRDI/III promoter activity 
compared with the parental UKtcNSP1 construct. This result agreed with the 
previous finding that the binding site for IRF3 in NSP1 is located at the C-terminal 
part of the NSP1. However, results from other NSP1 constructs containing smaller 
parts of the C-terminal region from UKtc NSP1 sequence, such as constructs A, L 
and F which contain the last 135 amino acids or last 88 amino acids from UKtcNSP1 
gene sequence, indicated that these amino acid sequences from UKtc NSP1 were not 
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sufficient to impact on the level of IRF3 activity induced. Interestingly, when using 
the ConA plasmid as the reporter, OSU NSP1 did not show an obvious reduction of 
the ConA promoter activity although, based on previous findings, OSU NSP1 should 
be able to reduce NFκB activity due to its interaction with β-TrCP. None of the 
constructs showed significant reduction of the ConA promoter activity. This might 
suggest that the reporter assay using this specific promoter was not sensitive enough 
to test the impact caused by the different NSP1 hybrid constructs. This might be due 
to the reason that the NFκB response could be inhibited by Adenoviral E1A protein 
expressed in 293 cells (Janaswami et al., 1992; Shao et al., 2001; Cook et al., 2002).    
 
One of the expected reasons for the reduced levels of induction of IFNβ promoter in 
the presence of NSP1 was the degradation of IRF3 or/and β-TrCP caused by NSP1 
proteins (Graff et al., 2002; Barro and Patton, 2005; Graff et al., 2009). To 
investigate whether the observed reduced induction of IFNβ by certain NSP1s 
correlated with the degradation of the corresponding cellular proteins, studies for 
cellular protein degradation were carried out in the presence or absence of the 
proteasome inhibitor MG132. The IRF3 degradation results were in agreement with 
the PRDI/III promoter assay results, such that the parental UKtcNSP1 together with 
the constructs D and H showed significant reduction of IRF3 in the absence of 
MG132 and the level of IRF3 was restored when MG132 was added. However, in 
the case of the β-TrCP degradation study, both UKtcNSP1 and OSUNSP1 caused 
significant decreases of the level of β-TrCP which were restored in the presence of 
MG132. Although this result was different from the published observation that UKtc 
NSP1 does not cause considerable β-TrCP degradation in transfected cells (Arnold 
and Patton, 2011), it was supported by the fact that two pairs of reciprocal constructs 
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C and D (containing the last 430 aa from OSUNSP1 and UKtcNSP1 respectively), G 
and H (containing the last 460 aa from OSUNSP1 and UKtcNSP1 respectively) also 
showed reduction of transfected β-TrCP protein levels in my observation. This result 
is difficult to explain, one possible reason might be that the regions responsible for 
IRF3 and β-TrCP degradation are close and there might be a conserved region in 
both UKtc and OSU NSP1s that is important for the interactions.  
 
Take together the previous results have showed that rotavirus NSP1 has evolved 
numerous ways to antagonize the IFN-β signalling pathway by targeting IRF family 
members, β-TrCP or RIG-I depending on different virus strains (Arnold and Patton, 
2011; Qin et al., 2011). However, relevant mapping studies on the interaction sites 
for NSP1 with cellular proteins were limited to using deletion mutants of bovine 
rotavirus (B641) (Graff et al., 2002). These results identified that a binding domain 
for IRF3 was located somewhere in the C-terminal region within the last 163 amino 
acids in the tested B641 NSP1 sequence. Subsequent studies using point mutations in 
the conserved zinc domain showed that these also abolished the NSP1-IRF3 
interaction indicated the importance of this structural domain in this interaction in 
addition to the C-terminal region (Graff et al., 2002).  
 
These published data taken together with the results reported in the thesis do not give 
a clear picture of which region in NSP1 is responsible for interactions with β-TrCP. 
However the regions in NSP1 responsible for IRF3 degradation-induced reduction of 
IFNβ activity can be summarised as shown in figure 6.1.  
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Figure 6.1. Schematic of proposed structural and functional domains in 
UKtcNSP1.  
NSP1 protein consists of a RNA-binding domain (RNA-BD), a zinc binding RING 
domain (RING) and a cytoplasm localization domain (Cyto-LD) near the N-terminal 
of the protein (Hua et al., 1994b, Arnold and Patton, 2009). The IRF3-binding 
requires sequences located between amino acids 326 and 356 at the C-terminal of the 
UKtcNSP1 protein (IRF3-BD). 
 
 
 
NSP1 has been postulated to have E3 ubiquitin ligase activity based on several 
observations. Like other known E3 ubiquitin ligases, NSP1 targets its binding 
partners for degradation (Pickart et al., 2001), a RING domain structure can be found 
in both NSP1 and other E3 ligases that is important for activity (Jackson et al., 2000, 
Graff et al., 2007), and both E3 proteins and NSP1 are subjected to proteasomal 
degradation and can accumulate in cells when treated with a proteasome inhibitor 
(Piña-Vázquez et al., 2007, Graff et al., 2007). The typical RING finger has been 
defined by the consensus sequence C3HC4 in which the Cys (C) and His (H) 
represent the zinc binding residues (Joazeiro et al., 2000), whereas the RING domain 
in NSP1 proteins has been predicted to be in a C4HC3 arrangement. However, this 
variant arrangement is typical of other viral RING-containing proteins such as p28 
protein from Poxvirus and K3 protein from Kaposi sarcoma herpesvirus (Aravind et 
al., 2003; Dodd et al., 2004; Nerenberg et al., 2005). Protein polyubiquitination 
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occurs through a series of events. It starts with the transfer of the Ub moiety to an E2 
Ub-conjugating enzyme by an E1 Ub-activating enzyme, the loaded E2 then interacts 
with E3 Ub ligases which can direct the transfer of ubiquitin from the E2 onto target 
proteins. The RING domain of the E3 ligase serves as an adaptor between the E2 
ligase and the target protein. However, in the case of rotavirus NSP1, direct evidence 
supporting its function as an E3 ligase has yet to be discovered as the putative E2 
conjugase for NSP1 remains to be identified although the targeted IRF3 or/and β-
TrCP can be degraded via proteasome dependent pathway. One of the reasons for 
using hybrid NSP1 proteins in this study rather than deletion mutants (as described 
previously by others) was to maintain the important functional domains in the protein 
and to try to avoid major structural changes of the protein. 
 
There are other viral proteins that act as an E3 ubiquitin ligase which have been 
studied in more detail. For instance, herpes simplex virus type I ICP0, which has 
been reported to act as E3 ubiquitin ligases during viral infection and to target 
several cellular proteins including DNA-dependent protein kinase, components of the 
PML nuclear bodies, and centromeric proteins for proteasome-mediated degradation 
(Boutell et al., 2002; Gu and Roizman, 2003; Lilley et al., 2010). Another classic 
example of viral proteins exhibiting E3 ligase activity is the adenovirus E1b55K/ 
E4orf6 complex. It assembles with subunits of the cellular cullin 5 class of E3 
ubiquitin ligases including elongins B and C, Rbx1 and cullin 5, substitutes for their 
substrate-binding subunits in order to redirect the ubiquitin ligase activity which 
causes p53 polyubiquitination, its recognition and degradation by proteasomes 
(Pennella et al., 2010). In addition, Poxvirus p28 protein and Kaposi sarcoma 
herpesvirus K3 protein haven also been shown to exhibit E3 ligase activity (Dodd et 
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al., 2004; Nerenberg et al., 2005). Thus there is considerable precedent for NSP1 to 
be a viral ligase enzyme.  
 
All the results described in the previous chapters have set a foundation for some 
interesting avenues for rotavirus research which would have been pursued had time 
permitted. Further studies and analyse are clearly required to investigate the role of 
NSP1 in rotavirus pathogenesis in more detail. The interaction site responsible for β-
TrCP degradation remains to be understood as the results, that UKtc NSP1 can 
degrade β-TrCP, have revealed some conflicts with other published data. 
Specifically, Arnold and Patton found that the NSP1 of NCDV and UKtc were 
unable to cause degradation in cells co-transfected with β-TrCP (Arnold and Patton, 
2011). However, in direct contrast, another group demonstrated that the NSP1 from 
the bovine strain NCDV was able to cause β-TrCP degradation in cells co-transfected 
with β-TrCP (Graff et al., 2009). NCDV and UKtc show great sequence similarity in 
terms of nucleotide and amino acid, 90% and 95% respectively (Figure 3.1). 
Therefore it is not entirely surprising when the results presented in this thesis were 
observed; UKtc NSP1 showed the ability to degrade transfected β-TrCP in the 
absence of MG132 which is similar to NCDV. However, a more intense sequencing 
study comparing NSP1 sequences from rotaviruses that target a broader range of host 
species might provide more information on this matter. Regarding to the E3 ubiquitin 
ligase activity, an obvious question to be determined is the identification of the E2 
partner protein involved in this process. In addition, although the plasmid-based 
reverse genetics for rotavirus has not yet been developed, the reverse genetics using a 
recombinant vaccinia virus expressing T7 RNA polymerase has been proved to be 
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successful (Taniguchi and Komoto, 2012) which might be applied to analyse the 
function of these NSP1 hybrid proteins in vivo.  
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